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ABSTRACT 
 
The purification of monoclonal antibodies and Fab’ antibody fragments are of central 
importance to the pharmaceutical industry. In 2008, 29 new therapies based on 
such molecules were approved for the US market. Traditionally, a multistep process 
achieves purification with the majority of steps being packed bed chromatography. 
Chromatography is the major contributor to the unit operation costs in terms of initial 
capital expenditure for packing and recurrent replacement costs.  
 
When considering the demand for biopharmaceuticals, it becomes necessary to 
consider alternative process strategies to improve the economics of purification of 
such proteins. To address this issue, this thesis investigates precipitation to 
selectively isolate Fab’ or remove protein impurities to assist the initial purification 
process. The hypothesis tested was that the combination of two or more 
precipitating agents will alter the solubility profile of Fab’ or protein impurities 
through synergistic multimodal effects. This principle was investigated through 
combinations of polyethylene glycol (PEG) with ammonium sulphate, sodium citrate 
and sodium chloride at different ratios in a novel multimodal approach.  
 
A high throughput system utilising automated robotic handling was developed in 
microwells at 1 mL scale per well to enable the rapid screening of a large number of 
variables in parallel using a Design of Experiments (DoE) approach to statistically 
design studies in a two stage process, based on Quality by Design principles. 
 
In the first stage, Fab’ precipitation using PEG was investigated using a screening 
study in the form of a full two level factorial DoE to investigate a large design space. 
This was followed by a second more focused central composite face centred DoE to 
find optimal experimental conditions to deliver a high Fab’ yield and purification 
factor in the range investigated. A design space comprised of the responses 
percentage Fab’ yield and purification factor was created to give a robust region 
where Fab’ yield was ≥ 90% with a maximum purification factor of 1.7. A normal 
operating range (NOR) was defined within this design space for operational 
simplicity when working at process scale. A confirmatory run was performed within 
the NOR with PEG 12000 15% w/v pH 7.4, which delivered a Fab’ yield and 
purification factor of 93% and 1.5 respectively. 
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In the second stage, optimum conditions from the first study were used in a central 
composite face centred DoE incorporating multimodal conditions combining PEG 
with three salts from the Hofmeister series namely, ammonium sulphate, sodium 
citrate and sodium chloride. It was found that 90% Fab’ yield with a purification 
factor of 1.9 was achievable with PEG 12000 15% w/v/0.30 M sodium citrate/0.15 M 
ammonium sulphate pH 7.4. This was an improvement of 26% relative to the use of 
15% w/v PEG 12000 pH 7.4 in single mode. However an alternative precipitation 
strategy to precipitate ~20% of protein impurities whilst Fab’ remained soluble using 
PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 was proposed instead. The 
advantage of this approach at process scale is the potential ease of processing due 
to removal of a solubilisation step and the significantly reduced viscosity of the 
precipitating agent relative to that of high concentrations of PEG. It was shown that 
this system could mimic process scale, which was verified at laboratory scale (50 
mL stirred tank reactor (STR)) and pilot process scale (5 L STR). 
 
A process run through was performed using a 1 mL SP Sepharose Hi Trap pre 
packed bed column (GE Healthcare, Uppsala, Sweden) to capture Fab’ from 
homogenate (control), multimodal (PEG 12000 6.25% w/v/0.4 M sodium citrate pH 
7.4) and single mode (PEG 12000 15% w/v pH 7.4) feedstreams. The final process 
purification factor for the three feedstreams were 2.5, 4.4 and 3.5 respectively. The 
use of multimodal precipitated impurities prior to a packed bed step had improved 
process performance by a purification factor of 1.9. This underlines the importance 
of assessing the interaction of individual processing steps, and the implementation 
of appropriate scale down models as a means of achieving process parameter 
ranging understanding. The impact of which has the further potential to improve the 
longevity of chromatography resins and reducing overall downstream purification 
cost. 
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1. INTRODUCTION 
1.1 Relevance of the Project 
 
In today’s pharmaceutical industry, pipelines bursting with drug candidates have 
pushed companies to invest in novel technologies to find quicker, cheaper and more 
robust routes through process development. Biotech drugs or biologics that include 
therapeutic proteins present new challenges, opportunities and options for 
optimising process development. Over the past decade, monoclonal antibodies 
(mAbs) synthesised by an animal in response to a foreign species, an antigen, have 
been responsible for several advances in the treatment of infectious diseases, 
cancer and autoimmune diseases (Farid 2006). They are increasingly accounting 
for a larger share of the pharmaceutical market. Monoclonal antibodies currently 
represent the second largest single category of biopharmaceutical substances 
under investigation as therapeutic drugs (Farid 2006). Forecasting firm 
EvaluatePharma predict that six of the top ten drugs in 2014 will be biologics. In 
contrast in 2008 only three biologics were in the list of top ten drugs, and not only 
will biotech drugs make up the majority of the bestsellers, EvaluatePharma predict 
that half of the top 100 drugs in 2014 will be biologics (Wenger 2010). The 
therapeutic protein sector has observed exponential growth in recent years due to 
the success of mAbs (Hood et al., 2002, Low et al., 2007), (figure 1.1). In 2008, 
there were 29 mAbs approved in the US market (Aggarwal 2009) with a projected 
growth of 14% per year through to 2012 (Reichert 2008). Developing and validating 
a process requires time and money, which is often restricted to unproven 
candidates in early clinical trials. Any delay to market of a potential blockbuster 
(defined as ≥ $1 billion in sales) risks losing over $3 million per day of potential 
revenue (Aggarwal 2009). The large (multi-hundred kilograms to tonne) quantities of 
monoclonal antibody production puts considerable economic pressure on both the 
current processes and the facilities required for purification (Low et al., 2007). 
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Figure 1.1: Projected annual production of monoclonal antibodies. Numbers are in 
metric tonnes (Low et al., 2007) 
 
 
1.2 Aims of Project  
 
This thesis seeks to create a novel, robust and cost effective multimodal 
precipitation process prior to packed bed steps. The primary focus will evaluate the 
precipitation of Fab’ antibody fragments from partially clarified homogenised 
material using precipitating agents that are readily acceptable by regulatory bodies. 
The optimisation of these precipitation procedures involve a large number of 
experiments due to the large number of variables involved in the process. In this 
thesis, polyethylene glycol (PEG) and salt combinations as a route to improve the 
performance of the precipitation step was investigated using a Design of 
Experiments (DoE) approach based on Quality by Design (QbD) principles outlined 
in ICH (The International Conference on Harmonisation of Technical Requirements 
for Registration of Pharmaceuticals for Human Use) guidelines. ICH guidelines help 
to ensure that safe and effective medicines are developed and registered in the 
most resource efficient manner. This approach was used to select process 
parameters and unit operations that impact critical quality attributes to define design 
spaces and create a robust scalable process.     
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The number of variables and hence experimental space to be studied increases 
considerably when considering multimodal precipitation relative to single mode 
precipitation. This led to the development of a high throughput system utilising 
automated robotic handling at 1 mL microscale to enable rapid screening of a large 
number of variables quickly.  
 
Volume reduction and product concentration have become major issues in early 
downstream processing steps and conventional processes based on adsorption or 
filtration will soon reach their limits in terms of economics, processing speed and 
scale in part due to high cell density (Bensch et al., 2007). The next generation of 
bioprocess development will integrate microscale bioprocessing techniques into 
bioprocess development to alleviate the challenges facing it. Microscale techniques 
accelerate process development by enabling parallel experimentation and 
automation while requiring microscale quantities of material (Galaev et al., 2005, 
Titchener-Hooker et al., 2008). Critical bioprocess information can be obtained 
earlier in the development timeline providing better opportunities to understand 
more process parameters. These microscale systems should be developed to mimic 
key engineering characteristics for scale up (Titchener-Hooker et al., 2008).  
 
 
Specific milestones of this project include:  
 
1. Development of a high throughput system utilising automated robotic 
handling in 96 deepwells at 1 mL scale per well to enable rapid 
screening of large design spaces in a Quality by Design (QbD) approach 
to integrate microscale bioprocessing techniques into conventional 
bioprocess development.  
 
2. Developing a novel multimodal precipitation process combining 
polyethylene glycol (PEG) with ammonium sulphate, sodium citrate and 
sodium chloride for the precipitation of Fab’ and or protein impurities 
from partially clarified homogenised E.coli feedstocks.  
 
3. Scale up validation of the microscale approach to 50 mL laboratory scale 
and 5 L pilot scale for process interaction studies 
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1.3 Production of Fab’ Antibody Fragments  
 
Every immunoglobulin (IgG) antibody consists of four polypeptide chains (2 identical 
light chains and two identical heavy chains joined by disulphide bonds) and has two 
antigen binding sites (i.e. is bivalent). Each light chain and heavy chain consists of a 
variable region and a constant region (Hames and Hooper 2000). It is this variable 
region, which gives antibodies the ability to bind to a number of different antigens. 
The removal of the fragment crystallisable region (Fc) in antibody fragment 
molecules reduces the potential for an adverse immune response in recipients (Neal 
et al., 2003). Monoclonal antibodies currently represent the second largest single 
category of biopharmaceutical substances under investigation as therapeutic drugs 
(Farid 2006). However, whole antibodies are large (~150 kDa) and require 
mammalian host organisms for expression, which require long culture times (~14 
days). An IgG molecule with the Fc region removed produces two Fab’ or fragment 
antibodies, which retain the antigen binding properties of the original IgG. The 
production of Fab’ fragments are beneficial as they are stable, retain antigen binding 
properties, are smaller (~54 kDa) and are less immunogenic molecules than the 
whole antibody (Berg et al., 2002). A benefit of Fab’s, due to their smaller size, is 
that Fab’s can be expressed in microbial cells, which results in significantly shorter 
culture times (~7 days) than mammalian based systems. 
 
Truncated forms of antibodies such as Fab’s and single chain Fv forms have many 
clinical applications. They are often used where Fc-mediated effector functions are 
not beneficial (Ljunglöf et al., 2007). Exhibiting a shorter circulating half-life than full 
length antibodies and due to their smaller size, they are often used in applications 
such as tumour penetration and for medical imaging (Anderssen and Reilly 2004). 
ReoPro, a product that blocks the final common pathway to platelet aggregation 
manufactured by Lilly and Centocor is an example of a Fab’ fragment used as a 
therapeutic (Farid 2006). For many applications, the effector functions of the 
antibody Fc region are not required for therapeutic activity (Chapman 2002). 
Furthermore, when trying to suppress an immune response, the presence of the Fc 
region is undesirable (Bowering 2004). In such cases, a Fab’ fragment containing a 
single antigen binding domain can be formatted to provide the required binding 
activity, optimal pharmacokinetic properties and an alternative structure to the full 
length IgG. For instance, it has been demonstrated that Fab’ can neutralise 
cytokines with equivalent potency to whole IgG antibodies (Weir et al., 2002). 
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Schematic representations of IgG and Fab’ are shown in figure 1.2. 
 
 
 
Figure 1.2: Schematic representations of IgG (A) and Fab’ (B) antibody molecules. 
Complementarity determining regions (CDRs) are regions 
within antibodies that complement an antigen's shape. CDRs determine the 
protein's specificity for specific antigens (Chapman 2002) 
 
The increasing commercial demand for antibody based molecules, such as Fab’ 
fragments, and the large requirement for the treatment of chronic illnesses 
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necessitate the development of processes, which allow efficient, high volume, 
impurity free production at low cost, whilst maintaining high quality of the product.  
 
There are a number of methods in the biotechnology industry for the production of 
protein products (Dainiak et al., 2000). The type of protein produced whether 
extracellular or intracellular will determine the route chosen for the purification of the 
product. Extracellular proteins are separated from the whole cell allowing easier 
purification relative to intracellular proteins. Intracellular proteins require the cells to 
be disrupted to release the product complicating purification due to the release of 
impurities. Microbial expression systems provide a more economical means of 
production than traditional mammalian expression systems for fragment production 
(Chapman 2002). Microbial platforms are currently the system of choice for 
producing Fab’ based antibody therapeutics, intercellularly, and the preferred 
expression host for Fab’s is E.coli. The advantages of shorter processing time and 
increased scale of operation associated with E.coli production counter some supply 
and cost-of-goods constraints inherent in mammalian cell expression. Furthermore, 
its faster growth rate provides shorter culture times, and fermentation processes can 
be operated at up to five times the scale of mammalian cell cultures (Bowering 
2004). It is possible that high production levels of antibody fragments are attainable 
when E.coli is used as the production organism (Anderssen and Reilly 2004). In 
addition, this process is virus free relative to mammalian systems and as there are 
no virus removal steps, which can reduce the downstream purification costs.  
 
In the manufacture of Fab’s, the costs of upstream processing are related to the 
production of the crude product, the fermentation media and fermentation plant. The 
costs that are associated with downstream processing are also substantial 
(Humphreys et al., 2004). The downstream purification process can be divided into 
three categories, primary recovery, capture of the product and purification/polishing. 
Primary recovery involves the initial removal of cell debris by filtration or 
centrifugation. In the case of Fab’ produced as an intracellular product, a cell 
disruption stage is required to release the product prior to primary recovery. 
Disruption of cells at industrial scale can be performed by mechanical means by 
using a homogeniser (Middelberg 1995).  
 
A homogeniser consists of a positive displacement pump and a homogenising 
valve. Effluent from the homogeniser is chilled to minimise thermal damage to the 
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product caused by frictional heat generated due to the high fluid velocity that 
elevates the feed temperature. The pump is used to force the fluid under pressure 
into the homogenising valve (Middelberg 1995). Effluent is forced through a small 
orifice between the valve and the valve seat shown in figure 1.3. The fluid leaves 
the gap in the form of a radial jet that stagnates on an impact ring before leaving the 
homogeniser (Diels and Michiels 2006).  
 
 
 
Figure 1.3: Flow path of fluid through a homogenising valve (Diels and Michiels 
2006) 
 
Following primary recovery, the product is isolated and purified from impurities by 
steps such as chromatography and ultrafiltration. Finally prior to drug formulation 
the product is further purified by filtration, chromatography and other affinity 
methods. The goal in this process is to maximise yield and purity while maintaining 
product stability and functionality. The current purification strategy is defined by cost 
and productivity of which half is associated with packed bed steps (Farid 2006). An 
example purification of a Fab’ process by Celltech UK (figure 1.4) illustrates the 
significant number of steps required for purification and thus cost (Chapman et al., 
1999).  
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Figure 1.4: Production of antibody fragments based on Celltech’s E.coli process 
(Chapman et al., 1999) 
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1.4 Mechanisms of Protein Precipitation  
 
The efficient purification of recombinant proteins for therapeutic applications from 
cell culture fluid is a major bottleneck of the industry (Taipa et al., 2001). Traditional 
purification techniques are based upon a number of separation steps. Each step 
contributes to a loss of product, yield and an increase in overall production time 
(Taipa et al., 2001). The major process limitations are currently dominated by 
chromatography, specifically Protein A based resins (Hahn et al., 2003). Protein A is 
a popular generic ligand for purification of monoclonal and antibody fragments 
(Hahn et al., 2003). Protein A binds immunoglobulin’s primarily through the Fc-
region, although the low affinity binding sites in the Fab’ region can also be used for 
purification of Fab’ fragments (Hansen et al., 1999). Chromatography can account 
for more than 70% of downstream costs, mainly from media cost and long cycle 
times (Przybycien et al., 2004). In a typical, bind-elute chromatography step, the 
product of interest is captured, whilst the unbound material flows through the 
column. The product is then eluted by a change of mobile phase composition 
(Jungbauer 2005). Recent progress has enabled the use of these affinity 
interactions in alternative applications to overcome issues with packed bed 
chromatography such as column fouling and high pressures (Chen 1990).  
A means of purification prior to a costly chromatography process is precipitation. 
Precipitation can be used to remove impurities in upstream feeds that may interfere 
with further downstream purification methods, and is therefore more effective early 
in the downstream purification process. A typical protein will have a surface that 
consists of regions with positive and negative charges along with hydrophilic and 
hydrophobic regions (Hilbrig and Freitag 2003). The complex interaction of these 
charged surfaces with its surrounding liquid environment will determine solubility. 
Precipitation achieves separation by causing the previously soluble protein to 
become insoluble or by adjusting the characteristics of the solvent resulting in 
precipitation of the product of interest (Stavrinides et al., 1993, Rothstein 1994). It 
has been observed that protein solubility is a property of its molecular surface 
groups and a surrounding hydration layer (colloid model). Electrostatic groups keep 
the protein soluble whereas hydrophobic patches are induced in precipitation to 
form weak bonds between molecules resulting in aggregation (Stavrinides et al., 
1993). This change in state is explained by Gibb’s free energy as the system strives 
to maintain high entropy so rather than opening a cavity around hydrophobic solute 
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particles it groups them together minimising entropic losses (Horváth et al., 1976). 
The precipitated solids may be removed from the bulk fluid by a solid-liquid 
separation step such as filtration or centrifugation (Hilbrig and Freitag 2003). 
Precipitation is a key process in the manufacture of chemicals and especially 
pharmaceuticals (Englard and Seifter 1990). Precipitation is most effective after 
having removed large solids (i.e. cell debris) from the processing stream. 
Precipitation allows low cost and high yield operation on much cruder feeds. Its 
early incorporation into the purification chain allows removal of major impurities and 
a reduction in processing volume whilst retaining a high product yield (Stavrinides et 
al., 1993, Bonnerjea et al., 1986). Thus, a “cleaner” process stream can be sent for 
column processing for which a reduced protein load can greatly reduce inventory 
costs and extend resin lifetime (Bonnerjea et al., 1986). However, precipitation of 
proteins is not new, although its application is not widely used for monoclonal 
antibodies.  
Fractional precipitation is the most common form of this operation due to its 
selective ability to precipitate impurities and proteins according to their solubilites 
such as the “double cut” fractionation method (Richardson et al., 1990). Precipitant 
is first added to sufficient concentration to precipitate less soluble impurities (“1st 
cut”) after which the concentration is further increased to recover the desired protein 
in a fresh precipitated phase (“2nd cut”) leaving the more soluble impurities in 
solution. Temperature and pH can also be adjusted to enhance yield and 
purification factor.  
 
There are seven techniques most commonly used to cause proteins precipitation of 
which four are described: 
1. Salting out by the addition of high concentrations of neutral salts 
2. Addition of non ionic polymers such as polyethylene glycol (PEG) to protein 
solutions 
3. pH adjustment to utilise the fact that solubility is a function of net charge and 
is at a minimum at the isoelectric point – zero net charge 
4. Addition of acids 
5. Reduction in the solvent dielectric constant by addition of miscible organic 
solvents 
6. Addition of charged polyelectrolytes which act as flocculating agents 
7. Interaction of polyvalent metal ions 
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1.4.1 Hofmeister Series 
 
The minimum solubility is considered the point at which the pH of the solution 
corresponds to the isoelectric point of the protein (Harden and Harris 1952). The 
isoelectric point being the point at which there is no net charge on the surface of the 
protein. The presence of hydrophobic residues and hydrogen bonds in the protein 
structure make the prediction of solubility properties difficult. A barrier to 
aggregation of protein may be considered to come from a number of sources. 
Surface associated water can interfere with the aggregation process by means of a 
small layer several tenths of a nanometre deep (Stavrinides et al., 1993). This 
induces a barrier to aggregation and it is only if this barrier is overcome that the 
effectiveness of collisions is improved. Adding a precipitation agent changes the 
surface characteristics so that the energy barrier is greatly reduced and aggregation 
can take place (Stavrinides et al., 1993). There are a number of factors, which effect 
protein solubility including availability of solvent, pH, ionic strength, dielectric 
constant, temperature and specific ion or solute effects (Janson and Rydén 1998).  
 
However, the protein solubility depends on the salt content of solvent and their 
location in the Hofmeister series (Zhang and Cremer 2006). The Hofmeister series 
is useful in considering the reagent for use in precipitation processes using salt. It 
was originally thought the Hofmeister series classifies ions based on their ability to 
change water structure. The mechanism is unclear, and it has recently been 
suggested that the interactions between protein ions and water ions are important in 
the mechanism (Zhang and Cremer 2006). The series ranks anions based on their 
effect on solubility of proteins in solution. The highest members such as sulphate 
increase the solvent surface tension and decrease the solubility of non polar 
molecules (the process of salting out). The lower ranked salts in the series weaken 
the hydrophobic effect thereby increasing solubility, known as the salting in effect 
(Richardson et al., 1990). The highest members of the series, such as sulphate, 
strengthen the hydrophobic effect by shielding dissociated ions, effectively salting 
out the protein.  
 
The choice of salt is mainly determined by its solubility and valency by its potential 
for denaturation (Melander and Horváth 1977). The anions of both acids and salts 
have been ranked in the Hofmeister series by their ability to reduce protein 
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Protein denaturation Kinder to protein 
solubility; additionally, this property is also inversely related to denaturation (figure 
1.5).  
 
   Citrate → Phosphate → Sulphate → Acetate → Chloride → Nitrate →Thiocyanate  
 
 
Figure 1.5: Hofmeister series in order of decreasing ability to cause salting out and 
increasing ability to cause denaturation  
 
The higher members of the series such as citrate work by increasing solvent surface 
tension, consequently affecting the solubility of non polar molecules (Melander and 
Horváth 1977). Ammonium sulphate is the industry’s most common reagent, owing 
its popularity to its high solubility, low cost operation and stabilising effect on 
proteins (King 1972, Walsh and Headon 1994). The density of the protein- 
ammonium sulphate precipitate is sufficiently low that it does not interfere with 
sedimentation significantly. However, precipitate sizes are small and large amounts 
of ammonium sulphate must be used, which can be potentially corrosive to 
downstream chromatography resins. Dialysis or diafiltration would be required to 
remove it, and there are environmental issues with disposal of large volumes of 
ammonium sulphate at scale (Hahn et al., 2003). 
 
Melander and Horváth (1977) proposed that the observed change in protein 
solubility was directly linked to the electrostatic free energy available for solvation 
(the protein forming a hydrophobic cavity). The presence of electrolytes raises the 
surface tension of the solvent (Przybycien and Bailey 1989). They found that the 
increase in the solution’s molar surface tension from adding salt ions was directly 
proportional to the hydrophobic interaction potential between protein particles and 
this forms the basis of the Hofmeister series.  
 
Sodium citrate is also a very capable precipitating agent as shown by the high 
position in the Hofmeister series but falls foul of limited solubility at room 
temperature (Kim and Bae 2003). Sodium sulphate has been used for IgG 
precipitation, as the precipitated IgG is usually very stable. Sodium sulphate is 
especially suited to heat stable proteins due to its high solubility at temperatures 
over 40°C (Kim and Bae 2003). 
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1.4.2 Salting Out 
 
 
Melander and Horváth (1977) proposed a mechanism of salt precipitation (figure 
1.6). The addition of neutral salts results in their ions bonding with water molecules, 
which would otherwise be hydrating proteins. Proteins will be forced by reduced 
hydration to aggregate in these conditions (utilising hydrophobic surface patches). 
The entropy cost of forming a cavity around non polar molecules is lower (the 
amphiphilic protein as opposed to polar salt ions) and thus the effect is driven by the 
loss of hydrogen bonding and the higher entropic. These losses can be minimised 
by forcing non polar molecules together. The loss in the water monolayer 
surrounding the protein reduces the barrier to aggregation as high concentrations of 
salt ions are introduced to the system allowing aggregation from solute collisions 
(formation of hydrophobic bonds), which is intensified by mixing. An increase in free 
energy is required to accommodate the protein in its dissolved state, i.e. opening a 
cavity in the solvent becomes unfavourably high in a high salt environment. 
However, at low ionic strengths, protein solubility is raised above that of its pure 
aqueous solution (termed salting in) because of solvating electrostatic interactions 
between salt ions and charged groups on the protein surface (Stavrinides et al., 
1993).  
 
The cavity theory proposed by Melander and Horváth (1977) was an extension of a 
theory by Sinanoglu and Abdulnar (1965). Sinanoglu and Abdulnar (1965) have 
suggested that the free energy of cavity formation reflected in the surface tension of 
solvent has a key role in the stability of proteins. The consequence of the proposed 
theory states that protein solubility is derived from a composite salting out constant, 
which incorporates an electrostatic salting in term and an opposing hydrophobic 
salting out term. Therefore, at low salt concentrations there is a salting in effect, 
however, by increasing the salt concentration the hydrophobic cavity increases 
resulting in precipitation due to a reduction in solubility (Richardson et al., 1990). 
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Figure 1.6: A potential mechanism of protein precipitation using neutralising salts 
(Melander and Horváth 1977) 
 
Salting out is generally used to for the purposes of protein purification by fractional 
precipitation (Richardson et al., 1990). Fractional precipitation is performed adding 
the first precipitant to precipitate less soluble impurities. After recovery, the 
concentration of the precipitant is increased to precipitate the desired protein, 
leaving impurities that are more soluble in solution (Richardson et al., 1990, Cheng 
et al., 2005). The decrease in solubility of a protein with the addition of increasing 
concentration of salt can be represented by the equation developed by Cohn 
(Foster et al., 1971, Atha and Ingham 1981). 
 
 
Log S =  - Kc                                              (1.1) 
 
 
Equation 1.1:  Cohn equation, where S is protein solubility (grams per litre) and c is 
precipitant ionic strength (moles per litre).  is protein solubility constant 
extrapolated to zero ionic strength. K is a salting out constant, which is a function of 
protein type and is independent of pH and temperature (Richardson et al., 1990). 
This equation is represented in figure 1.7 (Foster et al., 1971)   
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Figure 1.7: Salting out curve (Foster et al., 1971) 
The range of ionic strength is only valid until the point at which the protein solubility 
curve meets the straight line, which is represented by M in figure 1.7 (Foster et al., 
1971). This position has variability caused by the nature of the system and the initial 
concentration of the protein in solution (Foster et al., 1971).  
 
Salting out can be described as a phenomenon by which water is removed from the 
protein bringing opposing charges on the proteins surface together (Scopes 1987 
and figure 1.6). Water can also be removed by the addition of an organic solvent or 
by the addition of a non ionic polymer such as polyethylene glycol (PEG) (Scopes 
1987). The addition of an organic solvent will increase the hydrophobic regions of 
the protein, thus decreasing solubility. However, this property can also destabilise 
the hydrophobic protein core potentially denaturing the protein (Scopes 1987).  
 
1.4.3 Non Ionic Polymers 
 
 
It is known that the addition of non ionic polymers to a protein solution decreases 
protein solubility (Thrash et al., 1991). The use of non ionic polymers such as PEG 
has recently become a popular choice due to its cost, availability and stable use in 
affinity columns (salts can denature the affinity ligands so must be removed prior to 
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material being loaded onto a column) (Chapman 2002). Its precipitating action is 
similar to salts in that it works by volume exclusion, effectively minimising the water 
monolayer for protein solvation (Stavrinides et al., 1993).  
 
PEG is a non toxic, water soluble polymer available in many degrees of 
polymerisation commonly ranging from 4000 to 20000 (Atha and Ingham 1981, 
Scopes 1987, Lewis and Metcalf 1988). PEG is soluble in water due to the ether 
oxygen’s spread along the length of the polymer, which form hydrogen bonds with 
the surrounding water molecules. PEG has interesting biological properties, which 
have been exploited for use as a precipitating agent for proteins (Atha and Ingham 
1981). It has the advantage over salts of reducing the time required for precipitated 
material to equilibrate and achieve a physical state suitable for centrifugation 
(Ingham 1990). PEG has been used to concentrate a product of interest. Lewis and 
Metcalf (1988) successfully demonstrated PEG 6000 as an effective concentrating 
agent for the detection of human virus pathogens such as Hepatitis A.  
 
It has been suggested that the Cohn equation (equation 1.1) can be applied to PEG 
precipitation (equation 1.2). A theoretical expression has been developed based on 
the excluded volume effect (Foster et al., 1973). The equation has a similar form to 
that of the Cohn equation and is represented in equation 1.2. 
 
ln ln oS S aC                                                 
 
 
Equation 1.2: Solubility of proteins in polymer solutions, where S is the solubility of 
the protein, C is the concentration of the polymer, and So and a are constants. So is 
the solubility of the protein in the polymer free solution, a is the coefficient indicating 
the interaction between PEG and the protein (Atha and Ingham 1981) 
 
 
This equation is valid for dilute protein solutions. Higher concentrations of protein in 
solution require an additional bS term to be added to the left hand side of the above 
equation. This incorporates protein-protein interactions present at high protein 
concentrations in solution (Atha and Ingham 1981). 
 
Middaugh et al., (1979) found that at low concentrations, a linear relationship 
between log solubility and PEG was discovered based upon experimental data 
(1.2) 
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using various haemoglobin proteins.  Subsequently, an extrapolation of the protein 
solubility to zero PEG could be made to determine the thermodynamic activities of 
that protein in its saturated state. However, under conditions of high solubility the 
extrapolated intercept exceeds the actual solubility of the protein. The difference 
can be mathematically calculated and is a function of the protein-protein interactions 
and activity coefficient (Atha and Ingham 1981). The nature of the protein PEG 
complex at the extrapolated regions are poorly understood (Middaugh et al., 1979). 
However, to understand the thermodynamic solution process of proteins, two 
mechanisms have been suggested to account for the use of PEG as a precipitating 
agent (Lewis and Metcalf 1988).     
 
 
 
Figure 1.8: Effect of PEG (% w/v) on the solubility of various haemoglobin proteins 
at various concentrations on a semi log plot (Middaugh et al., 1979) 
 
The first mechanism was discussed by Atha and Ingham (1981). Their experimental 
work was designed to evaluate the excluded volume concept and how the theory 
applies to the precipitation of proteins with the addition of PEG. They evaluated a 
range of molecular weight PEG’s with a range of protein sizes. They suggested that 
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the effectiveness of PEG to precipitate proteins increases with the size of the 
polymer (figures 1.8 and 1.9).  
 
 
 
Figure 1.9: Effect of various polymers of PEG (% w/v) on the solubility of human 
serum albumin 14k-670k proteins on a semi log plot (Atha and Ingham 1981) 
 
However, their results based upon protein polymer interactions suggest that PEG 
has little interaction with proteins and precipitation is caused by excluded volume 
effects (Middaugh et al., 1979, Atha and Ingham 1981). Excluded volume refers to 
that part of the PEG molecule that cannot occupy space that is already occupied by 
another part of the same PEG molecule (Atha and Ingham 1981). They suggested 
that PEG acts as an “inert solvent sponge” that prevents interaction of all proteins 
present with the solvent, effectively increasing their concentration until solubility is 
exceeded and precipitation occurs (Lewis and Metcalf 1988). The approach is 
similar to salting out, and precipitation will be affected by factors including protein 
size, concentration, charge, and initial ionic strength (Lewis and Metcalf 1988).  
 
Lee and Lee (1981) have suggested the second mechanism, which emphasises the 
importance of protein charge. To understand the mechanism of PEG and protein 
interactions, the solvent interactions between PEG and lysozyme were studied by 
varying polymer size and concentration of PEG. They suggested that PEG does not 
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induce any structural changes to the protein, although PEG maintains the native 
confirmation of the protein. However, the addition of PEG to the system destabilises 
the solvent system to an unfavourable thermodynamic state. Therefore, the addition 
of PEG in the protein solution would provide the driving force for precipitation so that 
the system would return to a thermodynamically favourable state. The driving force 
effect is proportional to the size of the polymer, and it is assumed that the protein 
surface is fully charged. The addition of PEG results in an unfavourable 
thermodynamic effect on the solubilised PEG causing it to be excluded from the 
protein domains, resulting in precipitation of the protein (Lewis and Metcalf 1988). 
Therefore, highly charged and hydrophobic proteins will be more easily precipitated 
(Lee and Lee 1981).   
 
Furthermore, Lee and Lee (1981) suggested based on their work with tubulin and 
PEG of varying molecular weights that PEG does not induce any structural changes 
in proteins. It was found that PEG helps to maintain the native conformation of 
proteins under conditions in which the protein might otherwise assume structures 
other than its native form (Lee and Lee, 1981). It has also been found that in all 
cases the addition of protein to all PEG-water systems induces destabilisation 
allowing for phase separation (Perumalsamy and Murugesan 2006, Rosa et al., 
2007, Azevedo et al., 2009 (b)). The system always provides a driving force to a 
thermodynamically more favourable state, which generates phase separation. The 
magnitude of this driving force was found to increase with increasing concentration 
of the polymer. They also discovered a relationship between the driving force and 
molecular weight of the polymer used in which the concentration of PEG required 
decreased with increasing molecular weight (Lee and Lee 1981). 
 
Mahadevan and Hall (1990) have suggested that stearic constraints where 
polymers are excluded from the space separating two protein molecules are 
significant. The distribution of the polymer causes a “pressure imbalance” that 
pushes the proteins against each other. However, this fails to explain the effect of 
protein charge on protein precipitation by non ionic polymers, though it incorporates 
the effect of pH on protein precipitation by non ionic polymers. The positive 
chemical potentials of the proteins on the addition of PEG indicate that the 
predominant interactions between PEG and proteins in an aqueous medium are 
repulsive in nature and that this repulsion becomes stronger with an increase in 
PEG size (Mahadevan and Hall 1990). These models are approximate as they 
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assume that the solvent is a continuous fluid, ignoring the contribution of hydration 
forces to protein stability.    
 
When considering the choice of reagent, the entire process must also be 
considered. The precipitant must meet processing limitations, for example, 
hydrochloric acid (HCl) is highly corrosive and its use in high pressure devices such 
as homogenisers is ill advised. Salt precipitation can be integrated with a 
hydrophobic interaction chromatography column (HIC) to minimise the process 
steps prior to purification. A HIC column consists of a chromatographic matrix 
containing hydrophobic groups, and can bind proteins in the presence of high salt 
concentrations. It binds proteins from aqueous solutions to different extents 
depending on protein structures and a range of controllable factors including 
concentrations of salts, pH and organic solvents.  
 
PEG is a useful precipitant to combine with affinity purification techniques, as it does 
not denature the ligands, as some salts are known to. Protein integrity, ease of 
operation, the fractionation ability and the final use of the product are other factors 
to be considered. Some precipitants such as metal ions are associated with 
denaturation and safety concerns; ammonium sulphate is toxic with respect to 
clinical use (Dainiak et al., 2000). Medicinal products are subject to strict purity 
requirements so any reagent residues in the final product need to be safety tested 
or removed. 
 
1.4.4 Isoelectric Precipitation 
 
 
Isoelectric precipitation works at the isoelectric point (pI) of the protein so that a zero 
net surface charge is exhibited and thus diminishing hydrophilic interactions (figure 
1.10). This technique works best for proteins with hydrophobic surfaces and low 
hydration constants (Radola 1973). Caution should be exercised with proteins with 
an acidic pI to avoid denaturation (pH < 4); otherwise, acids are mostly inexpensive 
and well tolerated by proteins (Bramaud et al., 1997).  
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Figure 1.10: The effect of pH on soya protein concentration remaining in solution, 
expressed as a fraction of initial concentration of total water extract (Virkar et al., 
1982) 
 
 
Other methods used to precipitate proteins utilise ionic polyelectrolytes such as in 
flocculation and polyvalent metal ions, which are known for a strong precipitating 
action. They can subsequently be removed by chelating (formation or presence of 
two or more bonds between a ligand and central ion) or ion exchange 
chromatography.   
 
1.4.5 Acids 
 
Acids are usually inexpensive, require lower concentrations with respect to salts and 
are accepted in many protein food products. In fractional precipitation, it is 
sometimes possible to directly move to the next cut without removing the acid 
(contrary to many salts). However, acid use runs the risk of protein denaturation.  
 
Figure 1.11 shows the effect of pH on precipitation of lysozyme with sodium chloride 
(Shih et al., 1992). Lysozyme’s pI is at pH 10.5 where, as expected, its 
concentration is lowest but precipitation is also seen in the acidic data range.  
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Figure 1.11: Effect of pH on lysozyme solubility with sodium chloride (▪ 1 M, ○ 1.5 
M, ● 2 M, □ 2.5 M and ■ 3 M)  (Shih et al., 1992) 
 
 
1.5 Precipitate Formation 
 
Precipitation is generally described to take place over five distinct stages:  
 
Mixing Nucleation Growth by diffusion Growth by fluid motion Ageing (Bell 
and Dunnill 1982).  
 
The precipitant is responsible for creating a favourable environment for hydrophobic 
interactions between proteins resulting in aggregation upon molecular collisions 
during mixing.  
 
1.5.1 Nucleation 
 
Nucleation is the formation of miniature “crystals” that will eventually grow to 
sedimentation size. Following the onset of aggregate formation, both the number 
and size of aggregates increase while the native protein population is depleted (Chi 
et al., 2003). If the concentration of nuclei is too high, the precipitate will be too fine, 
as the growth of the precipitate will be spread over too many sites. This kind of 
precipitate will be difficult to sediment. Therefore, the control of nucleation will 
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determine the quality of the precipitate. The optimal strategy for precipitation is to 
keep the degree of super saturation low.  
 
Nucleation and growth is determined by diffusion controlled (Brownian motion), 
perikinetic growth resulting in a “primary particle” of roughly 0.2 μm (Virkar et al., 
1982, Bell et al., 1983). Therefore, at a greater rate of collisions a faster growth and 
higher particle concentration is observed. There is also a linear rate of increase of 
particle volume with time (figure 1.12). When surface properties of protein 
molecules have been changed, collisions between molecules will result in aggregate 
formation. Growth rate then becomes orthokinetic (convective collisions of primary 
particles) as large particles (> 1 μm) need additional energy provided by macro 
mixing to overcome the energy barrier for aggregation (Bell et al., 1983). This 
means that the growth rate of particles will increase with a greater mean velocity 
gradient (Ḡ) and greater particle concentration (equation 1.3). The size of the 
particle will increase exponentially with time. However, Smoluchowski's collision 
frequency theory, states that the probability of collision between small and large 
particles is greater than the probability of collision between small particles, and that 
large particles behave as nuclei around which small particles collect. Therefore, the 
effectiveness of a collision in forming an aggregate will decrease with greater size of 
the colliding particles (Bell and Dunnill 1982). Upon arrival at a critical size, growth 
stops and the ageing stage commences. Ageing is optimal in a low shear 
environment where erosion and rearrangement enhance particle strength.  
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Figure 1.12: Molecular weight-time plots for three concentrations of casein. Initial 
non linear phase of growth is due to modification of protein surface with calcium 
ions (Parker and Dalgleish 1977) 
 
 
1.5.2 Growth by Diffusion 
 
There are other factors affecting the rate of particle collisions and growth, such as 
protein concentration and temperature (Parker and Dalgleish 1977). Temperature 
also determines the strength of the hydrophobic bond between proteins (Gibb’s free 
energy). Overall, the final particle size is mainly determined by the mean velocity 
gradient (Ḡ) and particle strength.  
 
The mean velocity gradient (Ḡ) is a common engineering parameter for describing 
the shear rate within a stirred vessel (Camp and Stein 1943). 
 
Ḡ = [P / Vμ]0.5     (1.3) 
 
Equation 1.3: Mean velocity gradient (s-1), where μ is the dynamic viscosity           
(N s m-2), V is the volume (m3) and P is the Power input (W) (Rushton et al., 1950) 
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Ḡ has long been used to characterise turbulent velocity gradients in a variety of 
stirred vessels (figure 1.13). It is based on Power dissipation (P) per unit volume (V) 
for turbulent flow (Re > 105) where the Power number (Po) is 4-6 for a four baffled 
stirred tank with a 6 blade Rushton impeller (Rushton et al., 1950). In studies with 
soya protein it was seen that low Ḡ values (< 200 s-1) produced large precipitates 
while higher Ḡ values (> 400 s-1) gave rise to smaller aggregates (Bell and Dunnill 
1982). It has been suggested that there is a direct correlation between the final 
particle size and Ḡ (Tambo and Hozumi 1979). 
 
 
 
Figure 1.13: The effect of the mean velocity gradient (Ḡ) on particle size for soya 
protein precipitates (Glatz et al., 1986) 
 
1.5.3 Ageing 
 
The dimensionless, Camp number (Ca) can be used to describe overall mixing 
conditions in a stirred vessel.  
 
Ca = Ḡt         (1.4) 
  
Equation 1.4: Camp number to indicate mixing conditions. Where t is the time of 
mixing (s) and Ḡ is the mean velocity gradient (s-1) (Camp and Stein 1943) 
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Ca gives an indication of mixing conditions and the role of agitation in stabilising 
precipitates (Bell and Dunnill 1982). The approach has long been used in the water 
treatment industry for flocculation processing (Bell and Dunnill 1982). The strength 
and density of particles have been shown to be directly related and both are critical 
variables in centrifugal separation (Tambo and Hozumi 1979). Trouble arises when 
precipitates break up by experiencing shear stresses inherent to the recovery 
process (i.e. harsh pumping, centrifuge feed zones, etc.) and clarification becomes 
compromised. In such situations, the revised challenge is to create strong 
precipitates, which are smaller. To maximise particle strength it is recommended 
that a Ca value greater than 105 is used (Bell and Dunnill 1982). In the water 
treatment industry values of 104-105 (with Ḡ ranging from 10-100 s-1) are used 
(Camp and Stein 1943).  
 
Figure 1.14 illustrates the response of precipitates formed under a range of Ca to 
equivalent shear treatment. Soya protein precipitates were strongest when the Ca 
value were > 105 as were seen in the small change of final to initial mean diameter 
(Bell and Dunnill 1982). The shear treatment for these may have utilised similar 
shear conditions as during precipitate formation. 
 
 
 
 
Figure 1.14: Camp number (Ca) versus precipitate susceptibility to capillary shear 
(Bell and Dunnill 1982) 
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The precipitate will develop a tight and compact structure when it is sufficiently 
deformed under shear (Bell and Dunnill 1982). Extensive ageing has been shown to 
increase particle strength and consequently improve recovery (Bell and Dunnill 
1982). Fines are “mopped up” by larger particles, “filling in” gaps and increasing 
density. Figure 1.15, shows the reduction in the number of aggregates disrupted 
with increased ageing and by the increasing uniformity of the particle fragments that 
are broken off (Bell and Dunnill 1982).  
 
 
 
 
 
Figure 1.15: The effect of ageing on the frequency of “broken particles” after 
capillary shear (Bell and Dunnill 1982)  
 
During ageing the final mean particle size is determined by a dynamic equilibrium 
between the rates of aggregate growth and impeller induced breakage (Shamlou et 
al., 1996).  
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1.5.4 The Effect of Mixing, Turbulence and Time on Precipitate Particle 
Size Distribution (PSD) 
 
It is important to achieve good mixing between the feed and the precipitant solution 
particularly during nucleation. Otherwise, super saturation and under saturation 
regions will be present in the solution. 
 
Mixing, turbulence and time have a direct effect on precipitate PSD. Research has 
shown that precipitates which undergo turbulent flow result in particle breakage 
(Byrne and Fitzpatrick 2002). This is especially true for precipitates formed and 
aged under mild agitation conditions. Particles formed and aged under low shear 
conditions, though initially larger, are in fact weaker and fragment largely in 
turbulent flow. The strength of precipitate particles are important to withstand the 
fluid shear forces encountered in pumps and centrifuge feed zones without reducing 
the particle size. The particle size must meet the particle size criteria in the 
subsequent centrifugation stage for successful separation (Byrne and Fitzpatrick 
2002).   
 
For microscale data to be useful for designing large scale processes, the 
engineering environment within microwells needs to be understood and 
characterised. Rapid and efficient mixing is a key bioprocessing feature and 
underpins the quantification of precipitation reactions. There has been work on 
different forms of macro mixing within microwells including jet mixing, magnetic 
impellers and shaken microplates (Nealon et al., 2006, Titchener-Hooker et al., 
2008). The versatility of liquid handling robots has been studied in producing “micro-
substitutes” for large scale engineering parameters (Nealon et al., 2006).  
 
For many bioprocess applications, particularly biocatalysts and stability assays, 
shaken systems are not appropriate and mixing should be performed in static 
microplates (Aucamp et al., 2005). Rapid and efficient mixing can be provided from 
the liquid addition by the pipette tip of a liquid handling robot followed by repeated 
reaspirations and dispenses. However, this method does not suit the high 
throughput nature of the tests (Nealon et al., 2006).  
 
In precipitation reactors the mechanical impellers are an important source of shear, 
which helps, define precipitate size and structure (Shamlou et al., 1996). The longer 
a particle resides in the high shear impeller region, the stronger it is thought to be, 
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as shown in studies comparing continuous and batch prepared precipitates (Bell 
and Dunnill 1982). Jet mixing by entrainment can provide the appropriate 
homogenous distribution, but the shear element to cap particle growth and induce 
strengthening by rearrangement requires a high energy dissipation zone (Tambo 
and Hozumi 1979, Shamlou et al., 1996). This can be provided by repeatedly 
aspirating and dispensing the forming precipitate at speed through a pipette tip. 
Shearing of this nature has previously been accomplished with homogenisers and 
may provide insight into this substitute to the ageing phase (Aucamp et al., 2005).  
 
1.6 Precipitation Reactors 
 
 
The size, strength and rheological characteristics of aggregates have all been linked 
to precipitation reactor design and configuration. Vessel geometries, baffles, 
impellers and whether the operation is continuous or batch all contribute to the 
precipitate’s characteristics.  
 
Larger and faster impellers have greater tip speeds and hence higher maximum 
energy dissipation at the tip to shear the aggregates. The precipitates circulation 
time and the proportion spent near the impeller (turbulent viscous dissipation sub-
range) define precipitate strength and ageing (Shamlou et al., 1996).  
  
Bell and Dunnill (1982) demonstrated that continuous tubular reactors produced 
large, irregular, low density particles as compared with the stronger, smaller 
particles of the batch stirred tank (figure 1.16). They attributed the differences to the 
magnitude and distribution of mean velocity gradients (Ḡ), and residence times 
within the reactors. They observed that batch aggregates had been exposed to high 
flow stress zones (impeller region) for longer periods than their continuous 
counterparts had. The larger continuous precipitates had a more open structure and 
a wider distribution of sizes. Particles had infrequently been exposed to impeller 
action in the continuous system (a lower residence time in a high velocity gradient 
zone). Their centrifugal recovery predictably resulted in reduced clarification (shear 
in the feed zone had broken these large, hollow particles into fine fragments found 
in the supernatant). There was also a larger volume of fine particles (< 5 μm) in the 
continuous precipitate (figure 1.16).  
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Figure 1.16: Effect of preparation conditions on the separation efficiency and 
sludge dry solids content using a scroll discharge centrifuge (●○) and batch stirred 
tank (■□) (Bell and Dunnill 1982) 
 
 
1.7 Filtration 
 
Protein precipitates are mostly colloidal and compressible in nature, which would 
lead to fouling issues with filter meshes unless filter aids are used. Cartridge or 
guard filters have been used to protect more expensive unit operations such as 
ultrafiltration and chromatography, by removing fine solids, which may foul them. 
This use of guard filtration often results in lower pressure drops and higher fluxes for 
downstream membranes (Bracewell et al., 2008). Filter aids are not always suited to 
protein precipitates as they can decrease recovery efficiency or contaminate the 
product (Cui 2005). Filtration equipment is usually large and long start up times are 
required, creating containment concerns.  
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Filtration-centrifugation methods have been used where the centrifugal force 
provides the filter transmembrane pressure across a perforated bowl, although the 
compressible precipitate can cause severe blinding (Boulding et al., 2002). The 
substantial costs per filter and high driving forces used restrict the use of filtering 
centrifuges to high value products.  
 
1.8 Centrifugation  
 
 
Centrifugation coupled with depth filtration has become the main set of unit 
operations employed for the primary recovery of therapeutic proteins in recent years 
(Roush and Lu 2008). Centrifugal sedimentation clarifies the precipitate according to 
density differences between it and the solution. The precipitation and centrifugal 
recovery sequence is a mainstay of many industrial processes and is dependent on 
good separation for high yields (Hutchinson et al., 2006). However, the step can be 
made difficult by small aggregates and a low density difference between the 
precipitate and solution, requiring high centrifugal forces (Hutchinson et al., 2006). 
Nonetheless, centrifugation is the principal recovery method for protein precipitates, 
offering low cost continuous operation, lower contamination risks, brief preparation 
times and a smaller footprint than filtration.  
 
An efficient clarification and high level of dewatering ensures high product yields 
and a reduced drying load for subsequent protein purification. Due to the high 
capital and operating costs involved in solid-liquid separation, it is imperative that a 
high degree of clarification and solids dryness/dewatering is achieved. 
 
1.9 Scale Down of Development Processes 
 
Rapid volume reduction and product concentration have become major issues in 
early downstream processing steps. To date, conventional processes based on 
adsorption or filtration are about to reach their limits in terms of economics, 
processing speed and scale (Bensch et al., 2007). Microscale bioprocessing 
techniques offer a change in bioprocess development by accelerating process 
development by enabling parallel experimentation and automation while requiring 
microscale quantities of material (Galaev 2005, Titchener-Hooker et al., 2008). 
Critical bioprocess information can be obtained earlier in the development process, 
and it provides a better opportunity to understand more process parameters. These 
55 
 
microscale systems should be developed to mimic key engineering characteristics 
for scale up (Biddlecombe and Pleasance 1999).  
 
Microscale processing is an extension of ultra scale down (USD) by the use of 
microlitre quantities of material. It can be divided into two main branches, microwell 
systems and microfluidics (manipulation of fluids). Both techniques offer to 
significant benefits for the translation of new drugs to market by reducing 
development time and costs. Furthermore, USD combined with automation can 
increase experimental throughput in the early stages of process development 
(Micheletti and Lye 2006).  
 
This approach can be invaluable at the process definition stage of drug 
development when pilot scale trials are unfeasible or material is scarce i.e. for high 
value products. Large volumes of process data can be provided from low resource 
usage during route scouting enabling strong drug candidates to be spotted earlier 
and increasing process robustness. Rapid and accurate process development also 
holds the key in weeding out weaker candidates and saving company resources.  
 
Current research on microwell unit operations has mostly focused on fermentation 
with little to show for downstream unit operations (Kostov et al., 2000, Duetz et al., 
2001, Jackson et al., 2006, Micheletti and Lye 2006). Microwells are small plates of 
identical wells capable of holding microlitre volumes and are available in various 
geometries. Their origins are in analytical and high throughput screening 
applications and are now finding their way into process design (Ferreira-Torres et 
al., 2005). “Microwell bioprocessing” offers an automated platform to translate unit 
operations and even whole bioprocesses to microscale for generating process 
information (Ferreira-Torres et al., 2005). They are suited to automated batch and 
fed batch experimentation to be carried out with microlitre quantities (20-2000 μL) of 
representative samples. Mainstream acceptance is dependent upon defining the 
engineering fundamentals of microscale techniques and range of bioprocess unit 
operations that can be performed at this scale (Micheletti and Lye 2006).   
 
USD devices can be used to mimic critical process parameters at industrial scale, 
which may be missed in ideal laboratory equipment. The difficulties in replicating 
complex fluid flow patterns at bench scale can be alleviated with the USD device.   
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As stated by Pollard (2001), the bottleneck of process development is its initial 
stage of “route-scouting” that involves evaluating alternative process options, often 
with limited data. The stage usually consists of laboratory scale (10-100 mL) 
experiments using limited material, analysing changes to different conditions, 
reagents and operations. The experiments can be time consuming due to the 
sparing use of automation, slowing down data generation. Single step success not 
only requires the optimisation of its own performance (e.g. yield, purification factor, 
product quality) but also depends critically on subsequent processing (e.g. column 
chromatography) as well as the consequence of feed composition. 
  
1.9.1 Scale Down of Protein Precipitation Using Quality by Design 
(QbD) Principles 
 
At pilot or larger scale, it is not economically feasible to investigate a large number 
of operating conditions due to the number of resources that would need to be 
employed. To date, conventional processes based on adsorption or filtration are 
about to reach their limits in terms of economics, processing speed and scale 
(Bensch et al., 2007). Techniques, which can generate data with minimal resource 
expenditure by mimicking large scale processes, are in high demand. Microscale 
bioprocessing techniques offer an improvement in bioprocess development by 
accelerating timelines and enabling parallel experimentation using automation while 
requiring microscale quantities of material (Galaev 2005, Titchener-Hooker et al., 
2008). Critical bioprocess information can be obtained earlier in development 
providing better opportunity to understand a wide range of process parameters.  
 
In this thesis, microwell unit operations were used to scale down downstream unit 
operations. Microwells are small plates of identical wells capable of holding microlitre 
volumes and are available in various geometries. The scale down of protein 
precipitation should be generally simple and geometric; many of the parameters 
found in larger vessel including the Power per unit volume, Camp number, tip speed, 
rate of precipitant addition and diameter ratios (dimpeller:dtank and dbaffle:dtank) are kept 
constant. The scale down model should be able to create a comparable range of 
particle sizes and strengths. Scale down studies of subsequent recovery and high 
resolution chromatography steps depends on having precipitate available that 
qualitatively represents production material.  
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When scaling down precipitation it is vital that the ability to generate comparable 
results is maintained across an agreed predetermined set of operating conditions. 
Geometric similarities (e.g. aspect ratio, impeller, tip speed, etc.) and operational 
conditions (e.g. mean velocity gradient, residence time, tip speed, etc.) are usually 
kept constant although it should be stressed that it is material quality that is to be 
replicated and not the unit. Successful scale down of precipitation reactors has 
previously been accomplished by keeping Power dissipation per unit volume 
constant over the range 0.27 to 200 L (Bell et al., 1983). Many authors suggest a 
direct relationship between the mean velocity gradient and precipitate size, and the 
Camp number and particle strength (Tambo and Hozumi 1979, Bell et al., 1983, 
Shamlou et al., 1996).  
 
Sometimes the scale down to laboratory scale fails to reproduce the operational 
complexities of larger scales. Fluid flow patterns in stirred tanks are likely to change 
during scale down as it is difficult to replicate them exactly. The mean velocity 
gradient encompasses a wide range of velocity gradients in the vessel and scale up 
may change the distribution of the velocity profiles. Distinguishing the mixing 
between the high shear impeller region and the low shear bulk fluid may allow for 
further insight. The maximum spatial shear rate is thought to be at the impeller tip 
and this along with Reynolds Number (equation 5.1) and particle circulation time are 
known to change relative to a constant Power input per unit volume (Byrne and 
Fitzpatrick 2002).  
 
For more complex operations, where the engineering fundamentals are not fully 
characterised, pilot trials are more appropriate. Innovative devices such as the 
rotating disc shear device are sometimes available to fill in for the inadequacies of 
laboratory equipment (centrifuges) in mimicking larger scale equipment (section 
5.4.1). The effect of clarification by centrifugation can be seen from Stoke’s law, 
which describes the inverse relationship between viscosity and the particle settling 
velocity (u) of cell debris during solid–liquid separation (equation 1.5). Thus, particle 
settling can be increased by reducing the viscosity of the feedstream 
(Balasundaram et al., 2009). 
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    (1.5) 
 
Equation 1.5: Particle settling velocity (m s-1) where ρp is the density of the particle 
(kg m-3), ρ1 is the density of the suspension (kg m
-3), dp is the diameter of the 
particle, (m), g is the acceleration due to gravity, (m s-2), and µ is the viscosity of the 
process suspension in Pa s (Balasundarum et al., 2009) 
 
However, in terms of bioprocess development in the current biotech industry, 
product quality and robustness is tested at numerous stages in the manufacturing 
process against a number of FDA approved parameters. If a batch does not meet 
the required specification then it is discarded resulting in a waste of resources and 
money. Any changes to the manufacturing process require FDA approval and there 
is little scope on how the design of process scale up and subsequent manufacturing 
process can ensure product quality and robustness.  
 
An alternative to this approach is the Quality by Design (QbD) approach. The 
concept promotes greater understanding of all the critical parameters in the 
manufacturing process starting with product development, essentially building 
quality into the process, not testing it in the product. This is highlighted in figure 
1.17. 
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Figure 1.17: Quality by Design: The International Conference on Harmonisation of 
Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) 
guidelines Q8 (R2), Q9 and Q10. Processes are designed to be robust and to 
deliver consistent quality  
 
QbD is part of a regulatory driven initiative in how process development and 
manufacturing is conducted. As part of this process PAT (Process Analytical 
Technology) defined as a system for designing, analysing, and controlling 
manufacturing during processing of critical quality and performance attributes of 
processes, can be used to ensure the final product quality (Rathore and Winkle 
2009).  
  
ICH (The International Conference on Harmonisation of Technical Requirements for 
Registration of Pharmaceuticals for Human Use) is a collaborative body in the 
pharmaceutical industry combining the regulatory authorities of Europe, Japan and 
the USA to discuss scientific and technical aspects of drug registration. Its aim is to 
ensure that safe and effective medicines are developed and registered in the most 
resource efficient manner. A number of guidelines denoted ICH Q8 (R2), Q9, Q10 
and Q11, concern methods and principles to achieve this in a complex production 
process or analytical system. ICH guidance Q8 (R2) is intended to provide 
understanding of the product using the concept of “design space” (ICH Q8 (R2) 
2009). ICH guidance Q8 (R2) defines design space as “the multidimensional 
combination and interaction of input variables and process parameters that have 
been demonstrated to provide assurance of quality” (ICH Q8 (R2) 2009). Moving the 
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process parameters within the design space is not considered as a process change. 
Movement out of the design space is considered a change and would normally 
initiate a regulatory post-approval-change process. In this thesis, the effect of PEG 
and salts on the precipitation of Fab’ and or protein impurities are described to 
generate a process design space to characterise a suitable operating range. This 
type of experimental design will define whether operating conditions are safe, 
consistent and robust.  
 
As part of this process critical quality attributes and critical performance attributes 
are identified so that those process characteristics having an impact on product 
quality can be studied and controlled. Critical quality attributes are biological or 
chemical properties, which should be within range, and the critical process 
parameters whose variability has an impact on critical quality attributes should be 
controlled to ensure process robustness. Examples of these attributes for 
precipitation as described in this thesis are shown in table 1.1. 
 
Critical Quality Attributes 
Aggregation Charge variants 
Concentration Salts 
pH PEG 
 
Table 1.1: Examples of critical quality attributes for Fab’ and or protein impurity 
precipitation with PEG and salts 
 
ICH Q9 is trying to better define the principles by which risk management will be 
integrated into decisions by the industry, regarding quality and GMP compliance. 
Risk is defined as the combination of the “probability of harm and severity of that 
harm” (ICH Q9 2005). The importance of systems to maintain product quality 
throughout the lifecycle of the product is becoming increasingly important to ensure 
the high quality of the drug. The outcome should be a risk management framework 
intended to lead to a more consistent science based decision making across the 
lifecycle of a product (Rathore and Winkle 2009). Failure Mode Effects Analysis 
(FMEA) is a risk assessment tool for identifying and summarising factors that are 
likely to cause failures in the process. FMEA provides for an evaluation of potential 
risks in processes and their effect on product performance and quality. Once these 
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modes have been established appropriate risk reduction can be used to control 
these factors.   
ICH Q10 incorporates the concepts behind ICH Q8 (R2) 
(development/understanding) and Q9 (risk management) by providing a model for 
quality that can implemented throughout product life cycle. In essence, the overall 
goal is to complement the manufacturing processes for continual improvement and 
strengthen the link between the other guidelines (Rathore and Winkle 2009).       
ICH Q11 provides further clarification on the principles described in ICH guidelines 
Q8 (R2), Q9 and Q10. This guideline provides further clarification on the enhanced 
approach to process development. In an enhanced approach, risk management and 
scientific knowledge are used to select parameters that impact critical quality 
attributes to establish a design space and control strategies to be implemented 
throughout the lifecycle of the product. Therefore, as mentioned in ICH Q8 (R2), a 
greater understanding of operational design spaces can allow for flexibility and 
robustness at manufacturing scale, which gives a degree of flexibility with regulatory 
approaches.   
In the QbD approach, the product and processes are understood prior to 
commercialisation so that when adjustments or issues occur, they are quickly dealt 
with without requiring further investigation. For example, the adoption of QbD in this 
case will include the design of the manufacturing process from basic principles with 
a good understanding of the operating space by a Design of Experiments (DoE) 
approach. The identification of critical process parameters such as the 
concentration of PEG, salts, pH, feed concentration and potential sources of 
variability will achieve the most consistent quality and robustness. 
The complexity of biotech products and processes makes complete characterisation 
a challenge. Biologics present unique issues such as the differences in the 
manufacturing process for different molecules, which will need to be addressed in 
order for QbD to be implemented (Rathore and Winkle 2009).  
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1.10 Methods of Presenting Data 
 
1.10.1 Fractionation Diagram 
 
A fractionation diagram can provide a clear way to represent the purification of a 
product protein relative to total contaminating protein. The use of tie lines in this 
approach makes the determination and optimisation of purification factor versus 
yield more straight forward (Dixon and Webb 1961, Juckles 1971, Richardson et al., 
1990). Previous graphical methods included the specific property solubility test 
(Richardson et al., 1990), and while successful at predictions for final stages of 
purification of liver esterase for example, it may not be suitable for crude cell extract 
fractionation (Richardson et al., 1990). Figure 1.18 shows an example of this where 
total protein concentration on the y-axis is related to a property specific to desired 
product on the x-axis. The most favourable conditions for the purification of the 
active component will occur when the curve BCD approaches its tangent ECD as 
closely as possible. Precipitation conditions should therefore be adjusted to reduce 
the area BCE (Richardson et al., 1990). 
 
 
 
 
Figure 1.18: Example of specific property solubility test (Richardson et al., 1990) 
 
A second graphical method in existence was the derivative solubility curve method 
(Richardson et al., 1990). These plots essentially show the solubility curve gradient 
versus precipitant concentration, with the area bounded by the resultant peak and 
the ordinates of the two precipitant cuts is proportional to the amount of protein 
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precipitated (Richardson et al., 1990). This method is not ideal as while it shows the 
fractionation of proteins, solubility curve gradients must be obtained and 
reintegrated to determine the area of overlap. This makes the quantification and 
subsequent application cumbersome. For total protein no theoretical model exists to 
describe solubility unless the sum of all Cohn lines are combined, which can 
become complicated (Richardson et al., 1990). 
 
To overcome these previous problems, the fractionation diagram approach can be 
used. Firstly, enzyme and protein concentrations are plotted versus precipitant 
concentrations; this fractionation diagram eliminates precipitant concentration 
between the enzyme and protein solubilities by plotting one against the other. 
Figure 1.19 shows this representation as a process equilibrium curve. 
 
 
 
Figure 1.19: Enzyme-total protein fractionation diagram derived from the solubility 
profiles (Richardson et al., 1990) 
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1.10.2 Statistical Design of Experiments (DoE) 
 
The experimental approach based on statistical experimental design or Design of 
Experiments has been used extensively in research (Lundstedt et al., 1998). The 
purpose is to systematically analyse how the response of a system changes when 
parameters of that system are changed. DoE accommodates the variation of 
experimental conditions in a planned fashion. Doing this gives detailed information 
about how different experimental parameters influence the system response 
through the completion of only a limited number of experiments (dependent on the 
experimental design selected). Speed of research is essential and the structured 
carrying out of experiments with DoE has the ability to gain a maximum level of 
information from a minimum number of trials (Olsson et al., 2006). DoE is used for 
three main experimental objectives, regardless of scale. The first of these is 
screening, which is used to identify the most influential factors, and to determine the 
ranges across which they should be investigated. The second experimental 
objective is optimisation, which builds on the influential factors identified in 
screening to find optimal operating conditions. Optimisation requires a greater 
number of experiments per factor due to its complexity. The third experimental 
objective is robustness testing to determine how robust the process is with small 
changes in factor levels. For example, small changes can occur during production of 
therapeutic proteins, which can lead to batch failure. Therefore, understanding how 
design parameters affect process behaviour can provide an informed way to decide 
how to operate at large scale. 
 
The theoretical basis of experimental design can be found in a number of texts 
(Hicks 1974, Box et al., 1978) and more appropriate examples for biotechnology 
systems can be found in Haaland (1989). Statistical modelling using DoE can be 
used for the identification of the optimal process conditions. It allows the relationship 
between the variable factors and their response to be shown graphically in a 
response surface. DoE can identify interaction effects between variables, which are 
difficult to be realised in a traditional experimental approach. These complex 
interactions are often found in biological systems. Without the use of statistical 
design and analysis, these effects may never be realised. Statistical modelling 
software can analyse the response data and create a model. This model, no matter 
how simple, is powerful as it then enables predictions of any variety of conditions 
possible (Lutz et al., 1996). 
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DoE models created are only powerful if the most significant variables are chosen 
and their appropriate ranges are investigated. Having prepared a list of possible 
variables for the system, an initial screening study is performed in order to estimate 
the influence of these variables on the result. This can be achieved by using a full 
factorial or fractional factorial design. In either design, each of the factors or 
variables are varied in a systematic way. A possible way of doing this is measuring 
the response at extremes of the operating range of each factor. A linear or 
polynomial function can then be used to model the region between these points 
(Lundstedt et al., 1998). 
 
A linear model describes the linear relationship between the experimental variables 
and the response, and takes the form: 
 
1 1 2 2oy b b x b x residual     (Lundstedt et al., 1998) 
 
Where bo, b1, b2 are unknown constants determined by the software. x1 and x2 are 
the variables in the system and y is the response. 
 
The next level of polynomial models contains extra terms, which represent the 
interaction between different experimental variables. Thus, a second order 
interaction model takes the form: 
 
1 1 2 2 12 1 2oy b b x b x b x x residual      (Lundstedt et al., 1998) 
 
These models are usually sufficient for purposes of screening to determine the 
greatest variables and identify interaction effects. To locate an optimum on the 
response surface, quadratic terms are required. A quadratic model is obtained by 
using a different type of experimental design, such as central composite design. A 
quadratic model therefore has the form: 
 
2 2
1 1 2 2 11 1 22 2 12 1 2oy b b x b x b x b x b x x residual        (Lundstedt et al., 1998) 
 
 
The combination of factors leads to the effect of each factor and the interaction 
between each factor to be found. Two levels are usually chosen which represent the 
upper and lower expected limits of the variables. For a total of k factors investigated 
at two levels, the design will require 2k experiments. The design can be shown 
graphically for 3 factors as a cube (figure 1.20). 
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Figure 1.20: Experiments in a full factorial design of three variables (Lundstedt et 
al., 1998) 
 
Centre points should always be included in factorial designs, as they will show non 
linear relationships in the middle of intervals and by repeating the centre point a 
number of times will determine the confidence intervals in the data (Lundstedt, et 
al., 1998). 
 
A fractional factorial design offers a compromise between the information obtained 
and the total number of individual experiments required to model the system. With 
fewer experiments, less detail about the interactions is known, and depending on 
the resolution of fractional factorial design undertaken a certain amount of 
confounding is present. Confounding is a term used to refer to effects, that are 
either factors or interactions, which cannot be estimated independently. Instead, the 
constants are grouped together (Lutz, et al., 1996). A number of software packages 
such as MODDE by Umetrics will design the list of experiments required to be 
performed once a type of design is selected, and the list of factors and levels 
chosen. With the experimental data, a response surface can be modelled. 
Response surface modelling describes the use of the mathematics to determine a 
relationship between the factors and responses of the system. The models are 
usually presented in terms of contour or surface plots. Initial data is sufficient to 
provide an overall response surface; however, for added definition around the 
optimum, further experiments will be required (Lutz, et al., 1996). 
Using this approach, a large number of potentially expensive, and time consuming 
experiments are not needed, and it can provide a better understanding of the 
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investigated system or process. Several studies have successfully employed the 
use of robotic liquid handling and DoE in a number of biological systems. A similar 
approach will be used throughout this thesis for precipitation studies. 
 
1.11 Organisation of the Thesis 
 
This thesis seeks to characterise the microwell platform and demonstrate its use as 
an approach to accelerate process development. The material generated used 
throughout the thesis is described in chapter 2. In chapter 3, DoE studies using 
PEG are described. In chapter 4, DoE experimental studies on multimodal PEG-salt 
precipitation are investigated. Chapter 5 describes a clarification strategy based on 
conditions investigated in chapters 3 and 4. An overview is detailed in figure 1.21. 
 
 
 
Figure 1.21: Organisation of thesis 
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2. MATERIALS AND METHODS 
 
This chapter describes common materials and analytical procedures used 
throughout this thesis. Method details to certain experiments are described in the 
subsequent chapters.  
 
All the chemicals used in the current study were purchased from Sigma (Sigma 
Chemical Co., Dorset, UK) and were of analytical grade. All buffers were prepared 
using ultra pure water 0.22 µm filtered (Millipore, Hertfordshire, UK). 1.3 mL 96 
deepwell plates were sourced from Nunc (Nunc GmbH & Co., KG, Denmark) and 96 
well flat bottom Costar UV microwell plates from Corning (Corning, Leicestershire, 
UK). All buffers and reagents used for precipitation studies described in chapters 3-
5 had a pH range of ± 0.2 pH units.  
 
2.1 Quantification of Antibody Fab’ Fragments 
 
Fab’ concentration was determined by using a 1 mL GE Healthcare Protein G 
affinity column (GE Healthcare, Uppsala, Sweden) and a Agilent 1200 HPLC 
system (Agilent Instruments, Edinburgh, UK), consisting of a pump, an autosampler 
and an UV detector. Effluent was monitored at 220 nm. Solvents used were 20 mM 
sodium phosphate pH 7.4 for equilibration and 20 mM sodium phosphate pH 2.5 for 
elution at a pH range of ± 0.05 pH units. The column was equilibrated using 100% 
20 mM sodium phosphate pH 7.4 at a flowrate of 2 mL min-1 for 15 column volumes. 
100 L of sample was injected, a one minute linear gradient to 100% 20 mM sodium 
phosphate pH 2.5 was run, and held at that point for a further 15 minutes before 
returning to the equilibration conditions. The HPLC was configured to accept 96 well 
plates and allowed a maximum of 2x 96 plates to be assayed in one run. Rubber 
plate covers by Nunc (Nunc GmbH & Co., KG, Denmark) were used to seal the 
plates to limit evaporation over long runs. Triplicate set of Fab’ standards were run 
on the column as a calibration curve and replicates of standards samples were 
within 5% of their mean. Unknown sample concentrations were then determined by 
interpolation from the curve by linear regression. A typical calibration curve is shown 
in figure 2.1.   
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Figure 2.1: A typical calibration curve of Fab’ standards (●). The solid line extended 
to axes represents linear fit of data (r2 = 0.99). Error bars are shown for one 
standard deviation for triplicate experiment repeats  
 
 
2.2 Total Protein Concentration by the Bicinchoninic Acid (BCA) Assay 
 
Total protein concentration was determined by using the Pierce BCA kit (Pierce, 
Rockford, USA) in a 96 well format with liquid transfer performed using either a 
Multiprobe II EX (Packard Instrument Co., Meriden, USA) or a Tecan Freedom EVO 
200 (Tecan, Reading, UK) liquid handling robots. The assay was calibrated with 
bovine serum albumin (BSA) standards. Samples were prepared and analysed as 
per manufacturer’s instructions. Unknown concentrations were then determined by 
interpolation from the curve by linear regression. A typical calibration curve is shown 
in figure 2.2.   
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Figure 2.2: A typical BCA total protein calibration curve (●). The solid line extended 
to axes represents linear fit of data (r2 = 0.98). Error bars are shown are for one 
standard deviation for triplicate experiment repeats 
 
 
2.3 Quantification of Optical Density 
 
The optical density of samples were measured at 600 nm (OD600) with a Beckman 
DU 650 Spectrophotometer (Beckman Coulter Ltd., High Wycombe, UK). The OD 
was measured in triplicate with a standard deviation of ≤ 3%. 
 
2.4  Particle Size Analysis 
 
Protein precipitate suspensions were characterised by a Malvin Mastersizer 
(Malvern Instruments, Southborough, UK) to determine the particle size distribution 
of the precipitated material from a 2 mL sample. The detecting range of the 
instrument was 0.02-2000 m. Particle size measurements were calculated based 
on particle volume percentage, which was then calculated and represented 
graphically as normalised volume frequency. Burgess et al., (2004) have reported 
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that the biopharmaceutical industry prefers particle size distributions to be reported 
on a volume basis. In all cases, the d50 values quoted were given by the instrument. 
The d50 is a value of particle size indicating that 50% of the total volume of analysed 
particles has a diameter equal to or less than this reference value. Measurements 
were made in triplicate and the standard deviation was ≤ 5%. Each precipitated 
suspension to be analysed was well mixed before being added dropwise to the 
small volume dispersion unit until an obscurance of 11% to 13% was reached. The 
samples were mixed adequately during measurement (1400 rpm). 
 
2.5 Viscosity Measurements 
 
The viscosity of the samples were measured using a plate and cone viscometer 
(Bohlin Instruments, MA, USA). The temperature was maintained at room 
temperature using a cooling water bath. Approximately 1 mL of the sample was 
placed in the chamber and the shear rate (s-1) and the apparent viscosity data (in Pa 
s) was recorded on a PC using Wingather software (Bohlin Instruments, MA, USA). 
Measurements were made in triplicate and typical standard deviation was 0.64%. 
 
2.6 Light Microscope Images  
 
Particle size was assessed qualitatively by light microscopy. Microscopic images 
were taken on an Axioscope 2 plus microscope at 100x magnification (Carl Zeiss 
Micro Imaging Inc., Thornword, USA). 
 
2.7 Statistical Software  
 
The full factorial and central composite face centred DoE designs that were used to 
optimise precipitation operations were designed and analysed using MODDE 9.1 
statistical software (Umetrics, Malmö, Sweden). In all cases, the data was not 
transformed for analysis and the appropriate DoE design (for example, quadratic 
models) were selected using ANOVA assessments. Further details of these designs 
are discussed in chapters 3, 4 and 5. The overlay plots for yield and purification 
factor were performed in MODDE 9.1 (Umetrics, Malmö, Sweden).  All other graphs 
and fitting of data was performed in SigmaPlot 11.0 (Systat Software, CA, USA).  
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2.8 Production and Primary Recovery of Fab’ to Generate Material for 
Study 
 
This section describes the production and primary recovery of Fab’ fragments from 
E.coli cells for the use throughout this thesis. A number of research fellows from the 
Department of Biochemical Engineering, UCL performed this work. 
 
2.8.1 Introduction 
 
E.coli bacteria have been used as the host cell of choice for the production of many 
antibody fragments (Ali et al., 2012). The process materials used in this study is 
based on an E.coli host expressing a Fab’ antibody fragment. The fermentation 
protocol for the cultivation of E.coli strain W3110 with plasmid pTTOD A33 has been 
reported previously (Tustian et al., 2007). The increasing commercial demand for 
antibody based molecules, such as Fab’ fragments and the large requirement for 
the treatment of chronic illnesses necessitate the development of processes, which 
allow efficient, high volume production at low cost.  
 
2.8.2 75 L Fab’ Fermentation Process Overview 
 
2.8.3 Complex Shake Flasks 
 
For cultivation in shake flasks, a 1 mL vial of E.coli stock working cell bank (stored 
at -80°C in glycerol) was used for growth in 200 mL of complex media. Cells were 
incubated at 37°C in an orbital shaker (250 rpm) for approximately 4 hours to an 
OD600 1-2 with 10 g mL
-1 tetracycline. The complex media is defined in table 2.1. 
Compound Concentration (g L
-1
) Volume (L) Mass (g) 
Phytone 16.0 0.4 6.4 
Yeast Extract 10.0 0.4 4.0 
NaCl 5.0 0.4 2.0 
 
Table 2.1: Complex media for 2x 2 L baffled shake flasks containing 200 mL PY 
media plus 10 g mL-1 tetracycline 
 
 
 
 
73 
 
2.8.4 Defined Shake Flasks (New Brunswick) 
 
400 mL portion of the culture from the complex shake flasks was used to inoculate 
each defined medium shake flask (9x 2 L baffled shake flasks) defined in table 2.2. 
pH was maintained at 6.95 using 15% v/v ammonia solution and 20% v/v 
ammonium hydroxide. 400 mL portion of culture from the defined media shakes 
were used to inoculate a 4 L v/v New Brunswick fermenter (Eppendorf UK Ltd., 
Cambridge, UK). The fermenter was operated at 30°C until OD600 reached 5 at 
approximately 18 hours. 
 
Compound Concentration (g L-1) Mass (g) 
(NH4)SO4 5.20 18.72 
NaH2PO4.H2O 4.40 15.84 
MgSO4.7H2O 1.04 3.74 
KCl 4.03 14.51 
SM6 elements 10 mL L-1 36 mL 
Citric Acid.H2O 4.16 14.98 
Glycerol 112.00 403.20 
CaCl2.2H2O 0.25 0.90 
 
Table 2.2: Defined media for 9x 2 L baffled shake flasks containing 400 mL defined 
media plus 10 g mL-1 tetracycline and 112 g L-1 glycerol as a carbon source 
 
 
2.8.5 75 L Fermenter  
 
Table 2.3 lists the media preparation for the 75 L fermenter (Infors, AG, 
Switzerland), which contained 40 L defined minimal media including 112 g L-1 of 
glycerol as a carbon source. Foaming was manually controlled by addition of sterile 
solution of 0.28 mL L-1 of 25% v/v polypropylene glycol (PPG) as antifoam. 
 
Dissolved oxygen tension (DOT) was maintained above 30% where possible by 
computer controlled increases in stirrer speed to a maximum of 1000 rpm, and by 
manual control of airflow. Temperature was initially set at 30°C and was reduced to 
25°C when an OD600 of 38 was reached. Additions were made when OD600 = 38 
(360 mL 1 M MgSO4), OD600 = 54 (240 mL 1 M NaH2PO4), OD600 = 78 (360 mL 1 M 
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NaH2PO4 and glycerol feed induced) and when OD600 = 88 was reached for the start 
of induction (100 mL of 15.3 g L-1 IPTG on DOT spike). Online monitoring and 
control was performed using the Infors HT X-Controller software package. Growth 
was monitored by measuring OD600 with a spectrophotometer (Beckman Coulter 
Ltd., High Wycombe, UK) at hourly intervals. Samples were suitably diluted with pH 
7.4 phosphate buffered saline (PBS) solution and absorbance was measured in 
triplicate.  
 
Compound Concentration (g L-1) Mass (g) 
(NH4)SO4 5.20 208.00 
NaH2PO4.H2O 4.40 176.00 
MgSO4.7H2O 1.04 41.60 
KCl 4.03 161.20 
SM6 elements 10 mL L-1 400 mL 
Citric Acid.H2O 4.16 166.40 
Glycerol 112.00 4480.00 
CaCl2.2H2O 0.25 10.00 
 
Table 2.3: Defined media for 75 L fermenter (Infors, AG, Switzerland) 
 
2.8.6 Fab’ Fermentation Results 
 
Cell growth in the shake flask and the 75 L fermenter (Infors, AG, Switzerland) was 
assessed through OD600 (Beckman Coulter Ltd., High Wycombe, UK) by taking 
samples over regular intervals, diluting as required. Figure 2.3 shows the cell growth 
(OD600) over the whole fermentation cycle at 75 L. In the second growth phase, the 
maximum agitation and air flow rate (1 VVM) were not sufficient to maintain 
dissolved oxygen above 30% and air supply was switched to 40% oxygen. Cell 
density at stationary phase for Fab’ (OD600 = 102) fell within the 20% variation 
between fermentations typically observed in 75 L scale fermenters (Nesbeth et al., 
2012). Furthermore, decrease in cell densities was observed after 50 hours (figure 
2.3). 
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Figure 2.3: E.coli cell biomass profile for the 75 L fermentation (●) determined by 
absorbance measurements in triplicate at OD600. The standard deviation of the 
sample readings were ≤ 3% 
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Figure 2.4: DOT (●) and agitation profiles (▲) for the 75 L fermentation. At 30 
hours oxygen cylinder changed to 40% enriched cylinder. At 36 hours oxygen 
cylinder changed to 75% enriched oxygen cylinder and at 38 hours DOT spike was 
observed at which point glycerol feed was started and ITPG added. This is 
represented by the three lines respectively at 30, 36 and 38 hours 
 
Figure 2.4 shows the dissolved oxygen tension (DOT) and agitation profiles for the 
75 L fermenter (Infors, AG, Switzerland). The pH and temperature profiles are not 
shown as the pH values were controlled at 6.67 ± 0.83 and temperature was 
controlled at 30°C ± 5°C. At 30 hours, the oxygen cylinder was changed to the 40% 
oxygen enriched cylinder. At 36 hours, the oxygen cylinder was changed to the 75% 
enriched oxygen cylinder and the depletion of the carbon source was noted in at 
approximately 38 hours upon which the glycerol carbon source was added at a 
limiting rate that was sufficient to maintain cell survival. At this point isopropyl--D-
thiogalactopyranoside (IPTG) was added to induce the production of Fab’. These 
changes are represented by the three lines on figure 2.4 at 30, 36 and 38 hours 
respectively. The cell culture was harvested 36 hours after addition of the IPTG. The 
change in agitation profile can be explained by the changes in oxygen and glycerol 
content at these points. Typically, glycerol limitation is indicated by rise in DOT and 
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constant glycerol feed in batch culture leads to decreasing growth due to volume 
increases. The addition of glycerol at 1.6 mL L-1 h-1 was found by Tustian et al., 
(2007) to be optimal for productivity. Final harvest produced 5 kg of cell paste and 
~0.9 g L-1 of Fab’. 
 
2.9 Homogenisation and Primary Clarification 
 
Cells were harvested 36 hours post induction and centrifuged using a Carr 
Powerfuge P6 centrifuge (Pneumatic Scale Corporation, FL, USA) at a flowrate of 
60 L h-1 at 15000 rpm (20000 g). Cells were stored at -80ºC and homogenised prior 
to clarification studies. 
 
The release of intracellular Fab’ from E.coli was achieved by a high pressure 
homogenisation (HPH) unit, which was optimised for maximal cell disruption 
(Nesbeth et al., 2012). This typically results in significant levels of homogenate 
viscosity and contamination due to release of chromosomal DNA from disrupted 
cells, which can reduce performance of subsequent downstream purification steps 
(Nesbeth et al., 2012). However, additional rounds of HPH can reduce viscosity by 
breaking chromosomal DNA strands by mechanical shear stress (Balasundaram et 
al., 2009). However, this can result in increased micronisation of debris particles, 
which can compromise performance of key downstream purification steps such as 
centrifugation (Balasundaram et al., 2009). Centrifugation is one of the key unit 
operations in downstream processing, employed for solid–liquid separations 
following fermentation, cell disruption or precipitation. Particle settling in a centrifuge 
is a function of many variables such as the size of the particles and the viscosity of 
the feedstream, as shown in equation 1.5. 
 
The homogenisation step was investigated for the optimum release of Fab’. Frozen 
cells were resuspended in 100 mM Tris HCl pH 7.4 to give 15% w/v solids content 
and homogenised with an APV Manton-Gaulin Lab40 homogeniser (APV 
International, West Sussex, UK). The initial d50 value for the resuspended cell paste 
was 0.82 m measured using a Malvin Mastersizer (Malvern Instruments, 
Southborough, UK). After one pass at 500 and 750 bar pressure, d50 value had 
decreased to 0.30 m and 0.23 m respectively. However, after five passes at 500 
bar, the initial particle size had decreased to d50 0.12 m (figure 2.6). It was 
observed that an increase of micronisation of cell debris occurred with increasing 
78 
 
number of passes, increasing the difficulty in solid liquid separation (figure 2.6). This 
is in agreement with findings by Balasundaram et al., (2009), although they worked 
with fresh cell paste. Siddiqi et al., (1996) reported that the relationship between 
micronisation and disruption conditions, and thus product release profile, at 
discharge pressures greater than 115 bar was found to be non linear. The results 
from the current study are in agreement with the results of Siddiqi et al., (1996). 
Thus, maximal product release with the least number of passes to reduce the 
micronisation of cell debris was chosen as the criteria to determine the number of 
cycles required for homogenisation to maximise clarification by centrifugation. The 
release profile of Fab’ is presented in figure 2.5. It was observed that homogeniser 
pressure of 500 bar and 750 bar at one pass was sufficient to release the product. 
The equivalent d50 for the cell debris resulting from homogenisation using the APV 
Manton-Gaulin Lab60 homogeniser (APV International, West Sussex, UK) was 0.25 
m at 500 bar for one pass, which is comparable to the APV Manton-Gaulin Lab40 
homogeniser (APV International, West Sussex, UK). 
 
The initial measured viscosity of the fresh harvest was 0.002 Pa s at a shear rate of 
38 s-1 measured using a cone and plate viscometer (Bohlin Instruments, MA, USA). 
The measured viscosity of the freeze-thawed cells homogenised at 500 bar for 1 
pass was 0.003 Pa s at a shear rate of 38 s-1. The increase in viscosity was in part 
caused by the release of chromosomal DNA, which was further investigated by 
Balasundarum et al., (2009).  
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Figure 2.5: The release of Fab’ from the periplasm of E.coli cells as a function of 
the number of homogenisation passes at 250 (●), 500 (○) and 750 bar (▼) 
discharge pressures. A 40 mL suspension of E.coli cells (which were resuspended 
in 100 mM Tris HCl pH 7.4 to give a 15% w/v solids content) were homogenised 
using an APV Manton-Gaulin Lab40 homogeniser (APV International, West Sussex, 
UK) at these discharge pressures. The Fab’ concentration was determined by the 
Protein G assay as described in section 2.1 
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Figure 2.6: The particle size distribution of E.coli cell debris at 500 bar for 5 passes 
(control) (●), 500 bar for 1 pass (○) and 750 bar for 1 pass (▼). The starting 
suspension of E.coli was 15% w/v in 100 mM Tris HCl pH 7.4. Measurements were 
made using a Malvin Mastersizer (Malvern Instruments, Southborough, UK) in 
triplicate as described in section 2.4. The standard deviation for measurements 
were ≤ 5% 
 
 
2.9.1 Material Preparation for Subsequent Studies  
 
For subsequent studies homogenisation conditions of 500 bar for one pass was 
used unless stated. 2 L homogenised material using a APV Manton-Gaulin Lab60 
(APV International, West Sussex, UK) homogeniser and was primarily clarified for 
30 minutes at 15000 rpm using a CARR Powerfuge P6 centrifuge (Pneumatic Scale 
Corporation, FL, USA) at a flowrate of 25 L hr-1. Clarification achieved at these 
conditions was 85% calculated from OD600 readings. This material was stored in 
forty 50 mL falcon tubes at -20°C until needed. Material from a different falcon tube 
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was used for each experiment to prevent possible aggregation effects caused by 
multiple freeze thaw processes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
82 
 
3. DEVELOPMENT AND AUTOMATION OF A 
MICROSCALE DOWN PLATFORM FOR FAB’ 
PRECIPITATION WITH POLYETHYLENE GLYCOL 
 
3.1 Abstract 
A high throughput system utilising robotic handling has been successfully developed 
in microwells for the precipitation of Fab’ antibody fragments. This process was 
designed to accurately mimic that of an identical process at 6 mL scale, and to 
evaluate several process parameters quickly.  
 
A Fab’ precipitation screening study in the form of a full factorial design was 
performed to investigate a large design space based on Quality by Design principles 
stated in the ICH guideline Q8 (R2). Parameters of investigation were PEG 
concentration (% w/v), PEG molecular weight (MW), pH and dilution of the 
homogenate. This was followed by a central composite face centred DoE to find an 
optimal range of experimental conditions to deliver a high Fab’ yield and purification 
factor within the ranges investigated. A design space comprised of the responses 
percentage Fab’ yield and purification factor was created to give a robust region 
where Fab’ yield was ≥ 90% with a maximum purification factor of 1.7. A normal 
operating range (NOR) was defined within this design space and a confirmatory run 
was completed with PEG 12000 15% w/v at pH 7.4 and undiluted homogenate, 
which resulted in a Fab’ yield and purification factor of 93% and 1.5 respectively. In 
essence, the knowledge of the factors affecting Fab’ yield and purification factor can 
assist in the development of a manufacturing design space which lies at the heart of 
a practical realisation of Quality by Design. 
 
3.2  Introduction 
This chapter seeks to create a set of baseline data at 6 mL scale, which would be 
used as part of a strategy to apply one or a combination of pre column steps to 
target the removal of protein impurities. This chapter has been split into two 
sections, the first, investigated the precipitation of Fab’ with varying molecular 
weights of PEG at 6 mL total volume, and the second focusses on the development 
of a high throughput system designed to mimic this scale. The high throughput 
system was developed to enable screening of a large number of process variables 
using a DoE approach. The ability to understand how design parameters affect 
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processes can provide information on how to operate at full scale. This capability is 
the practical basis on which Quality by Design is realised. This allowed key factors 
in Fab’ precipitation from E.coli homogenates to be investigated including possible 
interaction effects between variables. 
 
Figure 3.1 highlights the structure of the chapter. At stage 1, a set of baseline data 
at 6 mL was created for development of an automated microscale platform. At stage 
2, a full two level factorial design was undertaken to investigate Fab’ precipitation 
using PEG with yield and purification factor as key responses using the automated 
microscale platform. A more detailed central composite face centred DoE was then 
performed, which examined potential operating regions identified in stage 2 in more 
depth. 
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Stage 1 
Create a set of baseline data at 6 mL scale for the development of a high throughput 
system to mimic this scale. 
 
 
 
Stage 2 
Full two level factorial DoE to investigate Fab’ precipitation using PEG by varying PEG 
molecular weight (4000 to 20000), pH (5 to 9), homogenate dilution factor (1 to 5) and PEG 
concentration w/v (5% to 20%) with yield and purification factor as key responses. Blue 
dots represent experiments conducted in the DoE design space. 
 
 
 
 
Stage 3 
Central composite face centred DoE (response surface methodology) was completed to 
find an optimal range of conditions to deliver high Fab’ yield and purification factor within 
the ranges investigated. Red dots represent the additional experiments in a CCF DoE 
compared to the full factorial DoE shown above. The midpoint of the original factorial 
design was repeated for data robustness. 
 
 
 
Figure 3.1: Flowchart of the approach used in this chapter to explore conditions for 
the initial Fab’ precipitation steps. Since the primary aim of such steps was to recover 
and purify the product, yield and purification factor was used as the key responses to 
judge performance 
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STAGE 1 
3.3 Results and Discussion 
 
3.3.1 Timescale Precipitation Experiments 
 
The time taken for the precipitation of Fab’ was investigated using PEG 4000 and 
20000. For each condition, a range of PEG concentrations (% w/v) was investigated 
shown in table 3.1.  
 
Stock solutions of PEG 4000 and 20000 were made at 50% w/v in 100 mM Tris HCl 
pH 7.4. The experiments were performed in 15 mL bijoux tubes using 10 mm stirrer 
bars for mixing controlled by a VWR magnetic stirrer plate (VWR International Ltd., 
Leighton, UK). This mixing plate did not have the speed of mixing as a quantitative 
output (a dial is numbered 1 to 10, with 10 being the fastest mixing speed) and 
therefore a mixing speed was used that was sufficient to enable turbulent conditions 
(number 8 on dial). The total experimental volume was 10 mL of which 3.3 mL 
consisted of homogenate, and the remainder 6.7 mL was a combination of 100 mM 
Tris HCl pH 7.4 and PEG. In all cases, feed was added to the precipitant. 2 mL 
samples of each condition as highlighted in table 3.1 were taken at 0, 30, 60, 90, 
120, 240 and 1000 minutes, and centrifuged in an Eppendorf 5415D centrifuge 
(Eppendorf UK Ltd., Cambridge, UK) for 10 minutes at 10000 rpm.  
 
The supernatant post centrifugation was analysed for Fab’ and total protein 
concentration using a 1 mL Protein G column (GE Healthcare, Uppsala, Sweden) 
on a Agilent 1200 HPLC system (Agilent, Edinburgh, UK) and the Pierce BCA total 
protein assay (Pierce, Rockford, USA) as described in sections 2.1 and 2.2 
respectively. The precipitated pellets readily dissolved in 2 mL of 100 mM Tris HCl 
pH 7.4 and the total protein mass balance was between 95% to 105%. 
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Final PEG 4000  
concentration (% w/v) 
Volume of PEG (mL) Volume of 100 mM 
Tris HCl pH 7.4 (mL) 
Homogenate volume 
(mL) 
2.5 0.5 6.2 3.3 
10.0 2.0 4.7 3.3 
20.0 4.0 2.7 3.3 
Final PEG 20000  
concentration (% w/v) 
Volume of PEG (mL) Volume of 100 mM 
Tris HCl pH 7.4 (mL) 
Homogenate volume 
(mL) 
2.5 0.5 6.2 3.3 
20.0 4.0 2.7 3.3 
 
Table 3.1: Table lists the volumes of homogenate pH 7.4, PEG (from a stock 
concentration of 50% w/v pH 7.4) and 100 mM Tris HCl pH 7.4 that were used in 
this experiment. C0 for Fab’ and total protein was 0.7 g L
-1 and 4.6 g L-1 respectively. 
Experiments were performed in 15 mm bijoux tubes at 10 mL scale. Samples were 
mixed using 10 mm stirrer bars for a total of 1000 minutes at turbulent mixing 
conditions on a VWR magnetic stirrer plate (VWR International Ltd., Leighton, UK). 
2 mL samples were taken periodically, centrifuged and then the supernatant was 
analysed for Fab’ and total protein concentration as described in sections 2.1 and 
2.2 respectively. The experiments were repeated in triplicate for robustness 
 
The Fab’ and total protein solubility profiles are shown in figures 3.2 and 3.3. There 
was an insignificant difference in the solubility of Fab’ with PEG 4000 and 20000 at 
2.5% w/v after 1000 minutes (65% and 66% Fab’ remaining soluble respectively). In 
both cases, total soluble protein remaining was 70% and 63% respectively as 
determined by the BCA assay (Pierce, Rockford, USA). However, with PEG 20000 
the plateau for maximum Fab’ precipitation was observed at 2.5% at 30 minutes 
relative to 60 minutes by PEG 4000.  
 
There was an insignificant change in the solubility of Fab’ by PEG 4000 and 20000 
at 20% w/v after 60 and 30 minutes respectively (0.4% and 0.3% Fab’ remaining 
soluble respectively). However, 27% total protein was remaining in solution with 
PEG 4000 compared to 18% with PEG 20000, which continued to decrease till 1000 
minutes. These results correlate with previous work performed by Atha and Ingham 
(1981) and Lewis and Metcalf (1988), where they reported that protein precipitation 
increased with increasing size of PEG polymer.    
 
The initial drop in solubility can be explained by aggregation of fine particulates 
formed during nucleation resulting in a reduction of the concentration of solids and 
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hence turbidity. This is in part due to the initiation of precipitation (the nucleation 
stage), which is characterised by the appearance of very fine particulates. This is in 
agreement with previous work by Knevelman et al., (2010). It was observed that the 
addition of PEG 4000 at 20% w/v resulted in 0.4% soluble Fab’ and 35% soluble 
protein remaining in solution after 60 minutes. Similarly, PEG 20000 at 20% w/v 
caused 0.3% soluble Fab’ and 29% soluble protein remaining in solution after 30 
minutes. The use of PEG 20000 20% w/v resulted in 50% reduction in the time 
taken for Fab’ precipitation to complete relative to PEG 4000 at 20% w/v. The 
difference in the time taken to precipitate Fab’ by PEG can be explained via the 
excluded volume effect further described in section 1.4.3. Excluded volume refers to 
that part of the PEG molecule that cannot occupy space that is already occupied by 
another part of the same PEG molecule (Atha and Ingham 1981). Lewis and Metcalf 
(1988) suggested that PEG acts as an “inert solvent sponge” that prevents 
interaction of all proteins present with the solvent, effectively increasing their 
concentration until solubility is exceeded and precipitation occurs.   
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Figure 3.2: Effect of PEG 4000 on the solubility of Fab’ (A) and total protein (B) 
over time at 2.5% (●), 10% (○) and 20% (▼) w/v at pH 7.4. C0 for Fab’ and total 
protein was 0.7 g L-1 and 4.6 g L-1 respectively. Total experimental volume in each 
reactor was 10 mL. Samples were mixed for a total of 1000 minutes at turbulent 
mixing conditions. 2 mL samples were taken periodically, centrifuged and then the 
supernatant was analysed for Fab’ and total protein concentration as described in 
sections 2.1 and 2.2 respectively. Error bars are shown for one standard deviation 
for triplicate experiment repeats 
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Figure 3.3: Effect of PEG 20000 on the solubility of Fab’ (A) and total protein (B) 
over time at 2.5% (●), and 20% (▼) w/v at pH 7.4. C0 for Fab’ and total protein was 
0.7 g L-1 and 4.6 g L-1 respectively. Total experimental volume in each reactor was 
10 mL. Samples were mixed for a total of 1000 minutes at turbulent mixing 
conditions. 2 mL samples were taken periodically, centrifuged and then the 
supernatant was analysed for Fab’ and total protein concentration as described in 
sections 2.1 and 2.2 respectively. Error bars are shown for one standard deviation 
for triplicate experiment repeats 
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3.3.2 Precipitation of Fab’ by the Addition of PEG at 6 mL Scale 
 
Stock solutions of PEG 4000, 6000, 8000, 10000, 12000 and 20000 were made at 
50% w/v in 100 mM Tris HCl pH 7.4. Experiments were performed in 15 mL bijoux 
tubes with a total working volume of 6 mL. 10 mm stirrer bars were used for mixing, 
controlled by a VWR magnetic stirrer plate (VWR International Ltd., Leighton, UK). 
This mixing plate did not have the speed of mixing as a quantitative output (a dial is 
numbered 1 to 10, with 10 being the fastest mixing speed) and therefore a mixing 
speed was used that was sufficient to enable turbulent conditions (number 8 on 
dial). 2 mL of reaction mixture consisted of homogenate, and the remainder 4 mL 
was a combination of 100 mM Tris pH 7.4 and PEG. In all cases, feed was added to 
the precipitant. 2 mL samples were taken after 60 minutes and centrifuged in an 
Eppendorf 5415D centrifuge (Eppendorf UK Ltd., Cambridge, UK) for 10 minutes at 
10000 rpm. Table 3.2 lists the conditions used for all PEG molecular weights. The 
precipitated pellet dissolved readily in 2 mL of 100 mM Tris HCl pH 7.4 and total 
protein mass balance was between 95% to 105%. These experiments were 
repeated at 3 mL total volume for comparative purposes. 
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Final PEG 
concentration (% 
w/v)  
Volume of PEG 
(mL) 
Volume of 100 
mM Tris HCl pH 
7.4 (mL) 
Homogenate 
volume (mL) 
0.0 0.0 4.0 2.0 
2.5 0.3 3.7 2.0 
5.0 0.6 3.4 2.0 
7.5 0.9 3.1 2.0 
10.0 1.2 2.8 2.0 
12.5 1.5 2.5 2.0 
15.0 1.8 2.2 2.0 
17.5 2.1 1.9 2.0 
20.0 2.4 1.6 2.0 
 
Table 3.2: Table lists the volumes of homogenate pH 7.4, PEG 4000, 6000, 8000, 
10000, 12000 and 20000 (from a stock concentration of 50% w/v pH 7.4) and 100 
mM Tris HCl pH 7.4 that were used in this experiment. Co for Fab’ and total protein 
was 0.7 g L-1 and 4.6 g L-1 respectively. This experiment was performed in 15 mL 
bijoux tubes at 6 mL scale. Samples were mixed using 10 mm stirrer bars for a total 
of 1000 minutes at turbulent mixing conditions on a VWR magnetic stirrer plate 
(VWR International Ltd., Leighton, UK). 2 mL samples were taken and centrifuged, 
and then the supernatant was analysed for Fab’ and total protein concentration as 
described in sections 2.1 and 2.2 respectively. Experiments were repeated in 
triplicate for robustness 
 
Figures 3.4 and 3.7 show the effect of PEG 4000 to 20000 on the solubility of Fab’ 
and total protein. It was found that greater than 15% w/v PEG concentration had 
minimal effect on the precipitation of Fab’ at all PEG molecular weights tested. At 
this point on average there was 0.04% and 82% soluble Fab’ and total protein 
remaining in solution. At 10% w/v, PEG 20000, 81% of total protein was soluble, 
which decreased to 50% at 20% w/v, comparatively to PEG 4000 which at 10% and 
20% w/v had 97% and 88% total protein remaining in solution (figures 3.6 and 3.7). 
This is agreement with Polson et al., (1964) who showed that as the size of PEG 
increases, its effectiveness for precipitating out proteins increased. The experiments 
repeated at 3 mL suggest there is an insignificant difference between Fab’ and total 
protein solubility profiles at 3 mL and 6 mL, suggesting a robust precipitation 
process.   
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PEG is a viscous polymer at 50% w/v for polymer size 20000. The viscosity of PEG 
4000, 6000, 8000, 10000, 12000 and 20000 was measured using a cone and plate 
viscometer (Bohlin Instruments, MA, USA) and was determined to be 0.1, 0.1, 0.1, 
0.2, 0.3 and 1.8 Pa s at 50% w/v at shear rate of 38 s-1 respectively. The viscosity of 
PEG did not change with increasing shear rates to a maximum shear rate tested of 
152 s-1. This suggested a Newtonian fluid system (Gonzalez-Tello et al., 1994).  
 
An increase in Fab’ solubility with PEG 12000 and 20000 in the region between 
2.5% w/v was observed. It is possible that at 0% w/v PEG, Fab’ was aggregated, 
which gave a measured concentration that is lower than its actual concentration, 
with the addition of low PEG concentrations, a salting in effect may have been 
induced. The mechanism could be similar to that of salts in the Hofmeister series, 
which weaken the hydrophobic effect by increasing solubility, resulting in the salting 
in effect (Richardson et al., 1990). This effect with PEG could be termed “PEGing 
in”. 
 
Polson et al., (1964) observed that the ability to precipitate a protein is an inverse 
function of the molecular weight of PEG used. Therefore, relatively low 
concentrations of high molecular weight polymers are required to precipitate Fab’, 
and thus high concentrations of low molecular weight varieties are required to effect 
the same degree of precipitation of Fab’. This study to precipitate Fab’ is not in 
agreement with work performed by Polson et al., (1964) as little difference in Fab’ 
solubility was observed with the PEG molecular weights in the range investigated, 
with this feedstream. They concluded that the precipitation by PEG cannot be 
explained by a possible dehydrating effect, which the polymer may have on the 
protein molecules. If this were the case, it might be expected that the low molecular 
weight varieties would dehydrate the protein molecules more rapidly largely 
because of their higher osmotic pressures than the higher molecular PEG weight 
varieties. 
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Figure 3.4: Effect of PEG 4000 (▼), 6000 (○) and 8000 (●) on the solubility of Fab’ at 6 mL 
scale at pH 7.4. Co for Fab’ was 0.7 g L
-1
. The samples were mixed for a total of 60 minutes 
at turbulent mixing conditions. 2 mL samples were taken and centrifuged, and then the 
supernatant was analysed for Fab’ concentration as described in section 2.1. Error bars are 
shown for one standard deviation for triplicate experiment repeats 
 
Figure 3.5: Effect of PEG 10000 (○), 12000 (●) and 20000 (▼) on the solubility of Fab’ at 6 
mL scale at pH 7.4. Co for Fab’ was 0.7 g L
-1
. The samples were mixed for a total of 60 
minutes at turbulent mixing conditions. 2 mL samples were taken and centrifuged, and then 
the supernatant was analysed for Fab’ concentration as described in section 2.1. Error bars 
are shown for one standard deviation for triplicate experiment repeats 
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Figure 3.6: Effect of PEG 4000 (○), 6000 (●) and 8000 (▼) on the solubility of total protein 
at 6 mL scale at pH 7.4. Co for total protein was 4.6 g L
-1
. The samples were mixed for a 
total of 60 minutes at turbulent mixing conditions. 2 mL samples were taken and centrifuged, 
and then the supernatant was analysed for total protein concentration as described in 
section 2.2. Error bars are shown for one standard deviation for triplicate experiment repeats 
 
Figure 3.7: Effect of PEG 10000 (●), 12000 (○) and 20000 (▼) on the solubility of total 
protein at 6 mL scale at pH 7.4. Co for total protein was 4.6 g L
-1
. Samples were mixed for a 
total of 60 minutes at turbulent mixing conditions. 2 mL samples were taken and centrifuged, 
and then the supernatant was analysed for total protein concentration as described in 
section 2.2. Error bars are shown for one standard deviation for triplicate experiment repeats 
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Figure 3.8: Fab’ and total protein fractionation diagrams derived from the solubility profiles shown in figures 3.4 to 3.7 
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Figure 3.8 illustrates the total fractionation diagrams derived from the data of figures 
3.4 to 3.7. The axes are the fraction of Fab’ and total protein remaining soluble. The 
figure is obtained by dividing the adjusted solubility by the initial concentrations 
derived from the total protein Pierce BCA (Pierce, Rockford, USA) and Fab’ Protein 
G HPLC (GE Healthcare, Uppsala, Sweden) assays. Figure 3.9 shows the 
combined fractionation diagrams of PEG 4000, 8000, 12000 and 20000 which 
illustrates an insignificant difference between PEG molecular weights in the range 
investigated for the precipitation of Fab’ and total protein impurities. However, PEG 
20000 precipitates more total protein than the shorter PEG polymers in the range 
investigated. 
 
 
Figure 3.9: Fab’ and total protein fractionation diagrams derived from the Fab’ and 
total protein solubility profiles using PEG 4000 (•), PEG 8000 (○), PEG 12000 (▼) 
and PEG 20000 (∆) shown in figure 3.8 
 
Theoretically, the gradient of the straight line will give the purification factor, which 
could be calculated for 100% theoretical yield. Subsequently, a strategy could be 
developed to improve the purification factor by using a double cut fractionation 
approach as described by Richardson et al., (1990). In essence, PEG is added to 
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precipitate the less soluble impurities, after which the concentration of PEG is 
increased to precipitate the Fab’. The fractionation efficiency could be affected by 
changes in temperature, pH and buffer. 
 
3.3.3 Development and Automation of a Precipitation Platform on a 
Liquid Handling Robot 
 
Rapid volume reduction and product concentration have become major issues in 
early downstream processing steps. To date, conventional processes performed in 
early development and optimisation experiments have reached their limits in terms 
of economics and processing speed (Bensch et al., 2007). Furthermore, it does not 
always lead to the most robust processes since the parameter space cannot be fully 
explored. Microscale bioprocessing techniques offer a change in bioprocess 
development timelines, accelerating process development by enabling parallel 
experimentation and automation while requiring microscale quantities of material 
(Galaev 2005, Titchener-Hooker et al., 2008). Critical bioprocess information can be 
obtained earlier in development providing better opportunity to understand process 
parameters. These microscale systems should be developed to mimic key 
engineering characteristics for scale up (Biddlecombe and Pleasance 1999). 
Microscale techniques enable a platform for next generation bioprocess 
development that decreases cycle times while increasing process understanding 
(Titchener-Hooker et al., 2008). 
 
Microscale bioprocess methods defined in this thesis refers to the significant scale 
down of a bioprocess unit operation or some feature of that operation, often with the 
goal being to directly model a critical parameter of the operation (e.g. shear during 
centrifugation described in section 5.4.1). This approach can be invaluable at the 
process definition stage of drug development when pilot scale trials are unfeasible 
or material is scarce i.e. for high value products. Large volumes of process data can 
be provided from low resource usage during route scouting experiments enabling 
strong drug candidates to be spotted earlier. Rapid and accurate process 
development also holds the key in weeding out weaker candidates and saving 
company resources.  
 
High throughput microscale screening experiments can be used to explore the 
design space and thereby predict subsequent laboratory scale development. A 
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small number of focused optimisation experiments are required at the laboratory 
scale, where scale up effects to pilot and manufacturing scales are well understood 
(figure 3.10). Detailed information regarding the design space can be rapidly 
acquired from microscale experiments, and since only small amounts of material are 
required, these experiments can be done very early on in process development 
(Rege et al., 2005). 
 
 
 
Figure 3.10: Value of microscale experiments in process development. High 
throughput microscale experiments are used to map a design space and to achieve 
high robustness, which reduces further experimentation at larger scale and cost 
 
Current research on microwell unit operations has mostly focused on fermentation 
with little to show for downstream unit operations (Kostov et al., 2000, Duetz et al., 
2001, Jackson et al., 2006, Micheletti and Lye 2006). The use of robotic liquid 
handling and DoE has been successfully employed for a number of biological 
systems ranging from fermentation processes to assay development (Lutz, et al., 
1996). One particular case involved the screening for operating conditions of an 
E.coli fermentation process (Islam et al., 2007). The use of a DoE approach enabled 
the complex fermentation system consisting of 10 key variables to be fully 
investigated. Of these 10 variables from initial screening, it was found that only six 
of these variables were significant. A second round of optimisation to improve the 
resolution around the expected optimum was performed, which reduced the number 
of key variables to 3. One of which was the plate shaking speeds pre and post 
induction. Further analysis then highlighted the importance of oxygen transfer in the 
fermentation at the microwell scale and allowed for appropriate considerations when 
scaling up to process scale (Islam et al., 2007). The advantage of running this DoE 
Microscale
Lab scale
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at microscale meant that for a process like fermentation where each experiment 
takes a significant amount of time, the ability to carry out 30 experiments with 
unique conditions was possible relatively quickly.  
 
In a similar way, a microscale system was developed for the high throughput 
screening of precipitation conditions using a statistical Design of Experiments study 
in 96 deepwell plates. 96 deepwell plates are small plates consisting of identical 
wells capable of holding microlitre volumes and are available in various geometries. 
Their origins are in analytical and high throughput screening applications and are 
now finding their way into process design (Duetz et al., 2001).  
 
Precipitation in 96 deepwell plates can be fully automated improving reliability, and 
are suited to the automated batch experimentation in microlitre quantities (20-2000 
μL). Although it can be performed manually with a pipette it is difficult to control 
consistency. An automated process enables the method to be easily deployed 
among a wide range of users. 
 
There were a number of considerations considered when developing the high 
throughput screening system: 
 
 Total reaction volume of 1 mL 
 The buffer provides the pH environment for the proteins in solution. Buffer 
pH can change with temperature, the magnitude of the change being 
dependent on the buffer itself and thus experiments were performed at room 
temperature to normalise any effects of temperature. 
 Accommodate PEG concentration in range of 0% to 20% w/v from 50% w/v 
stock solutions 
 Appropriate method of mixing when all reagents are added 
 Consideration for liquid handling of small volumes and in some cases 
handling highly viscous solutions 
 Use of the automatic liquid handling to aid in the analysis of experiments 
namely, the total protein assay and preparation of solutions for HPLC 
analysis. 
 
Nunc 96 deepwell plates (Nunc GmbH & Co., KG, Denmark) with a total working 
volume of 1.3 mL were used (figure 3.11). These plates were chosen to minimise 
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material consumption. The U-bottom design helps with forming compact sediment 
when centrifuged and for ease of removing supernatant without disturbing the 
precipitated pellet. 
  
 
 
Figure 3.11: Nunc 1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark) 
used in microscale experiments  
 
Mixing in the form of shaking plates was investigated. Micheletti et al., (2006) 
investigated the current understanding of mixing and mass transfer phenomena in 
shaken bioreactors to show how these can be used to define initial conditions for 
reliable scale up of microscale cultures. They monitored liquid hydrodynamics using 
a camera and a critical frequency (Ncrit) to identify liquid height and surface area 
change. The equation for critical frequency is shown in equation 3.1, which gives a 
minimum frequency to disrupt liquid surface tension.  
 
 
Equation 3.1: Critical frequency where σ is the liquid surface tension (N m-1), dɯ is 
the shaken microwell diameter (m), VL is the liquid volume (m
3), ρ is the liquid 
density (kg m-3), ds is the shaken diameter (m) (Micheletti et al., 2006) 
 
Critical frequency was calculated to be 233 rpm for a Thermo Scientific orbital plate 
shaker (Thermo Scientific, LA, USA), with an ds of 0.003 m and assuming liquid 
surface tension and density of water of 0.08 N m-1 and 1000 kg m-3 respectively. 
29.1 mm
8.5 mm
(3.1) 
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However, mixing by shaking proved difficult even at maximum shaking speed (1000 
rpm) with concentrations of PEG greater than 10% w/v due to its viscosity. For 
many bioprocess applications, such as stability assays, shaken systems are not 
appropriate and mixing should be performed in static microplates (Aucamp et al., 
2005). Rapid and efficient mixing can be provided from the liquid addition by the 
pipette tip of a liquid handling robot followed by repeated reaspirations and 
dispenses (jet mixing). However, this method does not suit the high throughput 
nature of the tests (Nealon et al., 2006). Therefore, due to size of the wells and for 
future process scale up considerations, magnetic coin stirrers were used as the 
method of agitation (figure 3.12). However, the control of the rate of agitation of 
these stirrers was difficult as a PC-611 magnetic stirrer plate (Corning, New York, 
USA) was used, which did not have mixing speed outputs. The rate of agitation was 
therefore not quantifiable and further scale up to 50 mL stirred tank reactors (STR) 
and 5 L STR pilot scale would prove difficult at this stage. 
Small PTFE magnetic coin stirrers (model VP 772FN) capable of fitting in each of 
the 96 wells were sourced from V&P Scientific  (V&P Scientific, San Diego, USA) 
(figure 3.12). The PTFE magnetic discs were 5 mm in diameter and 2.27 mm thick.  
 
 
Figure 3.12: Diagram represents magnetic coin stirrers (model VP 772FN) used for 
microscale experiments The stirrers were sourced from V&P Scientific (V&P 
Scientific, San Diego, USA) 
         
All microscale precipitation experiments were automated and performed by a four 
tip, Multiprobe II EX (Packard Instrument Co., Meriden, USA) liquid handling robot 
5 mm
Magnet
PTFE ring
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(LHR). The Multiprobe II EX workstation (Packard Instrument Co., Meriden, USA) 
(figure 3.13 A) was equipped with a four channel liquid handling arm for transferring 
liquids between labware and pipetting through the micro tips. 1 mL disposable 
conductive BioRobotix tips (VWR International Ltd., Leighton, UK) were used for 
liquid handling. The Multiprobe II EX (Packard Instrument Co., Meriden, USA) was 
configured for picking up the micro tips and setting the micro tips back into their 
racks only when buffer was used. Tips were discarded when used for the transfer of 
PEG and homogenate feed. Four micro tips were picked up at a time in each 
automated experiment.  
 
A typical deck layout for the experiments in this chapter is shown in figure 3.13 B, 
and the layout was modified for a specific application or higher throughput. In the 
setup shown, the deck is configured with three carriers for holding microtiter plates 
and deepwell plates. In addition, additional carriers were used for holding reagent 
troughs and micro tips.   
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Figure 3.13: Multiprobe II EX (Packard Instrument Co., Meriden, USA) liquid 
handling robot (LHR) used for microscale experiments. (A) photograph of instrument 
and (B) is an example deck layout for experiments 
 
The WINPREP application software controls the Multiprobe. BioRobotix (VWR 
International Ltd., Leighton, UK) disposable tips with a size of dinternal = 0.8 mm were 
used at injection flowrates of 7 µL s-1 (turbulent). Well additions were made at the 
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Sample reservoir
Tips
Waste tips
96 well microtitre plate for the 
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liquid surface, with liquid tracking to minimise droplet formation. The jet nozzle 
position was 1 mm below the liquid surface for which the liquid handling robot’s 
tracking function allowed the tip to follow the liquid surface as it rises or descends. 
The microconducive tips used were disposable. Experiments were performed with 
disposable tips due to corrosion concerns associated with the precipitant. The 
performance files in the form of .csv data files were used by the software for 
governing pipetting precision and accuracy, which had previously been optimised to 
within a 5% CV limit for low viscosity liquids (Nealon et al., 2006).  
 
The 6 mL design was scaled down to 1 mL and therefore, a volume of 330 L of 
E.coli Fab’ homogenate in each reaction was used. The remaining 670 L of the 
reaction volume was split between a combination of PEG and 100 mM Tris HCl pH 
7.4.  
 
The V&P Scientific (model VP 772FN) PTFE magnetic coin stirrers (V&P Scientific, 
San Diego, USA) were too strong leading to interference between the magnets in 
adjacent wells. A compromise of using alternate wells was reached, limiting 
throughput to 48 individual experiments on one plate (figure 3.14). A heavy duty 
stirrer, PC-611 (Corning, New York, USA) was used to stir the coin magnets within 
the wells (set to dial number 7). Mixing was similar to a tumbling effect and lasted 
60 minutes and a sealing film was used on each plate to prevent contamination. 
 
Figure 3.14: Top view representation of the wells used in a 1.3 mL 96 deepwell 
plate (Nunc GmbH & Co., KG, Denmark) for the microscale experiments. Shaded 
wells indicated wells used due to the strength of the magnets limiting throughput to 
48 individual experiments on one plate 
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A number of performance files were set up to deal with the different viscosities of 
PEG molecular weights. The Multiprobe II EX (Packard Instrument Co., Meriden, 
USA) liquid handling robot had by default an operation setting specifically for 
products of similar density and viscosity to water. This proved problematic with 
pipetting PEG accurately due to the PEG having a much higher viscosity than water 
(section 3.3.2). A change in a number of settings was required in order to ensure 
correct volumes were dispensed. This required changing liquid tracking settings, 
speed of aspiration and dispensing (7 L s-1 for buffers and 1 L s-1 for PEG), using 
the slowest speed of retraction of the tips from the solution and the use of 0.8 mm 
wider bore pipette tips. A number of tests were performed to ensure that no drop 
was left in the tips following a reagent transfer. Particularly with lower volume 
transfers, the presence of 1 drop in the pipette tip can yield a significant error.  
 
Following mixing, to separate the precipitated material from the solution, a deepwell 
0.45 µm filter plate (Millipore, Hertfordshire, UK) was initially trialled as an 
appropriate method for solid-liquid separation. This operation was desirable, as it 
would enable the resuspension of the pellet on the filter. Performing analysis of the 
samples with this method would allow a full total protein mass balance on the 
system to be performed relatively quickly by running the BCA total protein assay 
simultaneously on the deck. However, this proved problematic particularly with PEG 
of molecular weights ≥ 8000. Operating under vacuum helped to pass precipitated 
material through the filter plate, however for highly viscous solutions of high 
concentrations of PEG ≥ 8000 and ≥ 15% w/v, the material would not filter and 
crystallised. Centrifugation of the plates for solid-liquid separation was used in all 
experiments and is more typical of a downstream purification process (Farid 2006). 
It was found that centrifugation at 4000 rpm using a Eppendorf 5810R centrifuge 
(Eppendorf UK Ltd., Cambridge, UK) for 25 minutes separated the precipitated 
material to leave a pellet at the bottom of the microwell. A performance file was 
created to carefully remove the supernatant without disturbing the pellet and 
transfer samples to the appropriate 96 well microtiter plate for Fab’ and total protein 
analysis.     
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3.3.4 Comparative Study to Verify the High Throughput System 
 
Previous data in section 3.3.1 suggested that most Fab’ precipitation takes place 
between 30 minutes and 60 minutes of mixing dependant on the PEG molecular 
weight used, and therefore for consistency 60 minutes of mixing time was used 
throughout. Table 3.3 list the experiments and the corresponding volumes of 
components performed at this stage of the study for comparison with 6 mL scale. 
 
Final PEG 
concentration (% 
w/v)  
Volume of PEG 
(µL) 
Volume of 100 
mM Tris HCl pH 
7.4 (µL) 
Volume of 
homogenate (µL) 
0.0 0 670 330 
2.5 50 620 330 
5.0 100 570 330 
7.5 150 520 330 
10.0 200 470 330 
12.5 250 420 330 
15.0 300 370 330 
17.5 350 320 330 
20.0 400 270 330 
 
Table 3.3: Table lists the volumes of homogenate pH 7.4, PEG 4000, 6000, 8000, 
10000, 12000 and 20000 (from a stock concentration of 50% w/v pH 7.4) and 100 
mM Tris HCl pH 7.4 that were used in this experiment. Co for Fab’ and total protein 
was 0.7 g L-1 and 4.6 g L-1 respectively. This experiment was performed in 1.3 mL 
96 deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL scale per well using 
a Multiprobe II EX (Packard Instrument Co., Meriden, USA) for liquid handling. 
Samples were mixed for a total of 60 minutes using VP 772FN coin magnets (V&P 
Scientific, San Diego, USA) at turbulent mixing conditions on a PC-611 (Corning, 
New York, USA) stirrer. The plate was centrifuged and then the supernatant was 
analysed for Fab’ and total protein concentration as described in sections 2.1 and 
2.2 respectively. The experiments were repeated in triplicate for robustness 
 
Experiments from table 3.3 were performed using a range of different molecular 
weights of PEG, corresponding to the same molecular weight as in the 6 mL 
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studies; these were PEG 4000, 6000, 8000, 10000, 12000 and 20000 made at stock 
concentrations of 50% w/v in 100 mM Tris HCl pH 7.4. 
 
The reagents were added using the Multiprobe II EX (Packard Instrument Co., 
Meriden, USA) LHR and the experiment completed as per the designed protocol as 
follows (defined in .csv performance files): 
 
 100 mM Tris HCl pH 7.4 was added to appropriate wells of a 96 deepwell 
plate  
 PEG of appropriate molecular weight (stock 50% w/v pH 7.4) was taken from 
its carrier and added to its corresponding well on the 96 deepwell plate 
giving a total volume of 670 µL combined with 100 mM Tris HCl pH 7.4 
 Magnetic coin stirrers were added, and the plate was sealed with a sealing 
film, and the PEG/buffer mixture was mixed for 2 minutes on a PC-611 
stirrer (Corning, New York, USA) to ensure homogeneity 
 The 96 deepwell plate was returned to the Multiprobe II EX (Packard 
Instrument Co., Meriden, USA) LHR and 330 µL of Fab’ homogenate was 
added to the wells used 
 The 96 deepwell plate was resealed with a sealing film  
 The 96 deepwell plate  was then placed on a PC-611 stirrer (Corning, New 
York, USA) and mixed for 60 minutes 
 The 96 deepwell plate was centrifuged at 4000 rpm for 25 minutes using an 
Eppendorf 5810R centrifuge (Eppendorf UK Ltd., Cambridge, UK) 
 The supernatant was then carefully removed without disturbing the 
precipitated pellet and transferred to an appropriate 96 microtiter plate for 
Fab’ and total protein concentration analysis as detailed in sections 2.1 and 
2.2 respectively. 
 
Figure 3.15 shows fractionation diagrams of soluble Fab’ and total protein remaining 
in solution at 6 mL (A) and 1 mL (B) total volume. It was observed that PEG 12000 
was the best PEG molecular weight for precipitating Fab’ whilst precipitating the 
least amount of total protein. This provides the basis of precipitation as a means of 
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primary purification using PEG. For example, PEG 12000 15% w/v precipitates Fab’ 
whilst leaving significant protein impurities in solution (0.05% and 93% of Fab’ and 
total protein remaining in solution respectively at 1 mL scale).  
 
PEG 20000 was the most effective in precipitating total protein, yielding the highest 
insoluble protein concentration relative to the other PEG molecular weights. This is 
in agreement with Polson et al., (1964), Atha and Ingram (1981) and Knevelman et 
al., (2010). The total protein concentrations in solution at PEG 20000 20% w/v at 
both scales are comparable with 50% and 51% remaining soluble at the 6 mL and 1 
mL scale respectively.  
 
At the 6 mL scale, the Fab’ concentration remaining soluble decreases rapidly and 
reaches its minimum solubility at 15% w/v (PEG 4000 to 20000). On average 0.04% 
of Fab’ remains soluble at this point. However, at the 1 mL microwell scale the same 
level is not encountered, on average 0.08% of Fab’ remains soluble, which drops on 
average to 0.03% at PEG 20% w/v (PEG 4000 to 20000). 
 
The difference in these conditions in part could be due to the change in equipment 
design between the two scales. Both the height to diameter ratio of the mixing 
vessel and the magnetic stirrer mixing system cannot be emulated at the 1 mL 
scale. Due to the nature and geometry of the 96 deepwell plates, the design of the 
microwell scale is fixed. An appropriately designed system at a 6 mL scale may 
prove more useful in confirming the results of the high throughput system.  
 
The combination of high agitation at an unknown speed and the magnets location at 
the bottom of the well may contribute to break up of some aggregates during 
precipitation, caused in part by unwanted abrasion effects (Nealon et al., 2006, 
Titchener-Hooker et al., 2008). The break up of aggregates at 1 mL scale may have 
resulted in the higher concentration of total protein and Fab’ concentration observed 
in the solutions. In response to this issue, an alternative mixing strategy was used 
and is described in section 4.3.1. The two systems precipitation performances were 
comparable. However, there were differences in the fractionation profiles of PEG 
4000 and 12000 at 6 mL and 1 mL, which could in part be attributable to 
experimental design change and mixing variation. The 1 mL scale platform was 
used for future experiments due to the ability to screen many experimental 
conditions whilst reducing the amount of material consumed. 
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Figure 3.15: Comparative Fab’ and total protein fractionation diagrams at 6 mL (A) 
and 1 mL microscale (B) for PEG 4000 (●), 12000 (○) and 20000 (▼) respectively. 
Data for 6000, 8000 and 10000 PEG are not shown for simplicity and for the 
minimal differences between them (see figure 3.8 for comparison between different 
PEG molecular weights) 
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STAGE 2 
3.4 Results and Discussion 
 
3.4.1 Evaluation of Variables for Fab’ Precipitation using PEG  
 
The experimental approach based on DoE has been used extensively in research 
(Lundstedt et al., 1998). The purpose is to systematically analyse how the response 
of a system changes when parameters of that system are changed. DoE 
accommodates the variation of experimental conditions in a planned fashion and 
can give detailed information about how different experimental parameters influence 
the system response. 
 
PEG as a precipitating agent has been well documented for larger proteins (Atha 
and Ingram 1981, Melander and Horváth 1988). The first stage of the DoE for Fab’ 
precipitation was to screen parameters, which will affect the system. The key 
parameters investigated were PEG molecular weight, PEG concentration (% w/v), 
pH and homogenate dilution factor, these variables contribute to the factors studied 
in the initial development study. The variables of interest were: 
 
 PEG molecular weight 
 PEG concentration (% w/v) 
 pH of mixture 
 Dilution factor of homogenate 
Other factors such as temperature which affects the rate of particle collisions and 
growth, and also determines the strength of the hydrophobic bond between proteins 
(Gibb’s free energy) (Parker and Dalgleish 1977) were not investigated. All 
experiments were performed at room temperature as it was difficult to control 
temperature over a range with the current setup, and by operating at room 
temperature there would be reduced scalability issues.  
 
The pKa of Tris HCl, the buffer of use in this system is 8.1, and has a buffering 
range varying from pH 7 to 9. The upper limit of pH to be investigated was set to pH 
9. Previous work has shown pH induced precipitation at low pH and therefore the 
lower limit for this factor was set at 5 (Balasundarum et al., 2011). Tris HCl pH 5 had 
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no issues with buffering capacity at 100 mM despite the pKa of 8.1. Although pH 5 
is not low, it was chosen to have the process as generic as possible and avoid acid 
precipitation at lower pH values. The centre point in this case was pH 7.4 and a 
constant molarity of 100 mM was used in all cases. The pH of the buffers, 
precipitants and homogenate was pH adjusted to the appropriate pH using 
hydrochloric acid (37% HCl solution) and sodium hydroxide (5 M NaOH) where 
necessary to maintain consistency of pH. The specifications for maintaining pH in 
the system was ± 0.2 pH units. 
 
The inlet concentration or dilution factor of homogenate was the third factor 
investigated. There is a trade-off between the dilution of product before downstream 
processing and the cost involved in dealing with larger volumes (Balasundarum et 
al., 2011). Conversely, the performance of precipitation at lower inlet concentrations 
may prove worthwhile and was investigated. The upper limit was chosen to be 
clarified homogenate with no dilution (dilution factor of 1). A lower limit of inlet 
concentration was chosen to be a 5x dilution. While this may be unreasonable in a 
process setting, it is important in DoE screening studies not to confine the design 
space as valuable data may be lost. A centre point of dilution factor of 1.67 was 
chosen based on an estimate of 0.9 g L-1 of Fab’ in the starting homogenate and the 
required dilution to bring this down to 0.6 g L-1 was a 1.67x dilution (approximately 
the average Fab’ concentration between 1 and 5 homogenate dilution factor). The 
lower limit was set at a Fab’ concentration of 0.2 g L-1 (5x dilution).  
 
Yield is defined by the concentration of Fab’ precipitated as a percentage of the 
initial Fab’ added in the homogenate (equation 3.2). The initial Fab’ in the 
homogenate is taken to be the maximum calculated for all the experiments to allow 
for the potential PEGing in effect.  
 
       
                                                               
                           
               (3.2) 
 
Equation 3.2: Yield defined by the concentration of Fab’ precipitated 
 
For a primary purification step, the first priority is to maintain a high yield, followed 
by a suitable purification factor. Maximising yield at this point is necessary to 
maintain the cost effectiveness of the step and to ensure that the losses incurred 
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further downstream are minimal. A second parameter of interest in a purification 
process is the purification factor.  
 
The purification factor is a ratio of the purity of the product following the precipitation 
reaction to that of the initial purity of the feedstream (equation 3.3). The purification 
factor is defined as the concentration of Fab’ divided by the concentration of total 
protein in the sample. Therefore initial purification factor is set at the concentration 
of Fab’ in the feed divided by the total protein concentration in the feed. 
 
 
                     
                        
                                  
  
                        
                                 
           (3.3) 
 
Equation 3.3: Purification factor as a ratio of the purity of the product to that of the 
initial purity of the feedstream 
 
 
The yield should be kept to a maximum value with a high purification factor for an 
effective operation. However, as both Fab’ and protein impurities are precipitated, 
albeit at different rates, there will be a trade-off between the two. The criteria chosen 
for acceptable Fab’ yield was ≥ 90% with a purification ≥ 1.4.  
 
 
 
113 
 
 
Figure 3.16: Effect of PEG 20000 on the solubility of Fab’ at pH 5 (●) and pH 9 (▼) 
and total protein at pH 5 (○) and pH 9 (∆) at a homogenate dilution factor of 1. Co for 
Fab’ and total protein was 0.9 g L-1 and 4.8 g L-1 respectively. This experiment was 
performed in 1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL 
scale per well using a Multiprobe II EX (Packard Instrument Co., Meriden, USA) for 
liquid handling. Samples were mixed for a total of 60 minutes using VP 772FN coin 
magnets (V&P Scientific, San Diego, USA) at turbulent mixing conditions on a PC-
611 stirrer (Corning, New York, USA). The plate was centrifuged and then the 
supernatant was analysed for Fab’ and total protein concentration as described in 
sections 2.1 and 2.2 respectively. Error bars are shown for one standard deviation 
for triplicate experiment repeats 
 
Figure 3.16 shows the solubility profiles of Fab’ and total protein for changes in pH 
using PEG 20000 with a homogenate dilution factor of 1. The data is presented in a 
dimensionless form with the initial concentration taken to be the initial measured 
concentration, which was 0.9 g L-1 and 4.8 g L-1 for Fab’ and total protein 
respectively. The solubility profiles of Fab’ and total protein with PEG 20000 at pH 5 
was steeper than at pH 9. This suggests that low pH accelerates precipitation of 
both Fab’ and total protein, the effect of which in part is more pronounced at lower 
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PEG concentrations. The greatest variation was observed at 10% w/v of PEG, 
where at pH 5, 35% and 80% of Fab’ and total protein remained soluble, and at pH 
9, 50% and 98% Fab’ and total protein remained soluble. At higher concentrations 
of PEG ≥ 15% w/v pH had minimal impact on precipitation suggesting that the PEG 
concentration was sufficiently high to become the driving force of the process. The 
same trend was observed with PEG 4000 (figure 3.17). Lee and Lee (1981) 
suggested that the system always provides a driving force to a more 
thermodynamically favourable state and that the magnitude of this driving force was 
found to increase with increasing concentration of the polymer.  
 
 
Figure 3.17: Effect of PEG 4000 on the solubility of Fab’ (●) and total protein (○) at 
pH 9 and the effect of PEG 20000 on the solubility of Fab’ (▼) and total protein (∆) 
at pH 9. Homogenate dilution factor of 1 was used in both cases. Co for Fab’ and 
total protein was 0.9 g L-1 and 4.8 g L-1 respectively. This experiment was performed 
in 1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL scale per 
well using a Multiprobe II EX (Packard Instrument Co., Meriden, USA) for liquid 
handling. Samples were mixed for a total of 60 minutes using VP 772FN coin 
magnets (V&P Scientific, San Diego, USA) at turbulent mixing conditions on a PC-
611 stirrer (Corning, New York, USA). The plate was centrifuged and then the 
supernatant was analysed for Fab’ and total protein concentration as described in 
sections 2.1 and 2.2 respectively. Error bars are shown for one standard deviation 
for triplicate experiment repeats 
PEG w/v (%)
0 5 10 15 20
C
/C
o
 o
f 
F
a
b
' 
a
n
d
 t
o
ta
l 
p
ro
te
in
0.0
0.2
0.4
0.6
0.8
1.0
115 
Figure 3.17 shows the solubility profiles of Fab’ and total protein at pH 9 with PEG 
4000 and 20000 with a homogenate dilution factor of 1. It was observed that Fab’ 
concentration was lower at higher PEG molecular weights between 5% to 15% w/v, 
indicating that the use of a high molecular weight PEG at these interim 
concentrations would give a greater yield than the lower molecular weight PEG. The 
percentage remaining soluble Fab’ at 10% PEG was 58% and 41% for PEG 4000 
and 20000 respectively.  
 
The total protein solubility profile with PEG 20000 was relatively constant to PEG 
10% w/v, which decreases further by 20% at PEG 20000 20% w/v. The decrease in 
total protein solubility with PEG 4000 was more gradual over this range with a 10% 
reduction in total protein at PEG 4000 20% w/v.  
 
Operation between PEG 15% w/v to 20% w/v offers no significant difference in Fab’ 
solubility profiles between PEG 4000 and 20000. In terms of operating space this is 
a robust region where the use of PEG concentration is flexible in the range 
investigated for Fab’ precipitation. However, total protein drops on average for both 
PEG molecular weights by 12% in this range, which may be of particular 
significance in the choice of operating parameters at scale. Further experimentation 
in this range would be useful in developing a robust design space for both Fab’ and 
total protein precipitation.  
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Figure 3.18: Effect of feed dilution factor (DF) on solubility of Fab’ at DF 1 (●), DF 5 
(▼), total protein solubility at DF 1 (○) and DF 5 (∆) with PEG 20000 at pH 9. Co for 
Fab’ and total protein was 0.9 g L-1 and 4.8 g L-1 respectively. This experiment was 
performed in 1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL 
scale per well using a Multiprobe II EX (Packard Instrument Co., Meriden, USA) for 
liquid handling. Samples were mixed for a total of 60 minutes using VP 772FN coin 
magnets (V&P Scientific, San Diego, USA) at turbulent mixing conditions on a PC-
611 stirrer (Corning, New York, USA). The plate was centrifuged and then the 
supernatant was analysed for Fab’ and total protein concentration as described in 
sections 2.1 and 2.2 respectively. Error bars are shown for one standard deviation 
for triplicate experiment repeats 
 
 
Figure 3.18 outlines the effect of dilution on Fab’ and total protein solubility with 
PEG 20000 over 0% to 20% w/v at pH 9. There was a significant difference in the 
solubility profiles of Fab’ when the initial homogenate was diluted 5x compared to 
undiluted homogenate. On average there was a 17% decrease in Fab’ precipitation 
when the homogenate was diluted 5x over a PEG 5% to 20% w/v range. However, 
total protein concentration remains stable across the PEG concentration range 
relative to undiluted homogenate. At 20% w/v there was a 10% increase in total 
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protein solubility when homogenate was diluted 5x, which equates to a 1.7x 
increase in purification factor. However, Fab’ yield at PEG 20% w/v and 5x 
homogenate dilution was 80% relative to 90% at 20% w/v and 1x homogenate 
dilution. This would suggest that dilution factor was a strong factor in the 
determination of optimal conditions, particularly at PEG 20% w/v concentration. 
Therefore, a high yield was obtained with no dilution of feed material, whereas the 
purification factor increased with dilution of the feed material, and thus a trade-off 
was required between the two for optimum process conditions. Whilst traditional 
experimental designs are useful in spotting overall trends, information regarding 
possible interaction between factors is lost by only analysing one parameter at a 
time. The DoE approach of analysis allows further insight into the weighting of each 
of these parameters on performance, and provides an indication into interaction 
effects between parameters. 
 
3.4.2 Full Factorial DoE for the Study of Fab’ Precipitation Using PEG 
 
The full factorial and central composite face centred DoE designs that are described 
in this thesis to optimise precipitation operations were designed and analysed using 
MODDE 9.1 statistical software (Umetrics, Malmö, Sweden). A statistical DoE 
software package can evaluate multiple variables and response factors 
simultaneously. In addition, statistical analysis can allow specifications to be placed 
on data, requiring a result to be made between a minimum and maximum value for 
the output responses. The resulting design space is useful for understanding 
process limits and how design parameters affect process behaviour in order to 
decide how to operate at full scale. This capability is the practical realisation of 
Quality by Design. In a full factorial design, investigating the four variables 
described in section 3.4.1 over 2 levels with 2 centre points would require (24 + 2) 18 
experiments. However, it is known that Fab’ precipitation with PEG is highly non 
linear over the range previously examined (figures 3.4 to 3.7) and it was decided to 
carry out this design with a greater number of levels. The numbers of levels were 
set at increments of 5% PEG w/v over the effective range of PEG 0% to 20% w/v to 
provide a better understanding of how changes to PEG concentration would affect 
the precipitation of Fab’ and protein impurities. Therefore, the four factor full two 
level factorial design was completed with a range of PEG concentrations ranging 
from 0% to 20% w/v.  
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For each of the conditions outlined in table 3.4 the yield and purification factor was 
calculated as described in section 3.4.1. As a key requirement for a primary 
purification process, minimum yield of Fab’ of 90% was chosen for this primary 
process step.  
 
Experiment 
number 
pH  PEG 
molecular 
weight 
Homogenate 
dilution factor 
Final PEG 
concentration 
(% w/v) 
1 5.0 4000 1.00 5 
2 9.0 4000 1.00 5 
3 5.0 20000 1.00 5 
4 9.0 20000 1.00 5 
5 5.0 4000 5.00 5 
6 9.0 4000 5.00 5 
7 5.0 20000 5.00 5 
8 9.0 20000 5.00 5 
9 5.0 4000 1.00 20 
10 9.0 4000 1.00 20 
11 5.0 20000 1.00 20 
12 9.0 20000 1.00 20 
13 5.0 4000 5.00 20 
14 9.0 4000 5.00 20 
15 5.0 20000 5.00 20 
16 9.0 20000 5.00 20 
17 7.4 12000 1.67 15 
18 7.4 12000 1.67 15 
 
Table 3.4: Table listing the full two level factorial DoE experiments for the initial 
screening study. Homogenate (at the appropriate pH), PEG (from a stock 
concentration of 50% w/v at the appropriate pH) and 100 mM Tris HCl at the 
appropriate pH were prepared for this experiment. Co for Fab’ and total protein was 
0.9 g L-1 and 4.8 g L-1 respectively. This experiment was performed in 1.3 mL 96 
deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL scale per well using a 
Multiprobe II EX (Packard Instrument Co., Meriden, USA) for liquid handling. 
Samples were mixed for a total of 60 minutes using VP 772FN coin magnets (V&P 
Scientific, San Diego, USA) at turbulent mixing conditions on a PC-611 stirrer 
(Corning, New York, USA). The plate was centrifuged and then the supernatant was 
analysed for Fab’ and total protein concentration as described in sections 2.1 and 
2.2 respectively. Experiments were repeated in triplicate for robustness 
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One hundred and fifty experiments were run in triplicate and split over three 
microtiter plates with yield and purification factor as key responses. The precipitated 
pellets dissolved readily in 1 mL of 100 mM Tris HCl pH 7.4. 
 
 
 
Figure 3.19: Bar chart ranking the significant process parameters from high to low 
in terms of effect on Fab’ yield. Green and red bars have a positive and negative 
effect on yield respectively. Effects are significant in the range investigated, which 
are above the t-Value limit of 2.18 and p < 0.05 confidence level. Effects below 
these limits are not shown 
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There are a number of parameters, which are significant in relation to yield. Figure 
3.19 shows the t-Values for each of the parameters that have either a positive or 
negative effect on yield, which are above the t-Value limit of 2.18 and p < 0.05 
confidence level. 
 
Figure 3.19 shows that PEG concentration was the most important factor in the 
determination of yield for the range investigated. This is in agreement by 
experiments performed by Knevelman et al., (2010). PEG concentration had a 
positive effect in the range of variables investigated for improving Fab’ yield. 
 
Dilution factor was the second most important factor calculated based on the t-test 
analysis. This factor had a negative effect, signifying that the greater the dilution 
factor the lower the yield obtained. It was possible that when the feed material was 
diluted, although large amounts of PEG were present, the PEG had difficulty 
excluding water from the protein domain and causing precipitation of the protein. 
Water is more likely to be drawn from the water based buffer instead, and may 
require longer than 60 minutes mixing time for precipitation to effect. At no 
homogenate dilution, there was a higher concentration of Fab’ and other proteins in 
the sample where the PEG could work to remove relatively less water from around 
the proteins inducing precipitation. The third ranked parameter was a combination of 
PEG concentration and dilution of feed, which had a positive effect on yield. This 
was expected as PEG concentration had a larger positive effect individually than the 
negative effect imposed by dilution factor. The two factors effects on their own had 
positive and negative effects on yield respectively.  
 
High pH had a negative effect on yield. It was observed that a lower pH in the range 
of 5 to 9 can induce precipitation of Fab’ and increase yield. This is in agreement 
with previous analysis (figure 3.16) and as in agreement with previous research, 
which suggested that pH induced precipitation can take place at low pH values 
(Knevelman et al., 2010). This is interesting from the point of view that theory 
suggests that precipitation increases by operating at a pH in or around the pI value 
of the protein (Virkar et al., 1982). Fab’ pI was determined to be around pH 6.5. 
 
The final effect was an interaction effect between pH and PEG concentration. PEG 
molecular weight was not a significant factor in determination of yield (figures 3.8-
3.9). This is an interesting observation in that it is expected that a longer PEG 
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polymer size would be able to induce a greater level of hydration and induce more 
precipitation (Atha and Ingram 1981). It may be the case where this positive effect 
of increased hydration potential is negated by the fact that a smaller polymer size 
may be more mobile and can be accommodated more easily in the protein domain, 
allowing greater access to draw water and induce precipitation. Mahadevan and 
Hall (1990) have suggested that stearic constraints where polymers are excluded 
from the space separating two protein molecules are significant. The distribution of 
the polymer causes a “pressure imbalance” that pushes the proteins against each 
other. The positive chemical potentials of the proteins on addition of PEG indicate 
that the predominant interactions between PEG and proteins in aqueous medium 
are repulsive in nature and that this repulsion becomes stronger with an increase in 
PEG size (Mahadevan and Hall 1990).  
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Figure 3.20: Bar chart ranking the significant process parameters from high to low 
in terms of effect on purification factor. Green bars have a positive effect on 
purification factor. Effects are significant in the range investigated, which is above 
the t-Value limit of 2.23 and p < 0.05 confidence level. Effects below this limit are 
not shown 
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Figure 3.20 illustrates that dilution factor had the strongest effect on purification 
factor in the range investigated. In this case, this factor had a positive effect on the 
purification factor, and therefore a higher value of dilution factor would result in a 
higher purification factor. A trade-off between high and no dilution of feed material 
was required as an increase in the dilution of feed reduces yield (figure 3.19). The 
use of undiluted feed material was used in future studies, prioritising yield as the 
precipitation step is proposed as a primary purification step. 
 
It was suggested that PEG molecular weight was a significant factor for purification 
factor but it was not a significant factor for yield. There are process implications for 
using high PEG molecular weights and concentrations due to its viscosity (Lee and 
Lee 1981 and section 3.3.2), although increasing PEG molecular weight increases 
purification factor. Interestingly as per the volume excluded theory as the size of the 
polymer is increased the amount of volume left for protein molecules is reduced. 
However, it is possible that Fab’ is sufficiently small to penetrate the interior spaces 
of the polymer coil whereas the larger protein impurities are not, which may explain 
the negligible effect of PEG molecular weight on yield and not purification factor. 
Therefore, a compromise of working with the highest possible PEG molecular 
weight, which does not hinder the process is required as yield is the most important 
response for a primary purification step. For example operating with PEG 12000 can 
be acceptable at scale, while still more viscous than PEG 4000, it is manageable. 
 
Other positive effects include pH and a number of interaction effects between the 
parameters already deemed significant on their own. It is noted that PEG 
concentration was not deemed to have any effect on the purification factor in range 
between PEG 10% to 20% w/v. This is in part due to the ratio of precipitated Fab’ 
and total protein remains relatively constant at all concentrations, hence no 
improvement in purification factor.  
 
A summary of the factors affecting Fab’ yield and purification factor is shown in table 
3.5. 
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Favourable yield Favourable purification factor 
High PEG concentration (% w/v) High PEG molecular weight 
Low dilution factor High dilution factor 
Low pH High pH 
Interaction Effects Interaction Effects 
PEG concentration (% w/v) and dilution 
factor 
PEG molecular weight and dilution factor 
 pH and PEG concentration (% w/v)  
pH and dilution factor 
PEG molecular weight, pH and dilution 
factor 
PEG molecular weight and pH 
 
Table 3.5: Summary of factors that had a positive effect on Fab’ yield and 
purification factor in the range investigated  
 
Q2 is the goodness of prediction, which estimates the predictive power of the model. 
Q2 has the upper limit of 1, and the lower limit is minus infinity. The model had a Q2 
value of -0.11, which indicates that this model had poor predicitive power. The 
ANOVA parameters, calculated by MODDE 9.1 (Umetrics, Malmö, Sweden), 
indicated that the curvature in the model was significant (the p-value was 0.003).  
The two level full factorial design can show interactions between the factors, but 
cannot model curvature. A model with quadratic terms, can adequately model 
curvature, and therefore a response surface design in the form of a CCF DoE was 
performed as the next step to find an optimum range of conditions to deliver a high 
Fab yield and purification factor in the range investigated (section 3.5.1).  
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STAGE 3 
3.5 Results and Discussion 
 
3.5.1 Central Composite Face Centred DoE for Finding an Optimum 
 
The purpose of the full factorial study was to screen conditions for the precipitation 
of Fab’ and to attempt to achieve some selectivity. Precipitation can be desirable for 
an initial capture step in order to reduce the burden of subsequent downstream 
steps. In the first study, conditions were identified, summarised in table 3.5, for the 
precipitation of Fab’ from partially clarified cell culture fluid. In this second study, a 
response surface methodology design in the form of a central composite face 
centred (CCF) DoE was performed building on the factorial design for finding a 
range of optimal experimental conditions for high Fab’ yield and purification factor 
since the ANOVA showed that curvature was significant. In this design, the 
experiments are centred on the face of the cube, which implies that all factors have 
three levels, instead of two levels in the factorial design (figure 3.21). The flexibility 
of three levels per factor allows support for a quadratic model for response surface 
modelling. Quadratic models are flexible and can mimic many different types of 
response function (Lundstedt et al., 1998). 
 
 
Figure 3.21: CCF design for finding a range of optimal experimental conditions to 
deliver a high Fab’ yield and purification factor in the range investigated. In this 
design no further constraints were placed on parameter input ranges (pH 5 to 9; 
dilution factor 1 to 5; PEG molecular weight 4000 to 20000) except PEG 
concentration which was limited to 10% to 20% w/v as it was found that less than 
PEG 10% w/v resulted in unfavourable Fab’ yield < 90%  
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In this design no further constraints were placed on parameter input ranges (pH 5 to 
9; dilution factor 1 to 5; PEG molecular weight 4000 to 20000) except PEG 
concentration which was limited to 10% to 20% w/v as it was found that less than 
PEG 10% w/v resulted in unfavourable Fab’ yield of less than 90%. The 
experimental design is shown in table 3.6. 
Experiment 
number 
PEG 
molecular 
weight 
Dilution 
factor 
Final PEG 
concentration (% 
w/v) 
pH 
1 4000 1.00 10 5.0 
2 20000 1.00 10 5.0 
3 4000 5.00 10 5.0 
4 20000 5.00 10 5.0 
5 4000 1.00 20 5.0 
6 20000 1.00 20 5.0 
7 4000 5.00 20 5.0 
8 20000 5.00 20 5.0 
9 4000 1.00 10 9.0 
10 20000 1.00 10 9.0 
11 4000 5.00 10 9.0 
12 20000 5.00 10 9.0 
13 4000 1.00 20 9.0 
14 20000 1.00 20 9.0 
15 4000 5.00 20 9.0 
16 20000 5.00 20 9.0 
17 4000 1.67 15 7.4 
18 20000 1.67 15 7.4 
19 12000 1.67 15 7.4 
20 12000 5.00 15 7.4 
21 12000 1.67 10 7.4 
22 12000 1.67 20 7.4 
23 12000 1.67 15 5.0 
24 12000 1.67 15 9.0 
25 12000 1.67 15 7.4 
 
Table 3.6: Table listing the CCF DoE experiments. Homogenate (at the appropriate pH), 
PEG (from a stock concentration of 50% w/v at the appropriate pH) and 100 mM Tris HCl at 
the appropriate pH were prepared for this experiment. Co for Fab’ and total protein was 0.9 g 
L
-1
 and 4.8 g L
-1
 respectively. This experiment was performed in 1.3 mL 96 deepwell plates 
(Nunc GmbH & Co., KG, Denmark) at 1 mL scale per well using a Multiprobe II EX (Packard 
Instrument Co., Meriden, USA) for liquid handling. Samples were mixed for a total of 60 
minutes using VP 772FN magnets (V&P Scientific, San Diego, USA) at turbulent mixing 
conditions on a PC-611 stirrer (Corning, New York, USA). The plates were centrifuged and 
then the supernatant was analysed for Fab’ and total protein concentration as described in 
sections 2.1 and 2.2 respectively. Experiments were repeated in triplicate for robustness 
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Figure 3.22: 4D contour plots showing the yield of Fab’ as a function of PEG concentration (% w/v) and dilution factor at varying pH and PEG 
molecular weights. The response surfaces for yield were fit with a quadratic model. All data fitting was performed using the software package 
MODDE 9.1 (Umetrics, Malmö, Sweden) 
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Figure 3.23: 4D contour plots showing the purification factor of Fab’ as a function of PEG concentration (% w/v) and dilution factor at varying 
pH and PEG molecular weights. The response surfaces for purification factor were fit with a quadratic model. All data fitting was performed 
using the software package MODDE 9.1 (Umetrics, Malmö, Sweden) 
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Figures 3.22 and 3.23 show the response surface plots all of the variables 
investigated in the CCF DoE for yield and purification factor respectively. These 
plots were created using MODDE 9.1 (Umetrics, Malmö, Sweden). The response 
surface plot of yield (figure 3.22) suggested that operating at a condition to give 
maximum yield would require a high PEG w/v percentage, and under these 
conditions, PEG molecular weight was not a significant factor. This suggested that 
chemical interactions involving attractive or repulsive forces between different PEG 
molecular weights and Fab’ are relatively unimportant in the precipitation 
mechanism. However, an increase in purification factor was observed with 
increasing PEG molecular weight. For example, the purification factor doubled at 
PEG 20000 15% w/v, pH 5 and dilution factor of 5, compared to PEG 4000 at 
identical conditons. 
 
To achieve a Fab’ yield > 90%, PEG concentration should be ≥ 10% w/v whilst 
operating at a dilution factor of 1. Generally, an increase in dilution factor decreased 
yield. For example, by increasing the dilution factor from 1x to 5x using PEG 4000 
10% w/v at pH 5 the Fab’ yield dropped from ~90% to ~80%. It was suggested that 
as the feed was diluted the effect of PEG on Fab’ became negligible as per the 
excluded volume theory. As per this theory, it was expected that as the 
concentration was increased the amount of volume excluded per molecule was 
reduced resulting in precipitation. This was in agreement with work performed by 
Knevelman et al., (2010) who observed similar effects using IgG. However, an ~5 
fold increase in purification factor was observed with increasing dilution factor from 
1 to 5 at PEG 20000 20% w/v at pH 9, which is interesting as water is a key 
impurity. A 5x dilution is undesirable, as this will result in a greater volume of 
material to process at large scale where space and size of tankers can be limited.   
 
Figure 3.22 indicates that a lower pH increases Fab’ yield in the range investigated, 
whereas there was an minimal effect of pH observed with respect to purification 
factor from pH 5 to 9 (figure 3.23). Figure 3.22 suggests that an increase in yield 
was more pronounced at pH values below the Fab’ pI of 6.5, peaking at pH 5 and 
PEG 20% w/v (Coleman and Mahler 2003). Lee and Lee (1981) suggested that the 
concentration of polymer required to precipitate a protein component is a function of 
the net charge on the molecule as determined by the pH of the medium in which the 
molecule is suspended and there is some evidence to support this in figure 3.22.  
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ANOVA analysis suggested that the model had no lack of fit as the p-value was >  
0.05 (p-value was 0.22), with an Q2 value of 0.90. Therefore, this model can be 
used to find a sweet spot in the experimental design space, in which the 
combination and interactions of the process inputs reliably deliver a product with the 
desired quality. Recommendations as described in ICH Q8 (R2) guideline was used 
to create a design space by combining the response surface plots of yield and 
purification factor shown in figure 3.24. The proposed design space is a region 
where the combination of ranges delivers a Fab’ yield ≥ 90% with a maximum 
purification factor of 1.7. 
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Figure 3.24: Proposed Fab’ precipitation design space comprised of the overlap 
region for yield (%) and purification factor created using MODDE 9.1 (Umetrics, 
Malmö, Sweden). Knowledge space refers to the region of process understanding 
based on the CCF DoE inputs. Inputs were PEG molecular weight, PEG 
concentration, pH 7.4 and undiluted homogenate. The design space is a region 
where the combination of ranges that delivers a Fab’ yield ≥ 90% with a maximum 
purification factor of 1.7. The selected area within the design space was the 
proposed design space for scale up for operational simplicity. Outside of this region, 
viscosity of PEG may become an issue at process scale and therefore the Normal 
Operating Range (NOR) was set to ± PEG 1000 and ± 1% w/v within the dashed 
area of this design space 
 
Figure 3.24 is a graphical representation of the knowledge space (within the 
unexplored space), which refers to the region of process understanding defined by 
the input boundaries of the CCF DoE. The input boundaries were PEG 4000 to 
20000, PEG concentration 10% to 20% w/v, pH 7.4 and no homogenate dilution (DF 
of 1). The design space is comprised of the overlap of Fab’ yield (%) and purification 
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factor to give a robust region where Fab’ yield was ≥ 90% with a maximum 
purification factor of 1.7 within the knowledge space. However, the highlighted area 
within the design space is the proposed design space for operational simplicity. This 
is due to the use of PEG as precipitant, since at high PEG molecular weights and 
concentrations, the high viscosity of PEG could cause difficulties in processing at 
large scale. Therefore, the normal operating range (NOR) or control space was 
defined in a way that can be “demonstrated to provide assurance of quality” (ICH 
Q8 (R2) 2009) by having the distance from the edge of the design space at ± PEG 
1000 and ± 1% w/v. This is highlighted by the dashed area in figure 3.24 within the 
highlighted area of the design space. This allows for flexibility and robustness at 
manufacturing scale since “working within the design space is not considered as a 
change” (ICH Q8 (R2) 2009). Movement out of the design space is considered to be 
a change and would normally initiate a regulatory post-approval-change process. In 
essence, the knowledge of the factors affecting Fab’ yield and purification factor can 
assist in the development of a process manufacturing design space which lies at the 
heart of a practical realisation of Quality by Design. A robustness test was 
performed within the NOR using PEG 12000 15% w/v pH 7.4, which delivered a 
Fab’ yield and purification factor of 93% and 1.5 respectively. The model predicted a 
Fab’ yield of 95% and purification factor of 1.4, which was in good agreement with 
the experimental data. This result was within the specification of the design space.  
 
 
3.6 Summary 
 
This chapter has described procedures for developing methods for precipitating 
Fab’ directly from clarified homogenate using PEG, the approach is summarised in 
figure 3.25. Comparisons of the effects that multiple variables have on precipitation 
performance have been performed successfully in a high throughput format. A Fab’ 
precipitation screening study in the form of a full factorial design was performed to 
investigate a large design space based on Quality by Design principles (ICH 
guideline Q8 (R2)). Parameters of investigation were PEG concentration (% w/v), 
PEG molecular weight (MW), pH and dilution of the homogenate. This was followed 
by a central composite face centred design to find an optimal range of experimental 
conditions to deliver a high Fab’ yield and purification factor within the ranges 
investigated. A design space comprised of the responses percentage Fab’ yield and 
purification factor was created to give a robust region where Fab’ yield was ≥ 90% 
with a maximum purification factor of 1.7. A normal operating range (NOR) was 
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defined within this design space and a confirmatory run was completed with PEG 
12000 15% w/v at pH 7.4 and undiluted homogenate, which resulted in a Fab’ yield 
and purification factor of 93% and 1.5 respectively. 
 
 
 
Figure 3.25: Diagram to show use of microscale techniques described in this 
chapter for investigating Fab’ precipitation using PEG. Microscale techniques were 
used for range finding (stage 2) and optimisation (stage 3) 
 
 
Parameters for 
study
•PEG MW
•PEG conc (% 
w/v)
•pH
•Dilution factor
•Mixing time
•Literature
•Previous experiments
DoE designed for initial screening
Mulltiprobe II EX 
LHR used to run 
experiments at 1 
mLscale in 96 
deep well plates
HPLC to determine 
Fab’ concentration
BCA total protein assay to 
determine total protein 
concentration
P
E
G
 c
on
ce
nt
ra
tio
n 
(%
 w
/v
)
D
ilu
tio
n 
fa
ct
or
P
E
G
 c
on
ce
nt
ra
tio
n 
(%
 w
/v
) a
nd
 d
ilu
tio
n 
fa
ct
or pH
pH
 a
nd
 P
E
G
 c
on
ce
nt
ra
tio
n 
(%
 w
/v
)
t-
V
a
lu
e
 o
f 
e
ff
e
ct
0
20
40
60
80
100
120
Statistical 
analysis of data
More detailed DoE design
to identify an optimum
Design space 
identified for 
scale up  
STAGE 2
STAGE 3
134 
4. MICROSCALE MULTIMODAL PRECIPITATION TO 
ESTABLISH POLYETHYLENE GLYCOL AND SALT 
INTERACTION EFFECTS 
 
4.1 Abstract 
The setup, automation and operation of precipitation on a Tecan Freedom EVO 200 
liquid handling robot (Tecan, Reading, UK) combined with using a microscale mixing 
device increased throughput and speed of liquid handling by 50% relative to the 
mixing conditions described in section 3.3.3. 
 
A Fab’ precipitation study in the form of a response surface methodology DoE (three 
level full factorial) was performed to investigate a large multimodal precipitation 
design space based on the Quality by Design principles stated in the ICH guideline 
Q8 (R2) to improve the performance of single mode precipitation described in 
chapter 3. Parameters of investigation were PEG concentration (% w/v), PEG 
molecular weight (MW), pH, dilution of the homogenate, ammonium sulphate 
concentration and sodium citrate concentration. Salt concentrations ≥ 0.8 M with ≥ 
5% w/v PEG resulted in aqueous two phase formation which affected 40% of the 
design space. This was excluded from analysis as a two phase system was beyond 
the scope of this project.  
 
A second round of response surface experimentation in the form a CCF DoE with 
reduced ranges to avoid two phase formation was performed combining optimum 
operating conditions from the PEG CCF design space (section 3.5.1) for multimodal 
operation. PEG 12000 in addition to three salts, ammonium sulphate, sodium citrate 
and sodium chloride chosen from their locations in the Hofmeister series (section 
1.4.1) were used for multimodal precipitation. It was found that 90% Fab’ yield with 
a purification factor of 1.9 was achievable with PEG 12000 15% w/v/0.30 M sodium 
citrate/0.15 M ammonium sulphate pH 7.4. This was an improvement of 26% 
relative to the use of 15% w/v PEG 12000 pH 7.4 in single mode. However an 
alternative precipitation strategy to precipitate ~20% of protein impurities whilst Fab’ 
remained soluble in solution using PEG 12000 6.25% w/v/0.4 M sodium citrate pH 
7.4 was favoured instead. The advantage of this system at process scale is the 
potential ease of processing due to removal of a solubilisation step and the 
significantly reduced viscosity of the precipitating agent relative to that of high 
concentrations of PEG. 
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4.2 Introduction 
This chapter describes the evaluation of a microscale mixing device with a new LHR 
to improve throughput and scalability of the precipitation platform to investigate and 
potentially improve single mode Fab’ precipitation (PEG precipitant was discussed 
in chapter 3) by adding complexity in the form of a multimodal operation. Multimodal 
operation was investigated by combining two different types of precipitant, PEG with 
a mixture of ammonium sulphate, sodium citrate and sodium chloride 
concentrations. Salts as precipitating agents were chosen due to being readily 
accepted by regulatory bodies and by their different precipitating mechanism to that 
of PEG. It has been suggested that PEG has little interaction with proteins and 
precipitation is caused by excluded volume effects (Middaugh et al., 1979, Atha and 
Ingham 1981). Excluded volume refers to that part of the PEG molecule that cannot 
occupy space that is already occupied by another part of the same PEG molecule 
(Atha and Ingham 1981). PEG acts as an “inert solvent sponge” that prevents 
interaction of all proteins present with the solvent, effectively increasing their 
concentration until solubility is exceeded, and precipitation occurs (Lewis and 
Metcalf 1988). However, salts are known to interact with proteins (Harinarayan et 
al., 2008), and have been ranked in the Hofmeister series by their ability to reduce 
protein solubility (figure 1.5). The addition of neutral salts results in their ions 
bonding with water molecules, which would otherwise be hydrating proteins. 
Proteins will be forced by reduced hydration to aggregate and precipitate in these 
conditions. This loss in the water monolayer surrounding the protein reduces the 
barrier to aggregation as high concentrations of salt ions are introduced in the 
system allowing aggregation from solute collisions, which is intensified by mixing.  
 
Figure 4.1 highlights the structure of this chapter. At stage 1, an alternative mixing 
strategy with a new LHR (Tecan Freedom EVO 200 liquid handling robot (Tecan, 
Reading, UK)) was evaluated to improve throughput and scalability of the 
precipitation platform. At stage 2, a three level full factorial DoE was undertaken to 
investigate Fab’ precipitation using PEG and salts with Fab’ yield and purification 
factor as key responses. At stage 3, a second round of experimentation was 
conducted with more focused PEG and salt conditions to find a range of operating 
conditions to give a high Fab’ yield and purification factor. This was then followed by 
robustness testing. 
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Stage 2 
A response surface methodology design in the form of a 3 level full factorial DoE to model 
Fab’ precipitation by varying PEG molecular weight (4000 to 12000), pH (5 to 9), PEG 
concentration w/v (0% to 15% w/v), ammonium sulphate, sodium citrate (0 to 1 M) and DF 1 
with yield and purification factor as key responses. Black dots represent experimental 
conditions in the design space 
 
 
 
Figure 4.1: Flowchart of the approach used in this chapter to explore conditions for the 
initial Fab’ precipitation steps. Since the primary aim of such steps was to recover and 
purify the product, yield and purification factor was used as the key responses to judge 
performance  
Stage 3 
A second round of experimentation (CCF DoE) was conducted with more focused PEG 
conditions (PEG 12000, 0% to 20% w/v), salt conditions (0 to 0.6 M) at pH 7.4 and DF 1 with 
yield and purification factor as key responses This was followed by robustness testing. Black 
dots represent experimental conditions in the design space 
Stage 1 
Evaluation of a microscale mixing device with a new LHR for better scalability to laboratory 
and pilot scale. 
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STAGE 1 
 
4.3 Results and Discussion 
 
4.3.1 Validation of a Microscale Mixing Device 
 
Previous experimental DoE and automation were performed using a Multiprobe II EX 
(Packard Instrument Co., Meriden, USA) liquid handling robot. The Multiprobe II EX 
workstation (figure 3.13 A) was equipped with a four channel liquid handling arm for 
transferring liquids between labware and pipetting through the micro tips. The Tecan 
(Tecan, Reading, UK) was more advantageous as it was equipped with an eight 
channel liquid handling arm (LiHa) instead of the Multiprobe II EX (Packard 
Instrument Co., Meriden, USA) four channel arm, which increased liquid handling 
transfer by 50%. Furthermore, it was quicker, had superior reliability and was more 
customisable than the Multiprobe II EX (Packard Instrument Co., Meriden, USA). 
This part of the chapter describes the setup, automation and operation of a Tecan 
Freedom EVO 200 liquid handling robot (Tecan, Reading, UK) controlled by the 
Freedom EVOware software for microscale experiments.   
 
Accuracy of liquid handling on the Tecan (Tecan, Reading, UK) was controlled by 
water in the tubing and syringes to ensure pipetting accuracy. Liquid handling was 
defined by a set of conditions referred to as “liquid classes”. The parameters of 
which includes pipette calibration settings, aspiration dispense speeds in L s-1 
(range between 0.5 to 900 L s-1), airgap post aspiration (L), height, depth and 
location of pipette positions (z, y and x positioning), delay and detection modes. The 
Freedom EVOware software had predefined liquid classes for different applications 
and it was critical for the accuracy and precision of pipetting that the liquid classes 
were optimised to ensure accurate and reproducible results compared to the 
Multiprobe II EX (Packard Instrument Co., Meriden, USA) liquid handling robot.    

Custom liquid classes were developed for the pipetting of PEG to ensure accuracy. 
This involved decreasing the aspiration and dispense speeds from the standard 500 
L s
-1
 to 1 L s-1 and the z-max (depth of dispense) to dispense 1 mm below the 
stirrer plate surface (figure 4.3). Liquid tracking, which allows the tip to follow the 
liquid surface as it rises or descends was used to minimise droplet formation from 
continuing aspiration and dispense cycles, and the air gap post aspiration was set to 
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10 L. Water flushes were performed regularly to reduce cross contamination 
between liquid transfers.      
 
A typical deck layout for the experiments described in this chapter is shown in figure 
4.2 B; the layout was modified for a specific application or higher throughput. In the 
setup shown, the deck is configured with three carriers for holding microtiter plates 
and deepwell plates. In addition, the additional carriers are for holding reagent 
troughs.   
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Figure 4.2: Tecan Freedom EVO 200 liquid handling robot (LHR) (Tecan, Reading, 
UK) used for microscale experiments. (A) photograph of instrument and (B) is an 
example deck layout for experiments 
 
Mixing by the VP 772FN coin stirrers (V&P Scientific, San Diego, USA) at the 
bottom of microwells performed well under turbulent mixing speeds (section 3.3.3). 
However, it would be difficult to use the Power per unit volume as a scale up 
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parameter with this type of mixing due to the lack of control of speed and 
consistency of mixing. This parameter has been used successfully in scaling up 
bioreactors (Marques et al., 2010). There has been work on different forms of 
mixing within microwells including jet mixing, magnetic impellers and shaken 
microplates (Nealon et al., 2006, Titchener-Hooker et al., 2008). Efficient mixing in 
the form of jet mixing can be provided from the liquid addition by the pipette tip of 
the Tecan (Tecan, Reading, UK) followed by repeated reaspirations and dispenses 
(Nealon et al., 2006). However, this method does not suit the high throughput nature 
of this work. An alternative, robust and non variable mixing system was engineered 
and tested for better system scale up. The 5 mm PTFE magnetic coin stirrers 
(model VP 772FN) that were sourced from V&P Scientific (V&P Scientific, San 
Diego, USA) were mounted onto an acrylic plate to sit on top of the 1.3 mL 96 
deepwell plate (Nunc GmbH & Co., KG, Denmark). This allowed use of all 96 
deepwells and control over the speed of mixing. The speed of the mixing was 
controlled by a custom magnetic stirrer system connected to a tachometer, which 
was placed underneath the 96 deepwell plate (figure 4.2 B). The use of all 96 
deepwells improved throughput by 50% allowing twice the number of experimental 
conditions to be investigated on one plate compared to experimental conditions 
described in section 3.3.3. The mixing efficiency was visually observed using red 
food dye mixed with PEG 12000 15% w/v pH 7.4.   
 
For microscale data to be useful at large scale the design of the engineering 
environment within microwells needs to be understood and characterised. Rapid 
and efficient mixing is a key bioprocessing feature and underpins the quantification 
of precipitation reactions. There are a number of engineering principles to be 
considered for reactor design such as the impeller being located 1/3 of tank 
diameter off the bottom, impeller diameter 1/3 of tank diameter and liquid height = 
tank diameter. The impeller depth typically ranges from 1/3 to 1/6 off the vessel 
bottom. A very small clearance can cause radial flow with high shear, which may be 
beneficial for sweeping solids from the well bottom at the expense of bulk 
homogeneity (Boychyn et al., 2000, 2004). In this case, the stirrers were located 
approximately 1/3 from the bottom of the microwell. If the stirrers were mounted 
nearer to the base of the microwell this would have allowed use of smaller working 
volumes. However, this could have generated excessive turbulence and undesirable 
effects on the sensitive material. However, mixing at 1/3 clearance resulted in 
satisfactory mixing efficiency.  
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Figure 4.3: Diagram to show the microscale mixing device used for mixing with 1.3 
mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark). Stirrers (model VP 
772FN) were sourced from V&P Scientific (V&P Scientific, San Diego, USA) 
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A study to verify the reproducibility and robustness between the LHRs were 
performed at 1 mL scale on both the Multiprobe II EX (Packard Instrument Co., 
Meriden, USA) and Tecan (Tecan, Reading, UK) LHRs. Two experiments 
precipitating Fab’ in single and multimodal modes were performed on both LHRs. In 
single mode PEG 12000 was used to precipitate Fab’ and in multimodal mode PEG 
12000 was combined with 0.4 M sodium citrate. 
 
Stock solutions of PEG 12000 50% w/v in 100 mM Tris HCl pH 7.4 and 2.2 M 
sodium citrate pH 7.4 were made. The experiments were performed on a Tecan 
(Tecan, Reading, UK) and Multiprobe II EX (Packard Instrument Co., Meriden, USA) 
in 1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark). With the Tecan 
(Tecan, Reading, UK), the microscale mixing device (figure 4.3) was used for 
mixing. Mixing was controlled by a custom magnetic stirrer system connected to a 
tachometer placed underneath the 96 deepwell plate. Mixing speed was set to 1000 
rpm, which was sufficient to enable turbulent conditions. With the Multiprobe II EX 
(Packard Instrument Co., Meriden, USA), the V&P Scientific magnetic stirrers, 
model VP 772FN were placed at the bottom of the microwells for mixing. Mixing was 
controlled by a Corning PC-611 stirrer plate (Corning, New York, USA) set to an 
appropriate speed (dial number 7) to enable turbulent conditions.  
 
On both systems, 100 mM Tris HCl pH 7.4 and PEG (and sodium citrate in the 
second experiment) were added to appropriate wells of a 96 deepwell plate to give 
a volume of 670 L, followed by the addition of 330 L of homogenate feed to give a 
total volume of 1000 L. On the Tecan (Tecan, Reading, UK) the port on the 
microscale mixing device allowed liquid additions whilst mixing, as the stirrer plate 
was integrated into the workstation. Once liquid transfer was complete, the samples 
were mixed for 60 minutes. Mixing in this way was not possible on the Multiprobe II 
EX (Packard Instrument Co., Meriden, USA) and on this system, all reagents were 
added (PEG and buffer (and sodium citrate in the second experiment)), mixed for 2 
minutes prior to the addition of homogenate to ensure homogeneity of the 
precipitant) and then mixed for 60 minutes.  
 
After 60 minutes of mixing on both systems, the 96 deepwell plates were 
centrifuged at 4000 rpm for 25 minutes using an Eppendorf 5810R centrifuge 
(Eppendorf UK Ltd., Cambridge, UK). The supernatant was then carefully removed 
by the LHRs without disturbing the precipitated pellet and transferred to an 
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appropriate 96 well microtiter plate for Fab’ and total protein concentration analysis. 
Supernatant was analysed for Fab’ and total protein concentration using a 1 mL 
Protein G column (GE Healthcare, Uppsala, Sweden) on a Agilent 1200 HPLC 
system (Agilent, Edinburgh, UK) and the Pierce BCA total protein assay (Pierce, 
Rockford, USA) as described in sections 2.1 and 2.2 respectively. The precipitated 
pellets readily dissolved in 1 mL of 100 mM Tris HCl pH 7.4. Tables 4.1 and 4.2 give 
the list of conditions and the corresponding volumes of components for single and 
multimodal precipitation on both LHRs. 
 
Final PEG 12000 
concentration (% 
w/v)  
Volume of PEG (µL) Volume of 100 mM 
Tris HCl pH 7.4 
(µL) 
Volume of 
homogenate (µL) 
0.0 0 670 330 
2.5 50 620 330 
5.0 100 570 330 
7.5 150 520 330 
10.0 200 470 330 
12.5 250 420 330 
15.0 300 370 330 
17.5 350 320 330 
20.0 400 270 330 
 
Table 4.1: Table listing the composition of reaction mixtures for the comparative 
study between the LHRs at 1 mL scale per well in 1.3 mL deepwell plates for single 
mode precipitation. Table lists the volumes of homogenate pH 7.4, PEG 12000 
(from a stock concentration of 50% w/v pH 7.4) and 100 mM Tris HCl pH 7.4 that 
were used in this experiment. Co for Fab’ and total protein was 0.9 g L
-1 and 4.5 g   
L-1 respectively. This experiment was performed in 1.3 mL 96 deepwell plates (Nunc 
GmbH & Co., KG, Denmark) at 1 mL scale per well using a Multiprobe II EX 
(Packard Instrument Co., Meriden, USA) and a Tecan (Tecan, Reading, UK) for 
liquid handling. Samples that were prepared by the Multiprobe II EX (Packard 
Instrument Co., Meriden, USA) were mixed for a total of 60 minutes using VP 
772FN coin magnets (V&P Scientific, San Diego, USA) at turbulent mixing 
conditions on a Corning PC-611 stirrer plate (Corning, New York, USA). Samples 
that were prepared by the Tecan (Tecan, Reading, UK) were mixed for a total of 60 
minutes using the microscale mixing device at 1000 rpm. The plates were 
centrifuged and then the supernatant was analysed for Fab’ and total protein 
concentration as described in sections 2.1 and 2.2 respectively. The experiments 
were repeated in triplicate for robustness 
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Final PEG 12000 
concentration 
(% w/v)  
Volume of 
PEG (µL) 
Volume of 100 
mM Tris HCl pH 
7.4 (mL) 
Volume of 
sodium citrate 
(µL) 
Volume of 
homogenate 
(µL) 
0.0 0 490 180 330 
2.5 50 440 180 330 
5.0 100 390 180 330 
7.5 150 340 180 330 
10.0 200 290 180 330 
12.5 250 240 180 330 
15.0 300 190 180 330 
17.5 350 140 180 330 
20.0 400 90 180 330 
 
Table 4.2: Table listing the composition of reaction mixtures for the comparative 
study between the LHRs at 1 mL scale per well in 1.3 mL deepwell plates for 
multimodal precipitation. Table lists the volumes of homogenate pH 7.4, PEG 12000 
(from a stock concentration of 50% w/v pH 7.4), sodium citrate to give 0.4 M 
concentration (from a stock concentration of 2.2 M pH 7.4) and 100 mM Tris HCl pH 
7.4 that were used in this experiment. Co for Fab’ and total protein was 0.9 g L
-1 and 
4.5 g L-1 respectively. This experiment was performed in 1.3 mL 96 deepwell plates 
(Nunc GmbH & Co., KG, Denmark) at 1 mL scale per well using a Multiprobe II EX 
(Packard Instrument Co., Meriden, USA) and a Tecan (Tecan, Reading, UK) for 
liquid handling. Samples that were prepared by the Multiprobe II EX (Packard 
Instrument Co., Meriden, USA) were mixed for a total of 60 minutes using VP 
772FN coin magnets (V&P Scientific, San Diego, USA) at turbulent mixing 
conditions on a Corning PC-611 stirrer plate (Corning, New York, USA). Samples 
prepared by the Tecan (Tecan, Reading, UK) were mixed for a total of 60 minutes 
using the microscale mixing device at 1000 rpm. The plates were centrifuged and 
then the supernatant was analysed for Fab’ and total protein concentration as 
described in sections 2.1 and 2.2 respectively. The experiments were repeated in 
triplicate for robustness 
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Figure 4.4: Effect of PEG 12000 pH 7.4 on the solubility of Fab’ (●) and total protein 
(○) at 1 mL scale per well in a 1.3 mL deepwell plate using a Multiprobe II EX 
(Packard Instrument Co., Meriden, USA) for liquid handling and the effect of PEG 
12000 on the solubility of Fab’ (▲) total protein (∆) at 1 mL scale per well in a 1.3 
mL deepwell plate using a Tecan (Tecan, Reading, UK) for liquid handling. 
Homogenate pH 7.4, PEG 12000 (from a stock concentration of 50% w/v pH 7.4) 
and 100 mM Tris HCl pH 7.4 were used in this experiment. Co for Fab’ and total 
protein was 0.9 g L-1 and 4.5 g L-1 respectively. This experiment was performed in 
1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL scale per 
well using a Multiprobe II EX (Packard Instrument Co., Meriden, USA) and a Tecan 
(Tecan, Reading, UK) for liquid handling. Samples that were prepared by the 
Multiprobe II EX (Packard Instrument Co., Meriden, USA) were mixed for a total of 
60 minutes using VP 772FN coin magnets (V&P Scientific, San Diego, USA) at 
turbulent mixing conditions on a Corning PC-611 stirrer plate (Corning, New York, 
USA). Samples that were prepared by the Tecan (Tecan, Reading, UK) were mixed 
for a total of 60 minutes using the microscale mixing device at 1000 rpm. The plates 
were centrifuged and then the supernatant was analysed for Fab’ and total protein 
concentration as described in sections 2.1 and 2.2 respectively. Error bars are 
shown for one standard deviation for triplicate experiment repeats 
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Figure 4.5: Effect of PEG 12000/0.4 M sodium citrate pH 7.4 on the solubility of 
Fab’ at 1 mL scale per well in a 1.3 mL deepwell plate using the Tecan (Tecan, 
Reading, UK) for liquid handling with the microscale mixing device (▲) and 
Multiprobe II EX (Packard Instrument Co., Meriden, USA) (●) for liquid handling. Co 
for Fab’ was 0.9 g L-1. This experiment was performed in 1.3 mL 96 deepwell plates 
(Nunc GmbH & Co., KG, Denmark) at 1 mL scale per well using a Multiprobe II EX 
(Packard Instrument Co., Meriden, USA) and a Tecan (Tecan, Reading, UK) for 
liquid handling. Homogenate pH 7.4, PEG 12000 (from a stock concentration of 
50% w/v pH 7.4), sodium citrate to give 0.4 M concentration (from a stock 
concentration of 2.2 M pH 7.4) and 100 mM Tris HCl pH 7.4 were used in this 
experiment. Samples that were prepared by the Multiprobe II EX (Packard 
Instrument Co., Meriden, USA) were mixed for a total of 60 minutes using VP 
772FN coin magnets (V&P Scientific, San Diego, USA) at turbulent mixing 
conditions. Samples that were prepared by the Tecan (Tecan, Reading, UK) were 
mixed for a total of 60 minutes using the microscale mixing device at 1000 rpm. The 
plates were centrifuged and then the supernatant was analysed for Fab’ as 
described in section 2.1. Error bars are shown for one standard deviation for 
triplicate experiment repeats 
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A comparative study was performed to evaluate the performance of the Tecan 
(Tecan, Reading, UK) to that of the Multiprobe II EX (Packard Instrument Co., 
Meriden, USA). Figure 4.4 shows the effect of PEG 12000 pH 7.4 on the solubility 
profiles of Fab’ and total protein using both LHRs. There was a 9% and 12% 
difference on average between the Fab’ and total protein solubility profiles for the 
Tecan (Tecan, Reading, UK) and Multiprobe II EX (Packard Instrument Co., 
Meriden, USA) LHRs respectively. Figure 4.5 shows the effect of PEG 12000/0.4 M 
sodium citrate pH 7.4 on the Fab’ solubility profiles for both LHRs. There was a 5% 
difference on average between the Fab’ solubility profiles for the Tecan (Tecan, 
Reading, UK) and Multiprobe II EX (Packard Instrument Co., Meriden, USA) LHRs 
respectively. Interestingly, in both figures the percentage difference between the two 
LHRs was significantly reduced with increasing PEG concentration (> 8.5% PEG 
w/v) suggesting that any difference in liquid handling was normalised by the higher 
concentrations of PEG in the system. This is in part caused by the PEG becoming 
the driving force of the process. 
 
The two systems performance were comparable and the variation that was 
observed could be attributed in part to the experimental error in liquid transfer of the 
Multiprobe II EX (Packard Instrument Co., Meriden, USA) and the difference in 
mixing conditions. The disadvantage of using the Multiprobe II EX (Packard 
Instrument Co., Meriden, USA) for liquid handling, other than the four channel arm, 
was that the mixing conditions were difficult to control and thus difficult to use the 
Power per unit volume as a scale up parameter. This is a key scale up parameter, 
and has been used successfully in scaling up bioreactors for example (Marques et 
al., 2010).  The combination of high agitation at an unknown speed and the magnets 
location at the bottom of the microwells may have contributed to break up of some 
aggregates during nucleation caused in part by unwanted abrasion effects (Nealon 
et al., 2006, Titchener-Hooker et al., 2008). The consistency of pipetting was 
visually better with the Tecan (Tecan, Reading, UK). The Tecan (Tecan, Reading, 
UK) has an eight channel arm (LiHa), is more efficient, faster, reliable than the 
Multiprobe II EX (Packard Instrument Co., Meriden, USA) LHR and can integrate 
the microscale mixing device into the workstation (which was used for scale up 
studies described in section 5.3.2). The Tecan (Tecan, Reading, UK) can reportedly 
reproduce accurate pipetting within one microlitre (Wenger 2010) and was used for 
all future studies. 
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STAGE 2 
 
4.4 Results and Discussion 
 
Salts have two different and opposing effects on the solubility of proteins, firstly, 
electrostatic interactions at low salt concentrations, which increase the solubility of 
proteins (termed salting in), and secondly at higher salt concentrations hydrophobic 
effects result in salting out of proteins. Melander and Horváth (1977) proposed a 
“cavity theory” to describe the solubility of proteins in the presence of salts based on 
thermodynamics. This theory postulates that the surface tension of the water must 
be reduced to create a cavity that will accommodate the protein molecule in 
solution. Therefore, with the addition of high concentrations of salts, the solvent 
surface tension increases exposing the hydrophobic regions of the protein reducing 
protein solubility until precipitation occurs. The sequence of salts as described by 
Melandar and Horváth (1977) is a quantitative measure of the well known 
Hofmeister series (section 1.4.1) that describes the relative effectiveness of salting 
out properties of salts (Balasundaram et al., 2011). The addition of neutral salts 
results in their ions bonding with water molecules, which would otherwise be 
hydrating proteins. Proteins will be forced by reduced hydration to aggregate and 
precipitate in these conditions. This loss in the water monolayer surrounding the 
protein reduces the barrier to aggregation as high concentrations of salt ions are 
introduced to the system allowing aggregation from solute collisions, which is 
intensified by mixing.  
 
In chapter 3, experimental conditions within the NOR of the design space (figure 
3.23) for the precipitation of Fab’ from partially clarified cell culture fluid using PEG 
12000 15% w/v (undiluted homogenate and pH 7.4), delivered a Fab’ yield of 93% 
and a purification factor of 1.5. To improve the yield and purification factor, 
multimodal operation was investigated by combining PEG with a mixture of 
ammonium sulphate and sodium citrate concentrations. Salts were chosen due to 
being readily accepted by regulatory bodies and their different precipitating 
mechanism to that of single mode precipitation with PEG. Balasundaram et al., 
(2011) reported positive precipitation profiles of Fab’ using only ammonium sulphate 
and sodium citrate as precipitating agents at concentrations ˃ 0.4 M. It was reported 
that the higher the salt concentration used, the greater mass of total protein was 
precipitated.  
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4.4.1 Full Three Level Factorial DoE for the Study of Fab’ Precipitation 
Using PEG, Ammonium Sulphate and Sodium Citrate 
 
In section 3.4.2, a two level full factorial DoE design was used to screen conditions 
for Fab’ precipitation, which was followed by a CCF DoE (section 3.5.1) for 
optimisation using the Multiprobe II EX (Packard Instrument Co., Meriden, USA) for 
liquid handling. The full factorial DoE was completed first and then followed by a 
CCF DoE, reducing the number of potential experiments for the efficient mapping of 
the Fab’ precipitation system using PEG. This approach was taken due to the 
limitations of the LHR by having a four channel arm and only being able to use half 
a 96 deepwell plate caused by the strength of the magnets. However, the Tecan 
(Tecan, Reading, UK) had an eight channel arm (LiHa) and the microscale mixing 
device allowed for use of all 96 deepwells improving throughput by at least 50% 
relative to conditions described in section 3.3.3. Therefore, multimodal operation 
was investigated by combining PEG with a mixture of ammonium sulphate 
concentrations and sodium citrate concentrations in a three level full factorial design 
to efficiently map out a large design space without completing a screening study 
first. This design allowed the mapping of possible curvature in the response function 
in one experiment, essentially the equivalent of combining the DoE described in 
sections 3.4.2 and 3.5.1 in one experiment. Examples of both two and three level 
factorial designs are shown in figure 4.6. 
 
 
Figure 4.6: Examples of two and three level full factorial designs. The black dots 
represent the experiments in the design space. A three level full factorial design is a 
response surface methodology design allowing for full mapping of the response 
surface (which includes curvature). A full factorial two level design requires other 
designs such as CCF design to be augmented for mapping curvature in the design 
space 
Two level full factorial design Three level full factorial design
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PEG 4000, 8000 and 12000 at stock concentrations of 50% w/v were made in 100 
mM Tris HCl pH 5, 7.4 and 9. Stock solutions of each of the salts were made up to a 
maximum molarity of 2.2 M (pH 5, 7.4 and 9), limited by the difficulty in solubilising 
sodium citrate at higher concentrations. In addition, ammonium sulphate can made 
to 4 M; however, the maximum salt concentration that can be used without 
interfering with the Pierce BCA total protein assay is 1.5 M as per the 
manufacturer’s instructions. Therefore, all salts were made to a stock concentration 
of 2.2 M, and thus the maximum salt concentration in the system was 1.4 M as per 
table 4.3. 1 mL total working volume was used in 1.3 mL 96 deepwell plates (Nunc 
GmbH & Co., KG, Denmark), of this 1 mL volume, Fab’ homogenate was 330 L in 
each microwell. The remaining 670 L was split between a combination of PEG, 
salts and buffer for multimodal operation. The maximum molar stock solution of salt 
was 2.2 M, which resulted in a maximum of 1.4 M in the reaction mixture with PEG 
0% w/v. This value dropped to 0.8 M with the addition of 15% PEG (Table 4.3). The 
Tecan (Tecan, Reading, UK) was preprogramed to carry out all liquid handling.   
 
Maximum salt molarity combinations was determined at different PEG 
concentrations (0% to 20% w/v), ensuring that the maximum salt concentration was 
not exceeded in the DoE (table 4.3).   
 
PEG (% w/v) 
Volume of 
PEG (µL) 
Maximum 
molar of 
salt [M] 
Volume of 
salt (µL) 
Volume of 
buffer (µL) 
Volume of 
homogenate 
(µL) 
0 0 1.4 635 35 330 
5 100 1.2 545 25 330 
10 200 1.0 455 15 330 
15 300 0.8 365 5 330 
 
Table 4.3: Table listing the maximum molarity of salt possible at 1 mL scale using 
stock 2.2 M salt concentrations, PEG (stock 50% w/v concentration of PEG 4000, 
8000 and 12000) and 100 mM Tris HCl solutions in the pH range of 5 to 9 
 
For each of the conditions outlined in table 4.4 the yield and purification factor was 
calculated as described in section 3.4.1. As a key requirement for a primary 
purification process, a minimum yield of Fab’ of 90% was chosen as acceptable for 
this primary process step. The inputs of the DoE were: 
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 pH 5, 7.4 and 9  
 PEG molecular weights of 4000, 8000 and 12000  
 PEG concentration 5% to 15% w/v  
 Ammonium sulphate concentration 0 to 1 M  
 Sodium citrate concentration 0 to 1 M  
However, due to the limitations of stock PEG and salt concentrations. The maximum 
concentration of salt at PEG 15% w/v was 0.8 M (table 4.3). Salt concentrations in 
experiment number 16-17, 24-26 and 31-34 (table 4.4) were modified to the 
maximum amount of salt concentration possible in the system. This resulted in the 
upper right hand corner of the experimental design space being inaccessible for 
experimentation as shown in figure 4.7.   
 
 
Figure 4.7: Shows the irregular experimental design space where the upper right 
hand corner of the experimental design space was inaccessible for experimentation 
due to process limitations governed by stock salt and PEG concentrations used. For 
example the maximum concentration of salt possible in a microwell at PEG 15% w/v 
was 0.8 M (table 4.3). The black dots represent the experimental conditions in the 
design space. This experimental design was repeated for each PEG molecular 
weight (4000, 8000 and 12000) and pH (5, 7.4 and 9)  
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The experimental plan in table 4.4 was performed at pH 5, 7.4 and 9 using PEG 
4000, 8000 and 12000, and PEG concentrations 5% to 15% w/v. The experimental 
design was also completed at 0% w/v independently of the DoE shown in table 4.4 
resulting in a total of 324 experimental conditions. A study with this many conditions 
would not have been feasible at laboratory scale, highlighting a benefit of operating 
at microscale.  
Run 
PEG 
(% 
w/v) 
Ammonium 
sulphate [M] 
Sodium 
citrate [M] 
Run 
PEG 
(% 
w/v) 
Ammonium 
sulphate [M] 
Sodium 
citrate [M] 
1 0 0.00 0.00 19 10 0.40 0.00 
2 0 0.40 0.00 20 10 0.00 0.40 
3 0 0.00 0.40 21 10 0.40 0.40 
4 0 0.40 0.40 22 10 0.00 1.00 
5 0 0.00 1.00 23 10 1.00 0.00 
6 0 1.00 0.00 24 10 0.50 0.50 
7 0 0.75 0.75 25 10 0.27 0.67 
8 0 0.40 1.00 26 10 0.67 0.27 
9 0 1.00 0.40 27 15 0.00 0.00 
10 5 0.00 0.00 28 15 0.40 0.00 
11 5 0.40 0.00 29 15 0.00 0.40 
12 5 0.00 0.40 30 15 0.40 0.40 
13 5 0.40 0.40 31 15 0.00 0.80 
14 5 0.00 1.00 32 15 0.80 0.00 
15 5 1.00 0.00 33 15 0.21 0.53 
16 5 0.20 1.00 34 15 0.53 0.21 
17 5 1.00 0.20 35 10 0.50 0.50 
18 10 0.00 0.00 36 10 0.50 0.50 
 
Table 4.4: Table listing the full three level factorial design for multimodal 
precipitation. The experiments in this table were performed for PEG 4000, 8000 and 
12000 at pH 5, 7.4 and 9. The highlighted values (█ ammonium sulphate and █ 
sodium citrate) were modified to allow for the maximum salt concentration in the 
system (table 4.3). Homogenate at the appropriate pH, PEG (from a stock 
concentration of 50% w/v at the appropriate pH), sodium citrate and ammonium 
sulphate (from a stock concentration of 2.2 M at the appropriate pH) and 100 mM 
Tris HCl at the appropriate pH were prepared for this experiment. Co for Fab’ and 
total protein was 0.9 g L-1 and 4.5 g L-1 respectively. This experiment was performed 
in 1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL scale per 
well using a Tecan (Tecan, Reading, UK) for liquid handling. Samples that were 
prepared by the Tecan (Tecan, Reading, UK) were mixed for a total of 60 minutes 
using the microscale mixing device at 1000 rpm. The plates were centrifuged and 
then the supernatant was analysed for Fab’ and total protein concentration as 
described in sections 2.1 and 2.2 respectively 
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Interestingly, an aqueous two phase system was observed between PEG and salt at 
concentrations of salt ≥ 0.8 M and PEG concentrations ≥ 5% w/v after the 
centrifugation step, post precipitation at all PEG molecular weights investigated. The 
two phases may have been present before the addition of Fab’ and the 
centrifugation step, although it was difficult to observe this in non transparent 
deepwell plates. This affected 40% of the irregular design space, which was 
excluded from analysis as the study of an aqueous two phase system was beyond 
the scope of this project (figure 4.8). In this case, the initial design was too large 
resulting in an irregular design space, which was further reduced by the formation of 
an aqueous two phase system in 40% of that design space. If this study was 
conducted at laboratory scale where the volumes required are much larger than at 
microscale (10-100 mL relative to 20-2000 L), this study would have resulted in the 
waste of time and resources for minimal gain. In theory, there are two methods of 
handling irregular designs. The first is to shrink the factor ranges so that the design 
becomes regular and the second is the use of D-optimal design, which is adapted to 
spreading experiments in an irregular region (Lundstedt et al., 1998).  
 
 
 
Figure 4.8: The black dots represent the experimental conditions where two phase 
formation does not to occur in the irregular design space (figure 4.7). Two phase 
formation affected 40% of the irregular design space shown in figure 4.7. Two 
phase formation was observed at salt concentrations ≥ 0.8 M with PEG 
concentrations ≥ 5% w/v. This design was repeated for each PEG molecular weight 
(4000, 8000 and 12000) and pH (5, 7.4 and 9) 
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Eiteman and Gainer (1991), Perumalsamy and Murugesan (2006) and Rosa et al., 
(2007) reported two phase systems with PEG and sodium citrate at similar 
conditions. The aqueous two phase system of PEG and salt has been discussed in 
literature previously (Azevedo et al., 2009 (b)). Aqueous two phase systems are 
formed spontaneously upon mixing two aqueous solutions of structurally different 
components, such as two polymers or a polymer and a salt, above a certain critical 
concentration (Azevedo et al., 2009 (a)). An example is shown in figure 4.9 for PEG 
and salt (Azevedo et al., 2009 (a)). The partitions of proteins in aqueous two phase 
systems form as a result of the phase separation of mixtures of PEG polymer and 
salt (Huddleston et al., 1994, Huddleston et al., 1996). PEG and salt are present in 
the top and bottom phase respectively, due to the increase in hydrophobicity of PEG 
molecules (Perumalsamy and Murugesan 2006). Marcos et al., (1998) and Aguilar 
et al., (2006) demonstrated purification of penicillin acylase from extracts of E.coli 
from PEG and sodium phosphate systems.  
 
 
 
Figure 4.9: Schematic diagram illustrating the behaviour of antibodies and 
impurities in a PEG–salt two phase system (Azevedo et al., 2009 (a)) 
 
A PLS (partial least square) model was used to analyse the design matrix as this 
method can be useful for handling missing data in the response matrix (Lundstedt et 
al., 1998). However, the resulting model had a poor fit due to 40% of the irregular 
design space being omitted for analysis, and that the omitted results were not 
randomly scattered throughout the design space. Therefore, a more focused DoE 
was performed, which reduced the design space to form a regular design, avoiding 
the two phase formation between salts and PEG, discussed in section 4.5.2.  
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However, it was possible to observe the effect of several combinations of 
ammonium sulphate and sodium citrate at different ratios on the solubility profile of 
Fab’ through synergistic or antagonistic effects at zero PEG added (figure 4.10). 
The experimental conditions are listed in table 4.4 of which experiment run numbers 
1 to 9 were performed at pH 5, 7.4 and 9. ANOVA analysis suggested that the 
model had no lack of fit as the p-value was >  0.05 (p-value was 0.16), with an Q2 
value of 0.92. 
 
 
 
Figure 4.10: 4D contour plots showing the yield and purification factor of Fab’ as a 
function of ammonium sulphate concentration [M] and sodium citrate concentration 
[M] at varying pH. Experiment numbers 1 to 9 were performed at pH 5, 7.4 and 9 as 
per table 4.4. The experiment setup is described in the table 4.4 legend. The 
response surfaces for yield and purification factor were fit with a quadratic model. All 
data fitting was performed using the software package MODDE 9.1 (Umetrics, 
Malmö, Sweden) 
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Figure 4.10 shows contour plots for Fab’ yield and purification factor at pH 5, 7.4 
and 9. Figure 4.10 suggests that the precipitation of both Fab’ and proteins 
somewhat increased with the decrease in pH (at 1 M ammonium sulphate Fab’ yield 
increased from 52% at pH 9 to 56% at pH 5; purification factor decreased from 0.8 
at pH 9 to 0.6 at pH 5). Similar results with sodium citrate were observed (at 1 M 
sodium citrate Fab’ yield increased from 55% at pH 9 to 66% at pH 5; purification 
factor decreased from 0.8 at pH 9 to 0.6 at pH 5. The solubility of protein decreases 
with either decrease in pH or increase in salt concentration used, as reported 
previously (Foster et al., 1976). 
 
At ≤ 0.4 M concentrations of sodium citrate and ammonium sulphate Fab’ 
precipitation was low < 40% on average in the pH range suggesting electrostatic 
interactions dominate at this concentration range. The introduction of low 
concentrations of salt may be thermodynamically favourable resulting in an increase 
in solubility of the protein (Arakawa and Timasheff 1982). The precipitating potential 
of ammonium sulphate and sodium citrate at ˃ 0.6 M results in much higher Fab’ 
precipitation which suggests hydrophobic interactions are overwhelming 
electrostatic effects at higher salt concentrations. This is in agreement with the 
solvophobic theory proposed by Melander and Horváth (1977) who suggested that 
at high salt concentrations solvent surface tension is increased exposing 
hydrophobic regions of proteins resulting in precipitation. Harinarayan et al., (2008) 
suggested that the binding of citrate ions with Fab’ at high citrate concentrations 
could potentially displace water molecules from the Fab’ directly, helping to reduce 
solubility.  
 
At 1.5 M combined concentration, the combination of salts resulted in 20% to 30% 
greater precipitation of Fab’ compared to individual salts concentrations at 0.4 M. 
This indicates the synergistic effects of ammonium sulphate and sodium citrate on 
the precipitation of Fab’. This behaviour appears to be specific for Fab’ and not for 
protein impurities as the purification factor increased ~1.5x at this salt concentration 
and in the pH range investigated suggesting some selectivity. It is known that for a 
salting out system the solubility of a protein increases with salt concentration until 
the salt concentration becomes sufficiently high to cause salting out (Dixon and 
Webb 1961). Sodium citrate in single mode did not precipitate Fab’ efficiently (~55% 
at 1 M within the pH range investigated) indicating that hydrophobic effects by 
increasing sodium citrate concentration were not sufficient to precipitate Fab’ to 
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obtain high yields. Combining ammonium sulphate and sodium citrate at 2 M, Fab 
yield increased to ~70% within the pH range investigated. The purification factor 
was low (maximum of ~1.1 PF), which increased with increasing pH in the range 
investigated. Therefore, in the range investigated, to maximise yield and purification 
factor, precipitation conditions using high concentrations of ammonium sulphate and 
sodium citrate (> 1 M) and pH 9 are recommended. It was hypothesised that the 
synergistic properties of sodium citrate and ammonium sulphate with the addition of 
PEG in multimodal mode may improve both the Fab’ yield and purification factor. 
 
 
Figure 4.11: The effect of PEG 12000 (●), PEG 12000/0.4 M ammonium sulphate 
(○) and PEG 12000/0.4 M sodium citrate (▼) at pH 7.4 on Fab’ yield. Co for Fab’ 
was 0.9 g L-1. Homogenate pH 7.4, PEG (from a stock concentration of 50% w/v pH 
7.4), sodium citrate and ammonium sulphate (from a stock concentration of 2.2 M 
pH 7.4) and 100 mM Tris HCl pH 7.4 were used in this experiment. This experiment 
was performed in 1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark) at 
1 mL scale per well using a Tecan (Tecan, Reading, UK) for liquid handling. 
Samples that were prepared by the Tecan (Tecan, Reading, UK) were mixed for a 
total of 60 minutes using the microscale mixing device at 1000 rpm. The plates were 
centrifuged and then the supernatant was analysed for Fab’ as described in section 
2.1. Error bars are shown for one standard deviation for triplicate experiment 
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Figure 4.12: The effect of PEG 12000 (●), PEG 12000/0.4 M ammonium sulphate 
(○) and PEG 12000/0.4 M sodium citrate (▼) at pH 7.4 on Fab’ purity. Co for Fab’ 
and total protein was 0.9 g L-1 and 4.5 g L-1 respectively. Homogenate pH 7.4, PEG 
(from a stock concentration of 50% w/v pH 7.4), sodium citrate and ammonium 
sulphate (from a stock concentration of 2.2 M pH 7.4) and 100 mM Tris HCl pH 7.4 
were used in this experiment. This experiment was performed in 1.3 mL 96 
deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL scale per well using a 
Tecan (Tecan, Reading, UK) for liquid handling. Samples that were prepared by the 
Tecan (Tecan, Reading, UK) were mixed for a total of 60 minutes using the 
microscale mixing device at 1000 rpm. The plates were centrifuged and then the 
supernatant was analysed for Fab’ and total protein concentration as described in 
sections 2.1 and 2.2 respectively. Error bars are shown for one standard deviation 
for triplicate experiment repeats 
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Figure 4.11 shows the resultant Fab’ solubility profiles combining salt with PEG. The 
addition of ammonium sulphate and sodium citrate at a salt concentration of 0.4 M 
with PEG was investigated at microscale. PEG 12000 15% w/v pH 7.4 was required 
to obtain a yield of 95%, whereas 83% yield was achievable at 10% w/v. The 
percentage purity (calculated from the Pierce BCA total protein assay kit) did not 
increase beyond 20% indicating that substantial material was insolubilised due to 
non specific precipitation by PEG (figure 4.12).   
 
At 5% PEG with no salt added Fab’ percentage purity was 2%, which increased to 
54% and 49% with ammonium sulphate and sodium citrate at 0.6 M respectively 
(figure 4.12). Fab’ yield increased from 45% to 80% with PEG 10% and 15% w/v 
with 0.6 M ammonium sulphate respectively. This suggested that the concentration 
of ammonium sulphate was sufficiently low to induce a salting in effect of Fab’. At 
PEG 15% w/v Fab’ yield increased, due to the PEG becoming the driving force of 
the process resulting in a more thermodynamically favourable state (Lee and Lee 
1981) (figure 4.11). Interestingly, at this point purity dropped from to 37% from 57%, 
due to the increase in proteins precipitated simultaneously by the PEG. A two cut 
fractional precipitation process can be operated to selectively precipitate impurities 
according to their different solubilities. However, more investigation is required as 
ammonium sulphate does not appear to selectively solubilise Fab’ as the 
percentage purity does not alter significantly between PEG 0% to 10% w/v (figure 
4.12).   
 
The addition of 0.4 M sodium citrate caused purity to increase from 16% to 55% 
with PEG 0% w/v and 15% w/v respectively (figure 4.12). There appeared to be no 
change in yield by increasing concentrations of PEG, which on average was 48% 
(figure 4.11). Harinarayan et al., (2008) suggested that there was an electrostatic 
interaction associated with the trivalent citrate ions and Fab, which may in part 
explain the insignificant change in yield with increasing PEG concentration. This 
complicates the understanding of the behaviour of this protein in a complex mixture 
of salts containing citrate ions. Janson and Rydén (1998) discussed that larger 
proteins are less soluble than smaller proteins, and proteins with surfaces rich in 
hydrophobic amino acids are less soluble in water than those proteins whose 
surfaces are rich in hydrophilic amino acids. However, Fab’ was observed to 
precipitate out readily with PEG in part due to its size (~54 kDa) and higher 
hydrophobic properties. However, these properties in multimodal conditions may be 
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shielded increasing the solubility of Fab’, as a result of the added complexity of the 
multimodal precipitation mechanism. The differences in Fab’ and total protein 
solubility profiles between different PEG molecular weights and different pH values 
were marginal.  
 
STAGE 3 
 
4.5 Results and Discussion 
 
4.5.1 Evaluation of Variables for Fab’ Precipitation using PEG, 
Ammonium Sulphate, Sodium Citrate and Sodium Chloride 
 
The experimental approach based on DoE has been used extensively in research 
(Lundstedt et al., 1998). The purpose is to systematically analyse how the response 
of a system changes when parameters of that system are changed. However some 
understanding of the limitations of the system prior to investigating large design 
spaces is important in preventing a waste of resources for minimal gain.  
 
To prevent two phase formation between PEG and salts, the total salt concentration 
in the system was limited to 0.6 M. Further input ranges were limited to using PEG 
12000, pH 7.4 and homogenate dilution factor of one, as it was found that the 
precipitation system was robust in a wide range of PEG molecular weights and pH. 
The dilution of the feed material is undesirable as it results in large processing 
volume at process scale. Thus, the investigations of multimodal precipitation 
conditions were studied without any dilution of the process stream. Sodium chloride, 
an extra salt, was additionally investigated, as incorporating an extra factor in the 
previous three level full factorial design (section 4.5.1) would have resulted in the 
number of experiments to become prohibitively large even at microscale. The 
number of experiments would have been 972 (1944 in duplicate).  
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Figure 4.13: The effect of PEG 12000/0.2 M ammonium sulphate/sodium 
citrate/sodium chloride pH 7.4 on the solubility of Fab’ (●) and total protein (○). 
Homogenate pH 7.4, PEG (from a stock concentration of 50% w/v pH 7.4), sodium 
citrate and ammonium sulphate (from a stock concentration of 2.2 M pH 7.4) and 
100 mM Tris HCl pH 7.4 were used in this experiment. Co for Fab’ and total protein 
was 0.9 g L-1 and 4.5 g L-1 respectively. This experiment was performed in 1.3 mL 
96 deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL scale per well using 
a Tecan (Tecan, Reading, UK) for liquid handling. Samples prepared by the Tecan 
(Tecan, Reading, UK) were mixed for a total of 60 minutes using the microscale 
mixing device at 1000 rpm. The plates were centrifuged and then the supernatant 
was analysed for Fab’ and total protein concentration as described in sections 2.1 
and 2.2 respectively. Error bars are shown for one standard deviation for triplicate 
experiment repeats 
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Figure 4.14: The effect of PEG 12000/0.3 M ammonium sulphate/sodium citrate pH 
7.4 on the solubility of Fab’ (●) and total protein (○). Homogenate pH 7.4, PEG (from 
a stock concentration of 50% w/v pH 7.4), sodium citrate and ammonium sulphate 
(from a stock concentration of 2.2 M pH 7.4) and 100 mM Tris HCl pH 7.4 were 
used in this experiment. Co for Fab’ and total protein was 0.9 g L
-1 and 4.5 g L-1 
respectively. This experiment was performed in 1.3 mL 96 deepwell plates (Nunc 
GmbH & Co., KG, Denmark) at 1 mL scale per well using a Tecan (Tecan, Reading, 
UK) for liquid handling. Samples prepared by the Tecan (Tecan, Reading, UK) were 
mixed for a total of 60 minutes using the microscale mixing device at 1000 rpm. The 
plates were centrifuged and then the supernatant was analysed for Fab’ and total 
protein concentration as described in sections 2.1 and 2.2 respectively. Error bars 
are shown for one standard deviation for triplicate experiment repeats 
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Figures 4.13 and 4.14 show the solubility profiles for Fab’ and total protein with PEG 
12000/0.2 M ammonium sulphate/sodium citrate/sodium chloride pH 7.4 and PEG 
12000/0.3 M ammonium sulphate/sodium citrate pH 7.4 respectively. 
 
Increased solubility termed salting in at low concentrations of salt has been 
described earlier (Foster et al., 1976). In figures 4.13 and 4.14, additional soluble 
Fab’ was observed between PEG 0% to 5% w/v and low salt concentrations. In 
addition, in figure 4.14, the amount of Fab’ that became soluble was high (10%) to 
be attributed to the salting in phenomenon alone (Balasundaram et al., 2011). 
Balasundaram et al., (2011) suggested that positively charged Fab’ bound with 
negatively charged species such as micronised cell debris and chromosomal DNA 
in the homogenate via electrostatic interactions disassociate in the presence of low 
salt concentrations increasing Fab’ concentration. As PEG concentration increases 
beyond 10% w/v the electrostatic forces brought about by low concentrations of salt 
are eventually overcome by the opposing hydrophobic effects of PEG as the system 
becomes more thermodynamically stable (Lee and Lee 1981).  
 
In figure 4.13, the total protein content dropped by 20% from PEG 0% to 10% w/v, 
which then appeared to stabilise with increasing PEG concentrations, whilst the 
Fab’ solubility increased by 7% from PEG 10% to 20% w/v. This suggests a 
combination of electrostatic and hydrophobic interactions between the salts and 
PEG. The Hofmeister series is  a sequence of salts (anion) as described by 
Melander and Horváth (1977), which describes the relative effectiveness of salting 
out properties of salts in order of effectiveness in the increasing solvent surface 
tension to reduce the solubility of proteins (with citrate followed by sulphate followed 
by chloride). In this case, the behaviour of proteins in the presence of a mixture of 
salts with PEG is complex and hence the effectiveness of salts in multimodal 
precipitation with PEG cannot be predicted using Hofmeister series. 
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Figure 4.15: The effect of single/multimodal conditions on the solubility of Fab’ (▲) 
and total protein (●) at pH 7.4, (A) PEG 12000, (B) PEG 12000/0.6 M ammonium 
sulphate, (C) PEG 12000/0.6 M sodium citrate and (D) PEG 12000/0.6 M sodium 
chloride. Homogenate pH 7.4, PEG (from a stock concentration of 50% w/v pH 7.4), 
sodium citrate and ammonium sulphate (from a stock concentration of 2.2 M pH 7.4) 
and 100 mM Tris HCl pH 7.4 were used in this experiment. Co for Fab’ and total 
protein was 0.9 g L-1 and 4.5 g L-1 respectively. This experiment was performed in 
1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL scale per 
well using a Tecan (Tecan, Reading, UK) for liquid handling. Samples prepared by 
the Tecan (Tecan, Reading, UK) were mixed for a total of 60 minutes using the 
microscale mixing device at 1000 rpm. The plates were centrifuged and then the 
supernatant was analysed for Fab’ and total protein concentration as described in 
sections 2.1 and 2.2 respectively. Error bars are shown for one standard deviation 
for triplicate experiment repeats 
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Figure 4.15 shows the effect of multimodal conditions on the resultant solubility 
profiles of Fab’ and total protein. As a comparison figure 4.10 (A) represents a Fab’ 
and total protein solubility profile with PEG 12000 in single mode, (which has been 
discussed previously in section 3.3.2). An 18% increase in Fab’ yield was observed 
from PEG 10% to 20% w/v. However, an increase of 39% of protein impurities were 
observed between PEG 15% to 20% w/v. 
 
Figures 4.15 (B) and (D) show the solubility profiles of PEG 12000/0.6 M ammonium 
and PEG 12000/0.6 M sodium citrate. The phenomenon of increased solubility of 
salting in at low concentrations of salt is well known (Foster et al., 1976). A salting in 
effect of Fab’ over the PEG range 0% to 10% w/v was observed with ammonium 
sulphate and sodium chloride in part due to the electrostatic interactions, which 
appear to be specific to Fab’. Balasundaram et al., (2011) suggested that positively 
charged Fab’ bound with negatively charged species such as micronised cell debris 
and chromosomal DNA in the homogenate via electrostatic interactions 
disassociates in the presence of low salt concentrations increasing Fab’ 
concentration. The total protein concentration dropped on average 32% and 46% 
between PEG range 5% to 10% w/v for ammonium sulphate and sodium chloride 
respectively. As the concentration of PEG was increased, the hydrophobic 
interactions overwhelmed the electrostatic interactions, exposing hydrophobic 
regions of proteins, resulting in increased precipitation. However, sodium chloride 
appears to have stronger electrostatic interactions than ammonium sulphate at PEG 
15% w/v. Fab’ solubility in the presence of sodium chloride decreased by 10% 
relative to 80% with ammonium sulphate. This is predicted by the Hofmeister series 
as described by Melander and Horváth (1977), who suggested that sulphate is more 
effective than chloride in increasing the solvent surface tension to reduce the 
solubility of proteins. 
 
Figure 4.15 (C) shows the effect of sodium citrate on the resultant solubility profiles 
of Fab’ and total protein. At PEG 15% w/v with 0.6 M sodium citrate, there was 8% 
Fab’ remaining in the supernatant, which was the minimum solubility of Fab’ for all 
the conditions studied. This is supported by the Hofmeister series, which suggests 
that citrate is more effective than sulphate and chloride for precipitating proteins 
(Melander and Horváth 1977). The advantage of this system is that less total protein 
is precipitated out between the PEG range 5% to 10% w/v relative to the multimodal 
system with ammonium sulphate (26% relative to 32%), increasing purification 
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factor. These results are consistent with that reported by Shih et al., (1992) who 
found that the precipitation of lysozyme was improved with sulphate relative to 
chloride, consistent with the Hofmeister series. 
 
4.5.2 Central Composite Face Centred DoE for the Study of Fab’ and 
Protein Impurity Precipitation Using PEG, Ammonium Sulphate, 
Sodium Citrate and Sodium Chloride 
 
Compared to the traditional one-factor-at-a-time method, DoE drastically reduces 
the number of runs required to determine the desirable settings. In terms of QbD, 
regulators want assurance that all unit operations meet specification. Then the 
objective is to define a processing window that provides a high level of confidence 
to meet specifications (for example ≥ 95% confidence). A design space, based on 
QbD principles, can be used to map out a region where the product can be reliably 
manufactured. This gives boundaries by buffering them with tolerance intervals 
allowing for the inevitable process drift from changing raw materials and other 
sources of natural variability.  
 
A DoE was designed to study multimodal precipitation of Fab’ and protein 
impurities, whilst reducing those variables that would not have a significant effect on 
the system based on previous experimental data described in sections 3.4.2, 3.5.1 
and 4.5.1. A screening and optimisation DoE with PEG described in sections 3.4.2 
and 3.5.1, found that the precipitation system was robust in a wide range of PEG 
molecular weights and pH conditions. Therefore, input ranges were reduced to 
using PEG 12000 and pH 7.4, although it was found and supported by 
Balasundaram et al., (2011) that a decrease in Fab’ solubility was observed by 
decreasing pH from 7 to 3.5. This may in part be caused by acid precipitation. 
Dilution factor of feed material of one was used throughout, as the dilution of the 
feed material was undesirable as it results in a large processing volume at process 
scale. Thus, the investigations of multimodal precipitation conditions were studied 
without any dilution of process stream. Whilst it was possible that the optimum 
conditions defined may change with the addition of salts, the reduction in the 
amount of experimental runs required justified the holding of these parameters 
constant. Multimodal operation involved the addition of three salts from varying 
positions in the Hofmeister series with PEG over a concentration range of 0% to 
20% w/v. Salts, ammonium sulphate, sodium citrate and sodium chloride were 
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added in varying combinations to give a maximum concentration of 0.6 M to prevent 
two phase formation with PEG, and to maintain a regular design space.  
 
A central composite face centred DoE was designed using MODDE 9.1 (Umetrics, 
Malmö, Sweden) as it was known that each of the salts have a significant effect on 
the precipitation of Fab’ and protein impurities (Foster et al., 1971, Foster et al., 
1976, Melander and Horváth 1977, Shih et al., 1992, Balasundaram et al., 2010 and 
figure 4.10). A screening study at this point would just show that these variables are 
significant over the range chosen. In this design the experiments are centred on the 
face of the cube, which implies that all factors have three levels, instead of two 
levels in the factorial design. The flexibility of three levels per factor allows support 
for a quadratic model for response surface modelling (figure 4.16). 
 
 
Figure 4.16: CCF design for investigating Fab’ and total protein precipitation using 
PEG and salts in multimodal mode. Black dots represent experiments in the design 
space. Ranges were PEG 12000 0% to 20% w/v, ammonium sulphate, sodium 
citrate and sodium chloride 0 to 0.6 M at pH 7.4, and a homogenate dilution factor of 
1 
 
To prevent the formation of two phases with PEG and salts, the maximum 
concentration of salts at PEG ≥ 5% w/v was 0.6 M. Salt concentrations in table 4.4, 
experiment number 15-16 were modified to maintain a maximum of 0.6 M salt 
concentration in the system. Although experiment number 15 did not require the salt 
concentration to be altered, this was done to retain comparability with experiment 
16. PEG concentrations ranging from 0% w/v to 20% w/v were investigated due to 
the non linearity of the precipitation system. The solubility of both total protein and 
Fab’ varies considerably in this range and failure to account for this would result in 
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an inaccurate model for the system. The experimental design was repeated in 
duplicate for robustness.    
 
The Tecan (Tecan, Reading, UK) was preprogramed to carry out all liquid handling.  
PEG 12000 was made at a stock concentration of 50% w/v in 100 mM Tris HCl pH 
7.4. Stock solutions of each of the salts were made up to a maximum molarity of 2.2 
M at pH 7.4. 1 mL total working volume was used in 1.3 mL 96 deepwell plates 
(Nunc GmbH & Co., KG, Denmark), of this 1 mL, depending on conditions needed, 
670 L or reaction volume was split between a combination of PEG, salts and buffer 
for multimodal operation and the remaining 330 L was E.coli Fab’ homogenate, 
which was added last. Following addition, the plate was mixed for 60 minutes with 
the microscale mixing device at 1000 rpm, followed by centrifugation at 4000 rpm 
for 25 minutes using a Eppendorf 5810R centrifuge (Eppendorf UK Ltd., Cambridge, 
UK). The supernatant was then carefully removed by the Tecan (Tecan, Reading, 
UK) and assayed for Fab’ and total protein concentration as described in sections 
2.1 and 2.2. The precipitated pellets dissolved readily with 1 mL 100 mM Tris HCl 
pH 7.4.      
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Experiment 
number 
PEG 
concentration (% 
w/v) 
Ammonium 
sulphate [M] 
Sodium 
citrate [M] 
Sodium 
chloride [M] 
1 0 0.00 0.00 0.00 
2 20 0.00 0.00 0.00 
3 0 0.60 0.00 0.00 
4 20 0.60 0.00 0.00 
5 0 0.00 0.60 0.00 
6 20 0.00 0.60 0.00 
7 0 0.30 0.30 0.00 
8 20 0.30 0.30 0.00 
9 0 0.00 0.00 0.60 
10 20 0.00 0.00 0.60 
11 0 0.30 0.00 0.30 
12 20 0.30 0.00 0.30 
13 0 0.00 0.30 0.30 
14 20 0.00 0.30 0.30 
15 0 0.20 0.20 0.20 
16 20 0.20 0.20 0.20 
17 0 0.15 0.15 0.15 
18 20 0.15 0.15 0.15 
19 10 0.00 0.15 0.15 
20 10 0.30 0.15 0.15 
21 10 0.15 0.00 0.15 
22 10 0.15 0.30 0.15 
23 10 0.15 0.15 0.00 
24 10 0.15 0.15 0.30 
25 10 0.15 0.15 0.15 
26 10 0.15 0.15 0.15 
 
Table 4.5: Table listing the statistically designed experiments (CCF DoE) for 
multimodal precipitation using ammonium sulphate, sodium citrate and sodium 
chloride and PEG 12000 at pH 7.4. The experiment numbers 15 and 16 were 
modified to the salt concentration of 0.6 M to prevent aqueous two phase formation 
with PEG. Homogenate pH 7.4, PEG (from a stock concentration of 50% w/v pH 
7.4), sodium citrate and ammonium sulphate (from a stock concentration of 2.2 M 
pH 7.4) and 100 mM Tris HCl pH 7.4 were prepared for this experiment. Co for Fab’ 
and total protein was 0.9 g L-1 and 4.5 g L-1 respectively. This experiment was 
performed in 1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, Denmark) at 1 mL 
scale per well using a Tecan (Tecan, Reading, UK) for liquid handling. Samples 
prepared by the Tecan (Tecan, Reading, UK) were mixed for a total of 60 minutes 
using the microscale mixing device at 1000 rpm. The plates were centrifuged and 
then the supernatant was analysed for Fab’ and total protein concentration as 
described in sections 2.1 and 2.2 respectively 
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4.5.2.1 Ionic Strength of Salt 
 
The ionic strength of a solution is a measure of the concentration of ions in that 
solution. The total ionic concentration of the salts will affect the solubility of Fab’ and 
protein impurities.   
The ionic strength, I, of a solution is a function of the concentration of all the ions 
present in solution (equation 4.1). 
          (4.1) 
Equation 4.1: Ionic strength in moles, where ci is the molarity of ion [M], zi is the 
charge number of that ion, and the sum is taken of all salt ions in the solution 
(Balasundaram et al., 2011) 
The ionic strength was calculated for the three salts as per the CCF DoE inputs 
shown in table 4.6 
Ammonium 
sulphate 
concentration 
[M] 
Sodium 
citrate 
concentration 
[M] 
Sodium 
chloride 
concentration 
[M] 
Ammonium 
sulphate 
ions 
Sodium 
citrate 
ions 
Sodium 
chloride 
ions 
Total 
ions 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 
0.00 0.00 0.60 0.00 0.00 0.60 0.60 
0.15 0.15 0.30 0.40 0.90 0.30 1.60 
0.60 0.00 0.00 1.80 0.00 0.00 1.80 
0.30 0.00 0.30 1.50 0.00 0.30 1.80 
0.20 0.20 0.20 0.60 1.20 0.20 2.00 
0.00 0.30 0.30 0.00 1.80 0.30 2.10 
0.15 0.30 0.15 0.40 1.80 0.15 2.40 
0.30 0.15 0.15 1.50 0.90 0.15 2.50 
0.30 0.30 0.00 1.50 1.80 0.00 3.30 
0.00 0.60 0.00 0.00 3.60 0.00 3.60 
 
Table 4.6: Ionic strength of ammonium sulphate, sodium citrate and sodium 
chloride calculated from the CCF DoE inputs 
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The precipitation data was shown as a function of ionic strength of salts calculated 
using equation 4.1. Figure 4.17 shows the solubility profiles of Fab’ and total protein 
using PEG 12000 at pH 7.4 between 0% and 15% w/v PEG concentration. The 
solubility profile of Fab’ at PEG 0% w/v (figure 4.17 A) shows the solubility of Fab’ in 
the supernatant dropping to 65% on average at 3.6 [M], and the total protein 
appears to be significantly affected by increasing ionic strength, with solubility 
dropping to 48% on average at 3.6 [M].       
 
Figure 4.17 (B) shows the effect of increasing ionic strength of salt in PEG 5% w/v. 
The addition of PEG 5% w/v at zero salt causes the initial precipitation of Fab’, 
resulting in 20% yield. It was observed that on average 70% of Fab’ remained in 
solution at 3.6 [M], and there was on average 42% total protein remaining at 3.6 [M]. 
It was suggested that the addition of salt stabilises the precipitation of Fab’, leading 
to a possible alternative flowthrough process (figure 4.26). Interestingly, at 1.6 [M] 
there was 70% Fab’ and 43% total protein remaining in solution on average 
suggesting that there were synergistic effects of ammonium sulphate, sodium citrate 
and sodium chloride on the precipitation of Fab’. This behaviour appears to be 
specific for Fab’ and not for protein impurities in the range investigated.  
 
However, with increasing concentration of PEG at 10% and 15% (figures 4.17 C 
and D) the performance of multimodal operation was significantly altered. The 
maximum Fab’ yield observed at PEG 10% and 15% w/v was 79% and 90% with 
60% and 65% total protein being precipitated respectively. The addition of salts at 
low ionic strength appeared to resolubilise the proteins at PEG concentrations 
higher than 10% w/v. It was suggested that at lower ionic strength (0.5-1.6 [M]), 
which was the addition of ammonium sulphate and ammonium sulphate combined 
with sodium chloride with a maximum concentration of 0.6 M, the salt prevents the 
PEG from precipitating the Fab’ and other proteins. However, as the ionic strength 
increased beyond 2 [M], which includes the presence of sodium citrate, a more 
traditional solubility curve was observed, where the Fab’ and total protein are 
significantly precipitated. Increasing the ionic strength of the solution reduces the 
amount of water molecules available for any protein thus reducing the solubility 
indirectly, which is also reported by Melander and Horváth (1977) and Arakawa and 
Timasheff (1982). The addition of sodium citrate is the most significant salt when 
working with PEG in multimodal mode at higher concentrations of PEG to 
precipitant Fab’ and other proteins. In the case of dual salt precipitations, this effect 
is augmented by the electrostatic interaction of citrate ion which has been shown to 
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have a binding site on Fab’ that could potentially displace water molecules from the 
Fab’ directly, helping to reduce the solubility further (Harinarayan et al., 2008). 
 
Further addition of ammonium sulphate or sodium citrate beyond these 
concentrations was limited by the solubility of the salts (since concentrated stock 
solutions were used for precipitation). Higher concentrations of ammonium sulphate 
or sodium citrate could only be achieved by adding the salt in solid form. Addition of 
salt in the solid form at process scale is undesirable due to the potential localised 
super saturation effects during the precipitation reaction (Balasundaram et al., 
2011). 
 
Previous studies (Foster et al., 1971) have described the importance of mixing in 
protein precipitation at large scale. A steep solubility curve similar to that obtained in 
figure 4.17 (C) is desirable at large scale since the over precipitation and micro 
mixing effect due to rate of addition of precipitant can be avoided. Therefore, in a 
large scale precipitation process where mixing has a significant impact, the 
conditions in figure 4.17 (C) at 10% w/v PEG 12000  and 2 [M] can be expected to 
be perform better than at PEG 0% w/v (figure 4.17 A), and that 90% of the product 
can be recovered using this approach. This is supported by findings by 
Balasundaram et al., (2011) who reported 90% precipitation of Fab’ at equivalent 
ionic strength in dual salt precipitation with ammonium sulphate and sodium citrate.  
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Figure 4.17: The effect of increasing salt ionic strength on the solubility of Fab’ (▲) and total protein (■) with PEG 12000 0% (A) 5% (B) 10% 
(C) and 15% (D) w/v at pH 7.4. Ionic strength of salt [M] was calculated for ammonium sulphate, sodium citrate and sodium chloride as listed in 
table 4.6. Average data is shown from duplicate experiment repeats 
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Following the DoE, results were analysed to the two main responses of yield and 
purification factor as described in section 3.4.1. It was hypothesised that while 
maintaining the parameters previously examined in the Fab’ precipitation study 
using PEG (chapter 3), all factors in the present study would be significant. This 
was a reasonable assumption based on previous experimental data. 
 
In section 4.6.1, the initial screening with multimodal conditions suggested that the 
highest Fab’ yields were obtainable in the PEG range between 15% to 20% w/v. 
However, it had been observed that electrostatic interactions at low salt 
concentrations resulted in protein impurities being precipitated in favour of Fab’. 
Therefore, there were two possible windows of operation, the first maximising Fab’ 
yield by maximising conditions to favour hydrophobic interactions and the second 
by minimising Fab’ loss by maximising conditions to favour electrostatic 
interactions. MODDE 9.1 (Umetrics, Malmö, Sweden) was used to evaluate 
multiple variables and response factors simultaneously and was useful for the 
understanding of the process limits and how design parameters affect process 
behaviour to decide, which type of precipitation system would be better to operate 
at full scale.  
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Figure 4.18: Bar chart ranking the significant process parameters from high to low 
in terms of significance on Fab’ yield. Green and red bars have a positive and 
negative effect on yield respectively. Effects are significant in the range investigated 
which are above the t-Value limit of 2.36 and p < 0.05 confidence level. Effects 
below these limits are not shown 
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There were a number of parameters, which were significant to Fab’ yield. Figure 
4.18 shows the t-Values for each of the parameters that have either a positive or 
negative effect on Fab’ yield, which are above the t-Value limit of 2.36 and p < 0.05 
confidence level. 
 
Figure 4.18 showed that PEG concentration was the most positive factor in the 
determination of yield in the range investigated, which may in part be due the 
increased exclusion volume effect, as concentration of PEG is increased. This 
agreed with experiments performed by Knevelman et al., (2010). The combination 
of ammonium sulphate and PEG had a positive effect on yield in part due to the 
electrostatic interactions at low ammonium sulphate concentrations that are 
overcome by the opposing hydrophobic effects of PEG as the system becomes 
more thermodynamically stable (Lee and Lee 1981).  
 
Ammonium sulphate on its own and a combination of salts and PEG had a negative 
influence on Fab’ yield, which is supported by previous data described in this 
chapter. Singanoglu and Abdulnar (1965) have suggested that the free energy of 
cavity formation reflected in the surface tension of solvent has a key role in the 
stability of proteins. The addition of low concentrations of salts increase solvent 
surface tension increasing the stability of Fab’, as the thermodynamic effect is 
favourable at low salt concentrations. Further positive effects were observed with 
the combination of sodium citrate and sodium chloride, which suggests that there 
are synergistic effects for the precipitation of Fab’. Sodium citrate in single mode did 
not precipitate Fab’ efficiently (section 4.5.1) indicating that hydrophobic effects by 
increasing sodium citrate concentration are not sufficient to precipitate Fab’ to 
obtain high yields. However, combining sodium citrate and sodium chloride makes 
this factor significant. Interestingly, all three salts in combination had a negative 
influence on yield.   
 
 
177 
 
Figure 4.19: Bar chart ranking the significant process parameters from high to low 
in terms of significance on purification factor. Green and red bars have a positive 
and negative effect on yield respectively. Effects are significant in the range 
investigated which are above the t-Value limit of 2.30 and p < 0.05 confidence level. 
Effects below these limits are not shown 
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Figure 4.19 shows that PEG concentration (% w/v) had the strongest effect on 
purification factor in the range investigated. Sodium citrate with sodium chloride, 
ammonium sulphate with PEG had a positive effect on purification factor 
respectively. However, all combined salts have a negative influence on purification 
factor in the range investigated. It wassuggested that high concentrations of salts 
and high concentrations of salts with PEG, limit purification factor in part due to the 
reduced selectivity of precipitation by hydrophobic interactions.  
 
A summary of the factors affecting Fab’ yield and purification factor is shown in table 
4.7. 
 
Favourable yield Favourable purification factor 
PEG concentration (% w/v) PEG concentration (% w/v) 
Interaction Effects Interaction Effects 
Ammonium sulphate [M] and PEG 
concentration (% w/v) 
Ammonium sulphate [M] and PEG 
concentration (% w/v) 
Sodium citrate and sodium chloride [M] 
Sodium citrate and sodium chloride [M] All factors 
Sodium chloride [M]  
 
Table 4.7: Summary of factors that had a positive effect on Fab’ yield and 
purification factor in the range investigated  
 
Figures 4.20 and 4.21 show the response surface plots all of the variables 
investigated in the CCF DoE for Fab’ yield and purification factor respectively. 
These plots were created using MODDE 9.1 (Umetrics, Malmö, Sweden). An 
increase in yield and purification factor was observed with increasing PEG and 
sodium citrate concentration. Interestingly, yield and purification factor increased 
with increasing ammonium sulphate concentration till approximately 0.15 M. Further 
increase in ammonium sulphate concentration reduced both yield and purification 
factor in the ranges investigated. Sodium chloride somewhat decreased both yield 
and purification factor when combined with ammonium sulphate and sodium citrate, 
which can be better observed in figures 4.22 and 4.23.  
 
In terms of window of operation, this leads to a complex design task in which many 
variables must be considered simultaneously to select suitable values as to obtain a 
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desired level of performance. For example, one can operate at PEG 12000 15% w/v 
with 0.3 M sodium citrate and 0.15 M ammonium sulphate whilst giving a yield > 
90% with a purification factor of approximately 1.9. However, to favour electrostatic 
interactions, low sodium citrate and PEG concentrations can be used to precipitate 
protein impurities in favour of Fab’ (figures 4.24 and 4.25). This behaviour appears 
to be specific for Fab’ and not for protein impurities. Arakawa and Timasheff (1982) 
suggested that the anion is responsible for the thermodynamic stability of proteins 
possibly by the binding of salts in the protein domain. The increased net charge of 
the protein due to binding of these ions results in the increase of electrostatic 
repulsive forces of the protein. These electrostatic forces prevent protein 
aggregation increasing the solubility of proteins in aqueous solutions of salts, which 
is in agreement with known salting in properties of salts (Arakawa and Timasheff 
1985). 
 
This data supports the Hofmeister series, which predicts that citrate followed by 
sulphate and chloride would require increasing concentrations of salt to precipitate 
proteins, in this case Fab’. It may be the case where this positive effect of increased 
hydration potential of Fab’ allows PEG greater access to draw water and induce 
precipitation of protein impurities. Mahadevan and Hall (1990) have suggested that 
the distribution of the PEG polymer causes a “pressure imbalance” that pushes the 
proteins against each other. The positive chemical potentials of the proteins on 
addition of PEG indicate that the predominant interactions between PEG and 
proteins in aqueous medium are repulsive in nature and that this repulsion becomes 
stronger with an increase in PEG size and concentration. Furthermore, at higher 
concentrations of PEG ≥ 15% w/v, PEG concentration is sufficiently high to become 
the driving force of the process. Lee and Lee (1981) suggested that the system 
always provides a driving force to a more thermodynamically favourable state and 
that the magnitude of this driving force was found to increase with increasing 
concentration of the polymer.  
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Figure 4.20: 4D contour plots showing the yield of Fab’ as a function of ammonium sulphate concentration [M] and PEG 12000 concentration 
(% w/v) at varying sodium chloride concentrations [M] and sodium citrate concentrations [M] (at pH 7.4). The response surfaces for yield were 
fit with a quadratic model. All data fitting was performed using the software package MODDE 9.1 (Umetrics, Malmö, Sweden) 
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Figure 4.21: 4D contour plots showing the purification factor of Fab’ as a function of ammonium sulphate concentration [M] and PEG 12000 
concentration (% w/v) at varying sodium chloride concentrations [M] and sodium citrate concentrations [M] (at pH 7.4). The response surfaces 
for purification factor were fit with a quadratic model. All data fitting was performed using the software package MODDE 9.1 (Umetrics, 
Malmö, Sweden) 
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ANOVA analysis suggested that the model had no lack of fit as the p-value was >  
0.05 (p-value was 0.21), with an Q2 value of 0.83. Therefore, this model can be 
used to find a sweet spot in the experimental design space, in which the 
combination and interactions of the process inputs reliably deliver a product with the 
desired quality. In terms of QbD, this sweet spot is the design space of the process 
(figures 4.22-4.24).  
 
Figure 4.22 is a 4D plot created in MODDE 9.1 (Umetrics, Malmö, Sweden), to 
show the operational design space, created by superimposition of the yield and 
purification factor response contour plots (figures 4.20 and 4.21) to achieve a Fab’ 
yield ≥ 70% with a maximum purification factor of 2.3 in the range of conditions 
investigated. The resulting window of operation increased with increasing sodium 
citrate and ammonium sulphate concentrations, (the reasons for which have been 
discussed in section 4.5.1). For example, these criteria are met with 0.3 M sodium 
citrate and 0.15 M ammonium sulphate with PEG ≥ 10% w/v. However, with 
increasing sodium chloride concentration in the system, the window of operation to 
achieve this becomes smaller. For example, to achieve this criteria, with 0.3 M 
sodium citrate, 0.15 M ammonium sulphate concentrations and 0.3 M sodium 
chloride, greater than PEG 15% w/v is required. 
 
Figure 4.23 is a 4D plot, created by the superimposition of the yield and purification 
factor contour plots to achieve a Fab’ yield ≥ 90% with a maximum purification factor 
of 2.3 in the range of conditions investigated (≥ 90% Fab’ yield was selected as 
acceptable in section 3.4.1 for PEG). The addition of sodium chloride reduced this 
window of operation significantly, and as a result higher concentrations of PEG are 
required to achieve ≥ 90% Fab’ yield. 90% Fab’ yield with a purification factor of 1.9 
was achievable using PEG 12000 15% w/v/0.30 M sodium citrate/0.15 M 
ammonium sulphate pH 7.4. The model predicted a Fab’ yield of 93% and 
purification factor of 1.9, which was in good agreement with the experimental data. 
The resulting purification factor was an improvement of 26% relative to the use of 
15% w/v PEG 12000 pH 7.4 in single mode.     
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Figure 4.22: Fab’ precipitation design space comprised of the overlap region for yield (%) and purification factor created using MODDE 9.1 
(Umetrics, Malmö, Sweden). Working within this design space delivers a Fab’ yield ≥ 70% with a maximum purification factor of 2.3 in the range 
of variables investigated. Ammonium sulphate, sodium chloride and sodium citrate values are shown as molar concentrations  
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Figure 4.23: Fab’ precipitation design space comprised of the overlap region for yield (%) and purification factor created using MODDE 9.1 
(Umetrics, Malmö, Sweden). Working within this design space delivers a Fab’ yield ≥ 90% with a maximum purification factor of 2.3 in the range 
of variables investigated. Ammonium sulphate, sodium chloride and sodium citrate values are shown as molar concentrations 
185 
Similar Fab’ yield performance was observed with PEG as the precipitant (section 
3.5.1). The addition of low concentrations of ammonium sulphate and sodium citrate 
increased purification factor by 26% relative to PEG, without significantly increasing 
the cost and viscosity of the precipitant. However, observations made during this 
study at low concentrations sodium citrate and PEG (ammonium sulphate and PEG 
have a similar effect albeit at high PEG concentrations) suggested that there are 
electrostatic interactions of citrate ions with Fab’ resulting in precipitation of some 
protein impurities in favour of Fab’. This phenomenon appears to be specific to Fab’ 
and the presence of PEG may increase the precipitation of protein impurities further. 
Harinarayan et al., (2008) reported that there was an electrostatic interaction 
associated with the trivalent citrate ions and Fab at low citrate concentrations, which 
may in part explain the insignificant change in yield with increasing PEG 
concentration. For a primary process step it could be more beneficial to operate with 
this type of approach, where protein impurities are precipitated in favour of Fab’, 
since there is no resolubilisation step and the viscosity of the precipitant is 
considerably lower. This will enable this primary process step to be integrated into 
an existing early downstream step with relative ease compared to a step where Fab’ 
is precipitated, which requires high viscosity precipitant and a subsequent 
resolubilisation step.    
 
Figure 4.24 is a graphical representation of the knowledge space (within the 
unexplored space), which refers to the region of process understanding defined by 
the input boundaries of the combination of the full factorial and CCF DoE’s with 
sodium citrate and PEG 12000. The input boundaries were 0 to 1 M sodium citrate, 
PEG 12000, PEG concentration 0% to 20% w/v, pH 7.4 and homogenate dilution 
factor of 1. The design space, within this knowledge space, is comprised of the 
overlap of Fab’ yield (%) and purification factor to give a robust region where 
purification factor was ≥ 0.8 and Fab’ loss was ≤ 10%. The normal operating range 
(NOR) or control space was defined by a combination of PEG and sodium citrate 
concentration ranges at ± 0.5% w/v and ± 0.05 M respectively. This is highlighted by 
the dashed area in figure 4.24 within the design space to give a region of assurance 
of quality, flexibility and robustness at manufacturing scale.  
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Figure 4.24: Proposed protein impurity precipitation design space comprised of the 
overlap region for yield (%) and purification factor created using MODDE 9.1 
(Umetrics, Malmö, Sweden). Knowledge space refers to the region of process 
understanding based on the full factorial and CCF DoE inputs. Inputs were PEG 
12000, PEG concentration, sodium citrate concentration, pH 7.4 and homogenate 
dilution factor of 1. The design space is a region where the combination of ranges 
that delivers purification factor ≥ 0.8 and Fab’ loss ≤ 10%. The Normal Operating 
Range (NOR) was set to as a minimum of ± PEG 0.5% w/v and ± 0.05 M sodium 
citrate concentration within the dashed area of the design space 
 
The robustness of the NOR within the design space was further investigated by 
combining sodium citrate at 0.4 M with a range of PEG 12000 concentrations (% 
w/v) at pH 7.4 and homogenate dilution factor of 1. Figure 4.25 shows the resultant 
Fab’ and total protein solubility profiles using PEG 12000 pH 7.4 and PEG 
12000/0.4 M sodium citrate pH 7.4 precipitants. At PEG 12000 6.25% w/v/0.4 M 
sodium citrate pH 7.4 the change in Fab’ concentration was invariable. Fab’ 
solubility remained close to 100%, and the concentration of total protein dropped by 
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~20%. Balasundarum et al., (2011) suggested that millimolar quantities of sodium 
citrate may be sufficient in multimodal mode to precipitate protein impurities when 
combined with ammonium sulphate. However, present observations suggest higher 
concentrations of sodium citrate are required when combined with PEG 12000 in 
multimodal mode to achieve this. Sodium citrate on its own did not precipitate Fab’ 
efficiently, indicating that the potential additive effect of salting out effects that can 
be achieved by increasing the concentration of sodium citrate alone is not sufficient 
to precipitate Fab’. Arakawa and Timasheff (1982) suggested that the anion is 
responsible for the thermodynamic stability of proteins possibly by the binding of 
salts in the protein domain. The increased net charge of the protein due to binding 
of these ions results in the increase of electrostatic repulsive forces of the protein. 
These electrostatic forces prevent protein aggregation, increasing the solubility of 
proteins in the aqueous solutions of salts, which is in agreement with known salting 
in properties of salts (Arakawa and Timasheff 1985). Working within the NOR as 
shown in figure 4.24, a flow through precipitation strategy with PEG 12000 6.25% 
w/v/0.4 M sodium citrate pH 7.4 (homogenate dilution factor of one) was used to 
precipitate ~20% of protein impurities early in the downstream process. The 
advantage at process scale is the potential ease of processing due to removal of a 
solubilisation step and the significantly reduced viscosity of the precipitating agent 
relative to that of PEG. 
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Figure 4.25: Effect of single/multimodal conditions on the solubility of Fab’ (●) and total 
protein (○), (A) PEG 12000 pH 7.4, (B) PEG 12000/0.4 M of sodium citrate pH 7.4. Co was 
0.9 g L
-1
 and 4.5 g L
-1
 for Fab’ and total protein respectively. Homogenate pH 7.4, PEG 
(from a stock concentration of 50% w/v pH 7.4), sodium citrate (from a stock concentration 
of 2.2 M pH 7.4) and 100 mM Tris HCl pH 7.4 were used in this experiment. These 
experiments were performed in 1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, 
Denmark) at 1 mL scale per well using a Tecan (Tecan, Reading, UK) for liquid handling. 
Samples prepared by the Tecan (Tecan, Reading, UK) were mixed for a total of 60 minutes 
using the microscale mixing device at 1000 rpm. The plates were centrifuged and then the 
supernatant was analysed for Fab’ and total protein concentration as described in sections 
2.1 and 2.2 respectively. Error bars are shown for one standard deviation for triplicate 
experiment repeats 
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An alternative strategy for precipitation is proposed for precipitating protein 
impurities early in the downstream process (figure 4.26). Multimodal precipitation is 
performed after homogenisation (500 bar for 1 pass) and primary clarification with 
PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 resulting in ~20% of protein 
impurities precipitating out, while Fab’ remains soluble. The subsequent 
centrifugation step removes the precipitated impurities. The advantage at process 
scale is the potential ease of processing due to removal of a solubilisation step and 
the significantly reduced viscosity of the precipitating agent relative to that of high 
concentrations of PEG. Further concentrations of PEG could be added to 
precipitated Fab’ if the process requires.  
 
 
Figure 4.26: Proposed precipitation strategy in early downstream processing. The 
combination of PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 could be used as 
a flow through step whereby protein impurities are selectively precipitated in favour 
of the Fab’ 
 
 
4.6 Time and Cost Comparison between Automated Microscale and 
Laboratory Scale Studies 
 
Microscale methodology increases throughput by approximately 8 fold relative to 
laboratory scale, dependent on whether or not replicates are performed. This value 
was calculated assuming that at laboratory scale a full factorial DoE was performed 
with four factors. Material consumption is therefore reduced by at least an order of 
magnitude, whilst labour is reduced by at least 50%. The Tecan (Tecan, Reading, 
UK) LHR can also be run continuously for 24 hours if required. A full 96 deepwell 
plate (1 mL in each microwell) would require 32 mL of sample and 64 mL of a 
mixture of buffer, PEG and salt (96 mL total volume). In contrast to run 96 
experiments at 6 mL laboratory scale, the total volume required is increased six fold 
to 600 mL.  
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The predicted experimental schedules of microscale and 6 mL scale are shown in 
figure 4.27. The experimental time to complete a full factorial DoE at 6 mL 
laboratory scale was approximately 10 days based on an estimate to complete DoE 
studies. However, the time taken to complete triplicate DoE studies at 1 mL scale 
was approximately 5 days (3 fold the experiments), a saving of approximately 5 
days, whilst giving an increase in confidence and robustness of the data by 
completing replicates. In addition to completing experiments in replicate, larger 
studies can be undertaken without significantly increasing time and cost. Therefore 
critical bioprocess information can be obtained earlier in development providing a 
better opportunity to understand more process parameters. However, it is noted that 
the bottleneck of completing experiments is shifted to the analysis of samples. 
However, the total protein assay used in this thesis was automated increasing 
throughput by ~50% relative to manual analysis.   
 
Figure 4.27: Bar chart showing predicted schedules for automated microscale scale 
(█) and 6 mL laboratory scale (█) experiments 
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Total consumables cost using the automated method was significantly cheaper than 
the total consumables cost using conventional laboratory scale method due to the 
use of microwells, which have significantly reduced the amount of consumables 
needed. The data presented was sufficient to justify the continued use of the newly 
designed high throughput system for DoE approach evaluation.  
 
Kitchen and Wang (2002) developed a semi automated 96 well protein precipitation 
method for the determination of montelukast in human plasma using high 
performance liquid chromatography and fluorescence detection. Using this method, 
batch sample preparation of over 240 samples was easily accomplished in 
approximately 3.5 hours compared to approximately 6 to 8 hours with the manual 
method.  
 
The miniaturisation and automation of this purification step significantly decreases 
the amount of sample required, successfully reducing the bottleneck, and allows the 
possibility to scale down other processes such as fermentation and cell disruption 
steps, enabling whole microscale bioprocess strategies (Wenger 2010).  
 
 
4.7 Summary 
The setup, automation and operation of precipitation on a Tecan Freedom EVO 200 
liquid handling robot (Tecan, Reading, UK) combined with using a microscale mixing 
device increased throughput and speed of liquid handling by 50% relative to the 
mixing conditions described in section 3.3.3. 
 
A Fab’ precipitation study in the form of a response surface methodology DoE (three 
level full factorial) was performed to investigate a large multimodal precipitation 
design space based on the Quality by Design principles stated in the ICH guideline 
Q8 (R2) to improve the performance of single mode precipitation described in 
chapter 3. Parameters of investigation were PEG concentration (% w/v), PEG 
molecular weight (MW), pH, dilution of the homogenate, ammonium sulphate 
concentration and sodium citrate concentration. Salt concentrations ≥ 0.8 M with ≥ 
5% w/v PEG resulted in aqueous two phase formation which affected 40% of the 
design space. This was excluded from analysis as a two phase system was beyond 
the scope of this project.  
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A second round of response surface experimentation in the form a CCF DoE with 
reduced ranges to avoid two phase formation was performed combining optimum 
operating conditions from the PEG CCF design space (section 3.5.1) for multimodal 
operation. PEG 12000 in addition to three salts, ammonium sulphate, sodium citrate 
and sodium chloride chosen from their locations in the Hofmeister series (section 
1.4.1) were used for multimodal precipitation. It was found that 90% Fab’ yield with 
a purification factor of 1.9 was achievable with PEG 12000 15% w/v/0.30 M sodium 
citrate/0.15 M ammonium sulphate pH 7.4. This was an improvement of 26% 
relative to the use of 15% w/v PEG 12000 pH 7.4 in single mode. However an 
alternative precipitation strategy to precipitate ~20% of protein impurities whilst Fab’ 
remained soluble in solution using PEG 12000 6.25% w/v/0.4 M sodium citrate pH 
7.4 was favoured instead. The advantage of this system at process scale is the 
potential ease of processing due to removal of a solubilisation step and the 
significantly reduced viscosity of the precipitating agent relative to that of high 
concentrations of PEG. 
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5. INTEGRATION OF PRECIPITATION INTO A 
DOWNSTREAM PROCESS 
 
5.1  Abstract 
A high throughput system utilising robotic handling was developed in microwells to 
investigate conditions to increase particle size. It was found that d50 particle size 
was 313 m at low speed mixing conditions (800 rpm) with the addition of 
homogenate to PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 at 900 L s-1 
after 60 minutes of mixing.  
 
A USD system was used to mimic the shear rates found in the feed zone of a disk 
stack centrifuge in the laboratory. Good agreement of clarification was achieved 
between laboratory scale and the pilot centrifuge. Laboratory scale efficiency was 
93%, whereas the pilot scale separation efficiency was 87%.  
 
A process run through was performed with homogenate pH 7.4 (control), multimodal 
(PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4) and single mode (PEG 12000 
15% w/v pH 7.4) feedstreams. The clarification of the three feedstreams was 
examined after a membrane filtration operation using an automated multiwell 
filtration technique prior to packed bed studies. Filtration experiments of three 
feedstreams were performed with Cuno Zeta Plus 30SP membrane filters (Cuno, 
Meridan, USA). This was followed by a diafiltration step to prepare material for the 
following cation exchange chromatography step. A 1 mL SP Sepharose Hi Trap pre 
packed bed column (GE Healthcare, Uppsala, Sweden) was used to capture Fab’ 
from the three feedstreams. The final process purification factor of the three 
feedstreams were 2.5, 4.4 and 3.5 respectively. The use of multimodal precipitated 
impurities prior to a packed bed step had improved process performance by a 
purification factor of 1.9. Therefore, the investigation of whole process interactions 
with material prepared by precipitation demonstrated the importance of reducing 
impurities early in the process that can negatively interact with subsequent 
operations. 
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5.2  Introduction 
Improvements in upstream processing have been shown to be effective in 
increasing the product titer in the bioreactor phase (Taipa et al., 2001). However, 
the amount of impurities in the product stream must to be reduced prior to a 
chromatography step in order to realise the full benefits of this improvement. 
Precipitation through multimodal operation can remove contaminating proteins, 
improving the feedstream, prior to a costly chromatography step.  
 
In this chapter, the multimodal precipitation of Fab’ from homogenates was 
optimised by microscale mimics. The amount of shear in the system and the rate of 
addition of the feed to the precipitating agents are two important variables affecting 
the size and strength of the precipitates that are formed. These two factors were 
studied at microscale and verified at pilot scale. The process performance was 
evaluated through a process run through using particle size distribution of the 
precipitate, strength of the precipitate, amount of Fab’ left in the supernatant, the 
ease of clarification of the precipitates through microscale centrifugation studies and 
by a final cation exchange chromatography step. The structure of this chapter is 
shown in figure 5.1. 
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Stage 2 
 
A USD system was used to mimic the pilot scale centrifuge in the laboratory by 
mimicking the amount of shear experienced by the precipitated material in the feed 
zone of the CSA-1 disk stack centrifuge (Westfalia Separator, AG, Germany) 
 
 
 
Figure 5.1: Flowchart of structure of chapter 5    
Stage 3 
 
Process run through integrating precipitation into a downstream purification process  
Stage 1 
 
A two level full factorial DoE was used to identify conditions for maximising size of 
particles  
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STAGE 1 
 
5.3 Results and Discussion 
 
5.3.1 Particle Size Characterisation 
 
This part of the chapter describes the setup, automation and operation of particle 
size experiments performed on a Tecan Freedom EVO 200 liquid handling robot 
(Tecan, Reading, UK). A two level full factorial DoE was used to evaluate the 
parameters, which were believed to affect the particle size in the system for three 
feedstreams, namely homogenate pH 7.4 (control), PEG 12000 6.25% w/v/0.4 M 
sodium citrate pH 7.4 (multimodal) and PEG 12000 15% w/v pH 7.4 (single mode). 
The variables investigated were: 
 
 Mixing speed (rpm)  
 Mixing time (minutes) 
 Flowrate of feed into the vessel (L s-1) 
A full factorial DoE, examining these three factors over two levels with one centre 
point would require 23+1= 9 experiments with d50 particle size as the model output. 
The upper limit for mixing rpm was set to 2000 rpm (maximum speed of magnetic 
driven device) and the lower limit was set to 800 rpm, the minimum speed required 
for turbulent conditions. The Reynolds Number (equation 5.1) for turbulent mixing in 
literature is > 10 for non baffled, axial flow systems (Doran 1995).    
 
    
     
 
 
 
Equation 5.1: Reynolds Number, where N is the stirrer speed (rps), di is the 
impeller diameter (m), ρ is the density (kg m-3), µ is the viscosity (Pa s) (Doran 
1995) 
 
The Reynolds Number for mixing speeds at 800 rpm and 2000 rpm were calculated 
to be 111 and 278 respectively, which suggests that these speeds are turbulent 
mixing conditions.  
(5.1) 
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 = 111 at 800 rpm mixing 
 
    
                    
     
 = 278 at 2000 rpm mixing 
 
Mixing time has previously been investigated where it was found that at 60 minutes 
further precipitation was no longer observed (section 3.3.1). Therefore, the upper 
limit was set to 60 minutes with the lower limit set to 1 minute. While knowing this 
may be unreasonable in a process setting, it is important in DoE screening studies 
not to confine the design space as valuable data may be lost, and the design space 
can be refined with more detailed experiments once a suitable range has been 
identified. A centre point of 15.5 minutes was used.  
 
The flowrate of addition of feed was set to either 900 L s-1, 12 L s-1 and a centre 
point of 450 L s-1 to give a wide operating range. The dispense speeds at low 
flowrates were used to avoid the Command Overflow, which occurs at slower 
addition rates. The Command Overflow results in a timeout from the pipetting 
command that does not answer after 5 to 6 minutes since the command is carried 
out for a long time. The reaction was quenched with 1 mL 100 mM Tris HCl pH 7.4 
prior to particle size measurements using a Malvin particle size analyser (Malvern 
Instruments, Southborough, UK). The method for measurement is described in 
section 2.4. The experimental design is shown in table 5.1. 
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Experiment 
number  
Mixing 
Speed (rpm) 
Mixing time 
(min) 
Flowrate of 
feed into 
vessel  
(L s-1) 
1 2000 1 12 
2 800 60 900 
3 800 60 12 
4 2000 1 900 
5 2000 60 900 
6 800 1 12 
7 800 1 900 
8 2000 60 12 
9 1400 30 450 
 
Table 5.1: Table listing the full two level factorial DoE experiments with homogenate 
pH 7.4 (control), PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 (multimodal) 
and PEG 12000 15% w/v pH 7.4 (single mode) feedstreams for the study of particle 
size. Experiments were completed at 1 mL scale per well in 1.3 mL 96 deepwell 
plates (Nunc GmbH & Co., KG, Denmark) using a Tecan (Tecan, Reading, UK) for 
liquid handling. PEG (starting concentration 50% w/v pH 7.4), and sodium citrate 
(starting concentration 2.2 M pH 7.4) and 100 mM Tris HCl pH 7.4 were used in this 
experiment. Samples were quenched with 1 mL 100 mM Tris HCl pH 7.4 prior to 
particle size measurements using a Malvin particle size analyser (Malvern 
Instruments, Southborough, UK) as described in section 2.4. Measurements were 
made in triplicate with the d50 value used as the model output  
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Figure 5.2: Particle size distribution profiles of homogenate in 100 mM Tris HCl pH 
7.4 at 1 minute mixing time and 12 L s-1 feed addition rate (●), 1 minute mixing time 
and 900 L s-1 feed addition rate (○), 60 minutes mixing time and 12 L s-1 feed 
addition rate (▼) and 60 minutes mixing time and 900 L s-1 feed addition rate (∆) 
for 800 rpm and 2000 rpm mixing speeds respectively on a semi log plot. 
Measurements were made using a Malvin Mastersizer (Malvern Instruments, 
Southborough, UK) in triplicate as described in section 2.4. The standard deviation 
for measurements were ≤ 5% 
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Figure 5.3: Particle size distribution profiles of homogenate precipitated with PEG 
12000 6.25% w/v/0.4 M sodium citrate pH 7.4 at 1 minute mixing time and 12 L s-1 
feed addition rate (●), 1 minute mixing time and 900 L s-1 feed addition rate (○), 60 
minutes mixing time and 12 L s-1 feed addition rate (▼) and 60 minutes mixing time 
and 900 L s-1 feed addition rate (∆) for 800 rpm and 2000 rpm mixing speeds 
respectively on a semi log plot. Measurements were made using a Malvin 
Mastersizer (Malvern Instruments, Southborough, UK) in triplicate as described in 
section 2.4. The standard deviation for measurements were ≤ 5% 
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Figure 5.4: Particle size distribution profiles of homogenate precipitated with PEG 
12000 15% w/v pH 7.4 at 1 minute mixing time and 12 L s-1 feed addition rate (●), 
1 minute mixing time and 900 L s-1 feed addition rate (○), 60 minutes mixing time 
and 12 L s-1 feed addition rate (▼) and 60 minutes mixing time and 900 L s-1 feed 
addition rate (∆) for 800 rpm and 2000 rpm mixing speeds respectively on a semi 
log plot. Measurements were made using a Malvin Mastersizer (Malvern 
Instruments, Southborough, UK) in triplicate as described in section 2.4. The 
standard deviation for measurements were ≤ 5% 
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Figure 5.5: Microscopic images of material that has been precipitated with PEG 
12000 6.25% w/v/0.4 M sodium citrate pH 7.4 and PEG 12000 15% w/v pH 7.4 
respectively. Images were taken with a Axioscope 2 plus microscope (Carl Zeiss 
Micro Imaging Inc., Thornword, USA) at 100x magnification of material that was 
mixed for 60 minutes at 800 rpm mixing speed with feed added at 900 L s-1. Arrows 
indicate examples of particulates of interest, which indicates a diverse size and 
morphology of particulates. Particulates appear to be agglomerated 
 
It is important to achieve sufficient mixing between the feed and the precipitant 
particularly during nucleation, or else, super saturation and under saturation regions 
will be present in the solution affecting subsequent separation. The mixing 
turbulence and time have a direct effect on particle size distribution, and it has been 
reported that precipitates that that are formed and aged under mild agitation 
conditions result in particle breakage (Byrne and Fitzpatrick 2002). Particles formed 
and aged under low shear conditions, though initially larger, are in fact weaker and 
fragment to a greater extent in turbulent flow. Sufficient strength of particles is 
necessary to withstand the fluid shear forces encountered through pumps and 
centrifuge feed zones, and therefore, they must meet the particle size and strength 
criteria for successful separation during subsequent steps such as centrifugation 
(Byrne and Fitzpatrick 2002).   
 
The average d50 value for homogenised material mixed with 100 mM Tris HCl pH 
7.4 for all conditions investigated was 15 m and 12 m at 800 and 2000 rpm 
mixing speeds respectively (figure 5.2). The particle size distribution profiles for the 
feed control were similar for each of the two mixing speeds. 
 
Figure 5.3 shows the particle size distribution profiles for material precipitated with 
PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4. The frequency of large 
particulates at 800 rpm mixing speed suggests that a reduction in the number of 
Blank slide 15% w/v PEG 12000 
6.25% w/v PEG 12000/0.4 M 
sodium citrate
200 m200 m200 m
203 
small particles occured, which may be part of a mechanism involving the "mopping-
up'' of small particulates by the larger particulates. This is predicted by 
Smoluchowski's collision frequency theory, which states that the probability of 
collision between small and large particles is greater than the probability of collision 
between small particles, and so that large particles behave as nuclei around which 
small particles collect (Bell and Dunnill 1982). The d50 value was 313 m at 800 rpm 
with the addition of feed at 900 L s-1 after 60 minutes of mixing. However, at 2000 
rpm the d50 particle size reduced to 197 m, suggesting that high speed mixing 
results in partial break down of particles. Increased speed of mixing allows for an 
increase in collision frequency which can break down the larger particulates due to 
shear force effects. A similar trend was observed with the addition of PEG 12000 
15% w/v pH 7.4 as precipitant (figure 5.4). 
 
To understand the size and the morphology of the precipitated material, microscopic 
images were taken using a Axioscope 2 plus microscope at 100x magnification 
(Carl Zeiss Micro Imaging Inc., Thornword, USA) (figure 5.5). Material homogenised 
at 500 bar for 1 pass had a d50 particle size of 0.30 m, which could not be 
observed at 100x magnification. An image of a blank slide was taken as a reference 
of background noise, and examples of the particulates of interest have been 
indicated in figure 5.5. Interestingly, the images show a diverse size and 
morphology of particulates. Particulates with multimodal precipitant appear to be 
agglomerated and almost globular. However, smaller agglomerated particulates 
were observed with PEG 12000 15% w/v pH 7.4, which were both irregular in shape 
and size. 
 
MODDE 9.1 (Umetrics, Malmö, Sweden) was used to analyse the data from the 
particle size study. For the multimodal and PEG precipitated material it was found 
that d50 particle size increased at 800 rpm relative to 2000 rpm, when mixed for 60 
minutes relative to 1 minute in the range investigated. It was found that the rate of 
addition of feed was not a significant factor to increase d50 particle size at 60 
minutes mixing time. However, at one minute mixing time the faster addition rate 
(900 L s-1 compared to 12 L s-1) may improve the distribution of the feed, resulting 
in more heterogeneous population of particle sizes, the effect of which is normalised 
after 60 minutes of mixing. Figure 5.6 shows a response surface plot for multimodal 
conditions fit as a two factor interaction model with mixing speed (rpm) and rate of 
addition (L s-1) at 60 minutes mixing time. The p-value for curvature was greater 
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than 0.05 (p-value was 0.30) by ANOVA analysis, which suggested that there was 
no conclusive evidence for curvature in the model. Although the Q2 value of 0.33 
was low, this interaction model was used to define the relationship between 
variables without proceeding with a response surface methodology DoE with these 
factors in the range investigated. 
 
The data suggests that d50 particle size can be increased with a high rate of feed 
addition combined with a lower speed of mixing in the range investigated. For 
subsequent studies, mixing speed was maintained at 800 rpm for 60 minutes using 
a precipitant addition rate of 900 L s-1.    
 
 
Figure 5.6: Response surface plot of multimodal conditions at 60 minutes of mixing 
time (full factorial design, fit with a two factor interaction model). The contour lines 
indicate particle size in m. The design of the experiments is outlined in table 5.1. 
All data fitting was performed using the software package MODDE 9.1 (Umetrics, 
Malmö, Sweden). This data suggests that d50 particle size can be increased with a 
high rate of feed addition combined with a lower speed of mixing (at 60 minutes 
mixing time) in the range investigated 
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5.3.2 Scale Up of the Precipitation System to 50 mL Laboratory Scale 
and 5 L Pilot Scale 
 
The ability to predict the performance of a large scale precipitation by microscale 
mimics is important for the rapid development of successful operations at large 
scale. Therefore, it was necessary to examine the translation of 
microscale/laboratory scale to pilot scale processes.   
 
When scaling a precipitation process, the goal is to be able to mimic larger 
operating conditions and to provide the basis whereby the eventual larger scale 
process can be operated under identical feasible conditions. Several parameters 
should be kept constant, including tank geometry (height:diameter ratio), impeller 
type, diameter of the impeller relative to that of the tank, placement of the impeller 
and residence time (Boychyn et al., 2000). Most stirred tanks are cylindrical with a 
height:diameter ratio greater than one (H/dv > 1), and often have dished bottoms to 
prevent accumulation of solids in their corners (Boychyn et al., 2000). This 
cylindrical shape can induce undesirable tangential flow or swirling of the liquid 
resulting in reduced power draw by the impeller and lower mixing efficiency, 
although such effects can be minimised by the introduction of wall baffles. By 
contrast, a non cylindrical profile (H/dv < 1) can be beneficial for two reasons. First, 
the reduced height can improve top-to-bottom, axial-flow distribution; and second, 
the rectangular profile can minimise undesirable tangential flow, the corners acting 
like a baffle to break up the regular flow pattern and promote vertical flow (Botterill 
and Rawlings 2008). 
 
Power unit per liquid volume, (equation 5.2) was used as the scale up parameter, 
calculated for the microscale system and kept constant at the different scales. This 
parameter has been used successfully in scaling up bioreactors (Marques et al., 
2010). A Power number of 6 was assumed for the high power/shear estimate. 
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Equation 5.2: Power unit per liquid volume (W m-3). Where P is the Power input 
(W), P0 is the Power number, is the liquid density (kg m
-3), N is the agitation rate 
(rps), di is the impeller diameter (m), dV is the diameter of vessel (m), h is the reactor 
geometry height (m). P0 = 6 for turbulent mixing in non baffled systems (Re > 10
3) 
(Rushton et al., 1950) 
 
Table 5.2 lists the dimensions of the precipitation reactors used in this study, shown 
visually in figure 5.7 for laboratory scale. The mean velocity gradient was calculated 
as per equation 1.3 assuming a dynamic viscosity of 0.003 Pa s (section 2.9). Minor 
differences such as the material type, bottom shape and impeller type exist between 
the three scales, however, scaling parameters such as impeller diameter:vessel 
diameter (di/dv), mixing time, mixing Power per volume, mean velocity gradient and 
flowrate of feed into the vessel have been maintained constant. Stir tank geometries 
with H/dv < 1 were used to improve axial-flow distribution and minimise tangential 
flow so that the corners of the vessel act like baffles to break up the regular flow 
pattern (Botterill and Rawlings 2008). At laboratory and pilot scale, the impellers 
were located approximately 1/3 off the vessel bottom to match the microscale 
mixing system. Lowering the impeller nearer to the base of the vessel can allow for 
use of smaller working volumes without exposing the impeller above the liquid 
surface. However, such exposure can generate excessive turbulence and 
undesirable effects on sensitive products.  
 
At laboratory and pilot scale the flowrate of solutions into the vessel was 54 mL  
min-1 using a Watson Marlow 605 Di Peristaltic Pump (Watson Marlow Ltd., 
Falmouth, UK) to match the flowrate at microscale (900 L s-1). The flowrate was 
determined by calibration with water and direct measurement with the flow set to 54 
mL min-1 to match the addition rate of 900 L s-1 at microscale. In both cases the 
point of addition was located in the proximity to the impeller to mimic the same point 
at microscale. The experimental methodology at laboratory and pilot scale was 
completed to mimic that of the microscale process (described in section 4.3.1). 
Briefly, 100 mM Tris HCl pH 7.4 was added to the appropriate vessels, followed by 
the addition of PEG 12000 (stock 50% w/v at pH 7.4) and sodium citrate (stock 2.2 
  hd
dNP
V
P
v
i
2
53
0
4/


207 
M at pH 7.4) as necessary. This mixture was then mixed for two minutes to ensure 
homogeneity of the precipitant (mixing speeds shown in table 5.2). This was 
followed by the addition of feed, and total mixing time was 60 minutes. At micro and 
laboratory scale both 42 and 670 W m-3 mixing Power per volume runs were 
performed. At pilot scale only the 42 W m-3 mixing Power per volume run was 
performed due to limited material availability.  
    
Any differences in particle size may in part be caused by the differences in the time 
taken for the addition of feed to the precipitant between the three scales, although data 
in section 5.3.1 suggested that this effect might have become normalised after 60 
minutes of mixing. However, the impact on resultant particle size will need to be 
further investigated, and further experiments are proposed in section 6.2.2 where 
the rate of precipitant addition at different scales is scaled up accordingly to 
maintain time of addition.  
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 Microscale Laboratory scale Pilot scale 
Operating volume 
(mL) 
1 50 5000 
Maximum working 
volume (mL) 
1.30 200 10000 
Vessel height, H 
(mm) 
29 110 300 
Material type PTFE PTFE Polyethylene 
Bottom Shape Round Flat Flat 
Vessel diameter, dv 
(mm) 
8.50 63 270 
Impeller diameter, 
di (mm) 
5 40 162 
di / dv 0.58 0.63 0.54 
Impeller type 
5 mm VP 772FN 
PTFE coin magnets 
6 blade Rushton 
turbine 
12 blade 
Rushton turbine 
Mixing speed (rpm) 800 2000 90 230 42 
Mixing Power per 
volume (W m-3) 
42 
 W m-3 
670  
W m-3 
42  
W m-3 
670  
W m-3 
42  
W m-3 
Ḡ (s-1) 120 473 115 472 122 
Mixing time (min) 60 60 60 
Flowrate of feed 
into vessel (mL 
min-1) 
54 54 54 
Volume of feed 
added (mL) 
0.33 16.50 1650 
Time taken for 
addition of feed 
(min) 
0.01 0.30 28 
 
Table 5.2: Dimensions and characteristics of the precipitation vessels. Minor 
differences exist between the three scales, but scaling parameters such as di/dv, 
mixing time, mixing Power per volume, mean velocity gradient and flowrate of feed 
into the vessel have been maintained constant. At laboratory and pilot scale the 
flowrate of feed into the vessel was 54 mL min-1 using a Watson Marlow 605 Di 
Peristaltic Pump (Watson Marlow Ltd., Falmouth, UK) to match the flowrate at 
microscale (900 L s-1). Any differences in particle size may in part be caused by the 
differences in the time taken for the addition of feed to the precipitant between the 
three scales, although data in section 5.3.1 suggests that this effect may become 
normalised at 60 minutes of mixing     
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Figure 5.7: Diagram to show the laboratory scale up. The stirred tank reactor was 
equipped with a 6 blade Rushton turbine impeller located approximately 1/3 off the 
vessel bottom. The flowrate of solutions into the vessel was 54 mL min-1 using a 
Watson Marlow 605 Di Peristaltic Pump (Watson Marlow Ltd., Falmouth, UK) to 
match the flowrate at microscale (900 L s-1). The point of addition was located in 
the proximity to the impeller to mimic the same point at microscale. The 
experimental methodology was completed to mimic that of the microscale process 
(described in section 4.3.1). Briefly, 100 mM Tris HCl pH 7.4 was added to the 
vessel, followed by the addition of PEG 12000 (stock concentration of 50% w/v pH 
7.4) and sodium citrate (stock concentration of 2.2 M pH 7.4) as necessary. This 
mixture was then mixed for two minutes to ensure homogeneity of the precipitant. 
This was followed by the addition of feed, and total mixing time was 60 minutes. 
Mixing speeds are shown in table 5.2. At laboratory scale both 42 W m-3 and 670 W 
m-3 mixing Power per volume runs were completed  
 
 
 
 
40 mm
63 mm
35 mm
11 mm
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Figure 5.8: Particle size distribution profiles of laboratory scale experiments of 
homogenate precipitated with PEG 12000 6.25% w/v/0.4 M sodium citrate at 1 
minute mixing (●), 15 minutes mixing time (○), 20 minutes mixing time (▼) and 60 
minutes mixing time (∆) at 90 rpm and 230 rpm mixing speeds respectively on a 
semi log plot. Mixing was conducted with a 40 mm Rushton turbine. Measurements 
were made using a Malvin Mastersizer (Malvern Instruments, Southborough, UK) in 
triplicate as described in section 2.4. The standard deviation for measurements 
were ≤ 5% 
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Figure 5.9: Microscopic images of multimodal precipitated material at laboratory 
scale at 90 rpm and 230 rpm respectively. Images were taken using a Axioscope 2 
plus microscope (Carl Zeiss Micro Imaging Inc., Thornword, USA) at 100x 
magnification of material that was mixed for 60 minutes with feed added at 54 mL 
min-1. Arrows indicate examples of particulates of interest, which indicates a diverse 
size and morphology of particulates. Particulates appear to be agglomerated  
 
The size, strength and rheological characteristics of aggregates have all been linked 
to the precipitation reactor design and configuration. Vessel geometries, baffles, 
impellers and whether the operation is continuous or batch all contribute to the 
particulates characteristics. Larger and faster impellers have greater tip speeds and 
hence higher maximum energy dissipation at the tip to shear the aggregates. The 
particulates circulation time and the proportion of time spent near the impeller define 
precipitate strength and ageing (Shamlou et al., 1996).  
  
Bell and Dunnill (1982) demonstrated that continuous tubular reactors produced 
large, irregular, low density particles as compared with the stronger, smaller 
particles of the batch stirred tank. They attributed the differences to the magnitude 
and distribution of mean velocity gradients (Ḡ), and residence times within the 
reactors. They observed that the batch aggregates had been exposed to high flow 
stress zones (impeller region) for longer periods than their continuous counterparts 
had. The larger continuous precipitates had a more open structure and a wider 
distribution of sizes. Particles had infrequently been exposed to impeller action in 
the continuous system (a lower residence time in a high velocity gradient zone). 
Their centrifugal recovery predictably resulted in reduced clarification (shear in the 
feed zone had broken these large, hollow particles into fine fragments found in the 
supernatant).  
 
90 rpm 230 rpm 
200 m200 m
Blank slide
200 m
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A good agreement was observed for the particle size distribution profiles for 
microscale and laboratory scale with multimodal precipitation conditions (figures 5.3 
and 5.8 respectively). At laboratory scale, it was observed that the particle size was 
not as quickly formed relative to microscale. At one minute mixing time, the d50 
value was 262 m at microscale relative to 183 m observed at laboratory scale at 
42 W m-3 (90 rpm at laboratory scale). However, at 60 minutes of mixing, the d50 
value for laboratory scale was 200 m relative to 313 m for microscale. This may 
in part be due to the difference in the rate of addition between the different scales. 
Interestingly, the particle size and formation was quicker and smaller at 670 W m-3 
(230 rpm at laboratory scale; the d50 value after 60 minutes was 151 m). This 
suggested that the speed of mixing provided turbulent conditions and sufficient 
energy to overcome the energy barrier for aggregation (Rushton et al., 1950). 
However, it was noted that the d50 particle size at higher mixing speeds was smaller 
than that observed at slower mixing speeds (figure 5.8). 
   
To understand the size and the morphology of the precipitated material, microscopic 
images were taken (figure 5.9). Microscopic images were taken using a Axioscope 2 
plus microscope at 100x magnification (Carl Zeiss Micro Imaging Inc., Thornword, 
USA) after 60 minutes of mixing. Examples of the particulates of interest have been 
indicated in figure 5.9, which shows a diverse size and morphology of particulates 
with slightly smaller particles observed at 230 rpm. Particulates appear to be 
agglomerated and both irregular in shape and size. The increase in mixing speed 
has not reduced the size of the particles significantly. However, the pictures may not 
be truly representative of the precipitated particles as the pictures represent a small 
proportion of the material. 
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STAGE 2 
 
5.4 Results and Discussion 
 
5.4.1 Defining the Centrifugation Stage of the Precipitation Process  
 
The size of the chromatography columns and buffers volumes used in processes 
are increasing (Ljunglöf et al., 2007) and a precipitation step combined with a 
centrifugation step can be used to reduce the burden of subsequent 
chromatography steps. An ultra scale down (USD) method to measure the shear 
sensitivity of precipitated particles has been developed previously at University 
College London (Berrill et al., 2008). The concept is to mimic the disk stack 
centrifuge at laboratory scale, by exposing the feed to shear rates that are similar to 
that experienced by the feed in the feed zone of the pilot scale centrifuge. This is 
performed by exposing the feed to different shear conditions and measuring ease of 
clarification.  
 
The characteristics of the precipitated material are required to be strong and dense 
to prevent break up whilst in the feed zone of a disc stack centrifuge. In a disc stack 
centrifuge there are relatively high levels of shear, and the more resistant the 
particles are to shear the higher the speed the centrifuge can be operated at. This 
allows higher feed flow rates to be used without affecting yield and purification 
factor. To best mimic the pilot scale centrifuge, feed materials were exposed to 
shear levels similar to those found in the feed zone of the pilot centrifuge prior to 
laboratory centrifugation.  
 
Sigma theory, is a concept used to describe the solid-liquid separation performance 
of a centrifuge. The theory and method of mimicking entry shear has been 
thoroughly described in the literature (Boychyn et al., 2000, Reynolds et al., 2003, 
Boychyn et al., 2004). The sigma area, also called equivalent settling area, is 
defined as the surface area of a gravity settling tank with equivalent settling 
performance. Each type of centrifuge design has a unique correlation for calculating 
a sigma value. Equations 5.3 and 5.4 show the formulas for calculating the sigma 
value for laboratory and disc stack centrifuges respectively.  
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Equation 5.3: Where ∑lab is the equivalent settling area of the laboratory centrifuge 
(Eppendorf 5810R centrifuge) (m2), Vlab is the volume of processed material, ω is 
2N (rad s-1), N is the rotational speed (rps), g is the acceleration due to gravity (m 
s-2), R1 is the inner radius (m) (the distance between the centre of rotation and the 
top of the liquid), and R2 is the outer radius (m) (the distance between the centre of 
rotation and the bottom of the tube) (Maybury et al., 1998) 
 
 
 
Equation 5.4: Where ∑ is the equivalent settling area of the disc stack centrifuge 
(m2), nd is the number of active discs, r1 and r2 are the inner and outer disc radius 
(m), and ө is the half disc angle (degrees) (Boychyn et al., 2004)  
 
5.4.2 Microscale Precipitation and Centrifugation 
 
The first stage in the precipitation of Fab’ from partially clarified homogenates was 
optimised through the use of microscale mimics for two types of precipitating 
conditions namely PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 (multimodal) 
and PEG 12000 15% w/v pH 7.4 (single mode; partially clarified homogenised 
material was used as a control). The second stage, evaluated if low volume 
experiments could provide process relevant data similar to that obtained from a pilot 
scale study. Table 5.3 highlights the experimental procedures used. 
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Experimental 
procedure 
Laboratory scale Pilot scale 
Homogenisation of 
feed material 
APV Gaulin Lab60 
homogeniser (APV 
International, West Sussex, 
UK) 
APV Gaulin Lab60 
homogeniser (APV 
International, West Sussex, 
UK) 
Centrifugation 
CARR P6 Powerfuge 
centrifuge (Pneumatic Scale 
Corporation, FL, USA) 
CARR P6 Powerfuge 
centrifuge (Pneumatic Scale 
Corporation, FL, USA) 
Precipitation 
1. 100 mM Tris HCl pH 7.4 
(control) 
2. PEG 12000 6.25% w/v/0.4 
M sodium citrate 
3. PEG 12000 15% w/v 
1. 100 mM Tris HCl pH 7.4 
(control) 
2. PEG 12000 6.25% w/v/0.4 
M sodium citrate 
3. PEG 12000 15% w/v 
Shear 
Low shear (6000 rpm) 
High shear (18000 rpm) 
N/A 
Centrifugation 
Eppendorf 5810R centrifuge 
(Eppendorf UK Ltd., 
Cambridge, UK) 
CSA-1 disc stack centrifuge 
(Westfalia Separator, AG, 
Germany) 
 
Table 5.3: Experimental procedure to mimic pilot scale centrifuge by exposing feed 
material to different levels of shear at laboratory scale  
 
Precipitation at laboratory scale was performed on a Tecan Freedom EVO 200 
liquid handling workstation (Tecan, Reading, UK) controlled by the Freedom 
EVOware software with mixing at 800 rpm for 60 minutes and 900 L s-1 feed 
addition rate. Thirty microwells were used for each of the three precipitation 
experiments to produce sufficient volume of material for the rotating disc shear 
device. The construction of this device has been described previously (Hutchinson 
et al., 2006, Biddlecombe et al., 2009). The working volume for the rotating disc 
shear device was 20 mL. The rotating disc shear device consisted of a 50 mm 
diameter stainless steel chamber and height of 10 mm mounted onto a stainless 
steel shaft. The rotating disc had a diameter of 40 mm and a depth of 1 mm. The 
shaft of the element was connected to a high speed DC motor powered from the 
mains via a transformer. The transformer provided a range of speeds from 0 to 
20000 rpm measured using an optical probe. The top and bottom of the stainless 
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steel chamber were equipped with entrance and exit holes with luer fittings to allow 
the attachment of syringe fillers. The device was filled from the bottom allowing 
trapped air to escape through the top. Once the chamber was full, inlets and outlets 
were sealed prior to operation of the device. The assembly was mounted on a 
heavy metal base to reduce vibration during experiments (Hutchinson et al., 2006). 
 
The precipitated material was used to produce a well spun, low shear (6000 rpm) 
exposed material, and high shear (18000 rpm) exposed material samples. Shear 
exposure was performed for 20 s in the high speed rotating disc device (figure 
5.10). This was to allow reproducible operation and to avoid excessive break up of 
particles at longer times shear exposure times. This has been shown to be sufficient 
time to ensure all the sample has been exposed to the highest shear region at the 
tip of the disc for all rotational speeds of the centrifuges to be used (Neal et al., 
2003, Boychyn et al., 2004). 
 
 
 
Figure 5.10: Diagram representing the high speed rotating disc shear device. 20 
mL samples of all three precipitating conditions (table 5.3) were sheared for 20 
seconds at either low shear (6000 rpm) or high shear (18000 rpm)  
 
Low and high shear conditions of 6000 and 18000 rpm were used prior to 
centrifugation to mimic the impact of the shear regions in the inlet of the disc stack 
centrifuge (Neal et al., 2003). The remaining suspension was kept as a no shear 
control condition. 1.5 mL samples were taken and placed in 2 mL Eppendorf tubes 
(Eppendorf UK Ltd., Cambridge, UK) from the three types of precipitated material at 
no shear (control), low and high shear. The tubes were spun in a Eppendorf 5810R 
20 mL volume
Sample
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centrifuge, rotor T-60-11 (Eppendorf UK Ltd., Cambridge, UK; N = 1600-12600 rpm, 
lab = 0.009-0.617 m
2, tlab = 12 min) at six different speeds for twelve minutes, 
detailed in table 5.4. 
 
Centrifuge speed (rpm) Time (min) V/C.t.Σ (m s-1) 
1600 12 2.7E-07 
2800 12 9.0E-08 
3200 12 6.9E-08 
4400 12 3.6E-08 
7800 12 1.2E-08 
12600 12 4.4E-09 
 
Table 5.4: Centrifugal speeds in rpm and sigma values (equation 5.3) to mimic pilot 
scale clarification. Samples were spun for 12 minutes in an Eppendorf 5810R 
centrifuge, rotor T-60-11 (Eppendorf UK Ltd., Cambridge, UK; N = 1600-12600 rpm, 
lab = 0.009-0.617 m
2, tlab = 12 min) 
  
A well spun sample was prepared for the purpose of a clarification reference sample 
N = 12600 rpm, tref = 30 minutes and the OD600 measured (ODr) assuming 100% 
clarification. The optical density of the samples post centrifugation was measured at 
600 nm (OD600) using a Beckman DU 650 Spectrophotometer (Beckman Coulter 
Ltd., High Wycombe, UK) for both the sheared and the non sheared feed 
suspensions (ODf) to generate data to calculate percentage clarification from 
equation 5.5. 100 mM Tris HCl pH 7.4 was used as a blank, and where necessary 
samples were diluted with 100 mM Tris HCl pH 7.4 in order to operate in the linear 
optical range of the spectrophotometer. The clarification level was determined using 
equation 5.5. 
 
 
 100% x
ODrOD
ODOD
ionClarificat
f
sf


                 (5.5) 
 
Equation 5.5: Percentage clarification post centrifugation, where ODf, ODs and ODr 
are the optical density of the feed, the sample supernatant and the supernatant of 
the reference sample respectively (Boychyn et al., 2000) 
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5.4.3 Pilot Scale Precipitation and Centrifugation 
 
When scaling a precipitation process, the goal is to be able to mimic larger 
operating conditions and to provide the basis whereby the eventual larger scale 
process can be operated under identical feasible conditions. Total volume was 5 L 
at pilot scale for each of the three conditions (three different precipitants as in table 
5.3). This was performed in a 10 L vessel filled with 3.4 L of precipitant. The feed 
suspension of 1.6 L was fed continuously into vessel with the nozzle located in the 
proximity of a 162 mm Rushton impeller via a Watson Marlow 605 Di Peristaltic 
Pump (Watson Marlow Ltd., Falmouth, UK). Flowrate was maintained at 3.3 L hr-1 
(54 mL min-1) to replicate conditions at micro/laboratory scale. Impeller speed was 
set at 42 rpm to maintain the Power per unit volume of 42 W m-3 (equation 5.2 and 
table 5.2). The feed addition was monitored and controlled using a weighing 
balance. The total mixing time was 60 minutes (table 5.2). 
The precipitated material was clarified using a CSA-1 disk stack centrifuge 
(Westfalia Separator, AG, Germany) at a flowrate of 100 L hr-1. The optical density 
was measured at 600 nm (OD600) with a Beckman DU 650 Spectrophotometer 
(Beckman Coulter Ltd., High Wycombe, UK) with 5 mL samples taken every minute. 
Temperature was maintained at approximately 7°C using a glycerol feed. The 
resulting solids were discharged immediately upon the bowl reaching capacity.  
The strength and density of particles have been shown to be directly related and 
both are critical variables in centrifugal separation (Tambo and Hozumi 1979). The 
starting feed material at pilot scale prior to CSA-1 operation had a d50 particle size of 
301 m, which was in good agreement with microscale data, which had a d50 
particle size of 313 m at the same conditions. Particulates in the pilot feed were 
observed visually as shown in figure 5.11, which suggests that particulates had 
irregular morphology. At high shear, the particulates appeared to be smaller relative 
to the low sheared material suggesting that the material was sensitive to shear.   
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Figure 5.11: Microscopic images of the feed at pilot scale and laboratory scale 
(high and low shear) for PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 
precipitated material. Images were taken using a Axioscope 2 plus microscope (Carl 
Zeiss Micro Imaging Inc., Thornword, USA) at 100x magnification of multimodal 
material at pilot scale and laboratory scale exposed to 6000 rpm (low shear) and 
18000 rpm (high shear). Arrows show examples of the particulates of interest, which 
indicate irregular shape and size of particulates in all conditions. Particulates appear 
to be smaller after being exposed to high shear suggesting particle break up, 
suggesting that the material was sensitive to shear 
 
Figure 5.12 suggests that the feed material was not shear sensitive with little effect 
on clarification without any precipitant added. This was confirmed with visual 
observation using microscopic images showing that there was an insignificant 
difference between different shear rates. The percentage clarification was low ≤ 
80% throughout the V/C.t.∑ (m s-1) investigated. However, data in figures 5.13 and 
5.14, which represents clarification of material precipitated with PEG 12000 15% 
w/v pH 7.4 and PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 respectively 
200 m 200 m
Low shear High shear
200 m
Pilot feed Blank slide
200 m
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suggests that the particle size decreases with increasing shear. It was possible that 
the breakage of particles during high shear resulted in sub visible particles, which 
may have consequences on the efficiency of the clarification of the material.  
 
The centrifugation speed (equivalent flow rate to equivalent settling area ratio) was 
changed to the different spin down velocities shown in table 5.4 to adjust the 
equivalent settling area while maintaining the 12 minute centrifugation time. There 
was a significant difference in the percentage clarification between PEG single 
mode and multimodal precipitated material before and after material was exposed to 
high shear (figures 5.13 and 5.14). It was observed that low shear does not have a 
significant effect on clarification at higher speeds, where clarification of 99% was 
possible in some cases. This was in part due to the removal of smaller particles at 
higher centrifugation speeds. It was not possible to run the pilot centrifuge at these 
conditions as the lowest flowrate with the highest speed resulted in the data points 
shown in figure 5.14. Similar trends were observed by Tustian et al., (2007) and Tait 
et al., (2009). 
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Figure 5.12: The probability-log relationship of percentage clarification and 
equivalent flowrate for centrifuge separation area for homogenised feed material 
without added precipitant at pH 7.4. This material was exposed to no shear (●), 
6000 rpm low shear for 20 s (○) and 18000 rpm high shear for 20 s (▼). Feed 
material was homogenised at 500 bar for 1 pass using an APV Manton-Gaulin 
Lab60 homogeniser (APV International, West Sussex, UK). The x-axis is the ratio of 
the equivalent flowrate to equivalent settling area. Data points were plotted on 
probability logarithmic axes. Solid line represents linear fit of data extended to axes 
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Figure 5.13: The probability-log relationship of percentage clarification and 
equivalent flowrate for centrifuge separation area for homogenised feed material 
precipitated with PEG 12000 15% w/v pH 7.4. This material was exposed to no 
shear (●), 6000 rpm low shear for 20 s (○) and 18000 rpm high shear for 20 s (▼). 
The x-axis is the ratio of the equivalent flowrate to equivalent settling area. Feed 
material was homogenised at 500 bar for 1 pass using an APV Manton-Gaulin 
Lab60 homogeniser (APV International, West Sussex, UK). Data points were plotted 
on probability logarithmic axes. Solid line represents linear fit of data extended to 
axes 
 
V/Ct ms
-1
)
1e-9 1e-8 1e-7 1e-6
%
 c
la
ri
fi
c
a
ti
o
n
 
5
10
20
30
50
70
80
90
95
98
99
99.8
99.9
223 
 
 
Figure 5.14: The probability-log relationship of percentage clarification and 
equivalent flowrate for centrifuge separation area for homogenised feed material 
precipitated with PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 exposed to no 
shear (●), 6000 rpm low shear for 20 s (○), 18000 rpm high shear for 20 s (▼), pilot 
scale run 2 (feed homogenised for 500 bar for 1 pass) (■) and pilot scale run 1 (feed 
homogenised at 500 bar for 5 passes) (▲). Feed material was homogenised using 
an APV Manton-Gaulin Lab60 homogeniser (APV International, West Sussex, UK). 
The x-axis is the ratio of the equivalent flowrate to equivalent settling area. Data 
points were plotted on probability logarithmic axes. Solid line represents linear fit of 
data extended to axes 
 
 
A previous run at pilot scale with homogenisation conditions of 500 bar for 5 passes 
was investigated in which the clarification at pilot scale was not in agreement with 
the scale down prepared precipitates. Percentage clarification of 40% was observed 
for the pilot scale. The recoveries obtained for both laboratory and pilot scale were 
significantly different (80% and 54% respectively), which suggested possible 
differences in the settling properties of the precipitates in part caused by the 
excessive homogenisation step of 500 bar for 5 passes. 
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It has been shown in research that it is possible to over predict the clarification of 
solids at laboratory scale caused by the reaggregation of material at the laboratory 
scale (Berrill et al., 2008). At laboratory scale, as the solids concentration increases, 
the settling rate of particles decreases due to interparticle forces. It is possible that 
the particles form a large floc that sweeps up the fine particles in the supernatant. 
This leads to an over prediction in the laboratory scale to that observed at the pilot 
scale. Hindered settling can occur when the solids concentration is high, which for 
this type of material, could be above 2% w/v. As the solids concentration increases, 
the settling rate of particles decreases due to the increase in interparticle forces. 
Particles settling slowest will be hindered by those underneath them. This is 
particularly noticeable in the confined space of a laboratory centrifuge. At very high 
solids what is known as “blanket” sedimentation can occur. This is when particles all 
settle at the same rate and form a large floc that sweeps up the fine particles in the 
liquid. This leads to an overprediction at laboratory scale to that of the pilot scale 
centrifuge (Berrill et al., 2008). 
 
In part, the much lower clarification observed at the pilot centrifuge was the result of 
break up of aggregates in the feed zone of the centrifuge, which was caused by the 
high flow stresses as the material enters the pilot centrifuge. The use of a peristaltic 
pump excluded the possibility of precipitate damage due to pumping, as Bell et al., 
(1983) demonstrated that this type of pump had no disruptive effect on precipitates. 
However, at laboratory scale the length of time between shearing material and 
clarification may be enough to allow reaggregation, which consequently increases 
clarification performance in the laboratory scale compared to the pilot scale at an 
equivalent separation condition.  
 
It was decided to homogenise E.coli cells at 500 bar for one pass to improve the 
percentage clarification at pilot scale. Homogenisation conditions were investigated 
in chapter 2. Figure 5.14 illustrates a significant improvement in percentage 
clarification compared to material homogenised through 5 passes (87% clarification 
compared to 40% clarification). It was suggested that the reduction of the level of 
sub visible particles had allowed a greater number of smaller debris to aggregate 
increasing strength and improving separation. A good agreement of clarification was 
achieved between the scale down and pilot centrifuge. The pilot scale separation 
efficiency improved from 40% to 87% with a recovery of 72%. The same conditions 
at laboratory scale with material exposed to high shear, 93% separation efficiency 
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was achieved. Since all the variables were kept constant and the significant 
difference in particle size distribution between the two levels of homogenisation for 
frozen E.coli cells, the gain in clarification was attributed in part to the reduction of 
micronisation of cell debris.  
 
The benefits of better clarification will positively impact subsequent process steps. 
In this case, precipitated material has been used for selective product capture from 
a microbial homogenate and the selection of solid–liquid separations fit for purpose 
is critical. Post centrifugation cartridge or guard filters have been used to protect 
more expensive unit operations such as ultrafiltration and chromatography, by 
removing fine solids, which may foul them (Bracewell et al., 2008). As the filter 
collects solids, an increasing pressure is required to maintain flow until it is not 
possible to maintain flow at which point the filter is changed. When preceding solid–
liquid separation steps are performing well a guard filter is rarely heavily challenged 
and adds minimal capital and running costs, but can protect extremely valuable 
processes in many instances (Bracewell et al., 2008). Step change improvement in 
clarification between low and high shear samples at the various clarification 
conditions studied was observed. For example, from figure 5.13 it can be observed 
that approximately 20% improvement in clarification can be expected at a V/C.t.∑ of 
6.8 x 10-8 m s-1, and therefore the subsequent filter size could be reduced by 20% 
for similar performance. Further investigation with filters is described in section 
5.5.2. In this case, microscale down methods that have been established for the 
study of operations such as centrifugation, which predict full scale operation is 
feasible (Boychyn et al., 2004, Hutchinson et al., 2006). However, it is necessary to 
predict the effect of this performance on the whole process before committing to 
large scale operations. 
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STAGE 3 
 
5.5 Results and Discussion 
 
5.5.1 Process Run Through Integrating Precipitation into a Down 
Stream Process 
 
Cation exchange chromatography is a key step in generic purification processes 
(Farid 2006). In this section, a 1 mL SP Sepharose Hi Trap packed bed column (GE 
Healthcare, Uppsala, Sweden) was used to capture Fab’ from the three feedstock 
solutions described in this chapter. Figure 5.15 highlights the process run through 
using three different feedstreams, namely partially clarified homogenate pH 7.4 
(control), PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 (multimodal), and PEG 
12000 15% w/v pH 7.4 (single mode). 
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Figure 5.15: Process run through based on three feedstreams described in section 5.5.1 
Crossflow filtration
50 cm2  10k GE Healthcare membrane 
Diafiltration factor 5x
SP Sepharose chromatography
1 mL Hi Trap column
Step elution 25 mM sodium acetate/99 mM 
sodium chloride pH 5
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Process Recovery 71%
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chloride pH 5
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sodium chloride pH 5
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Resuspension of material
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228 
5.5.2 Automated Depth Filter Investigation Using an Eight Well Custom 
Filter Block Design  
 
The clarification of the three feedstreams were examined during membrane filtration 
operation using an automated multiwell filtration technique prior to packed bed 
studies. The normal flow filtration method used has been established by Kong et al., 
(2010). The build up of materials on or within the membrane pores would eventually 
lead to flux decline over time and the selection of membrane materials can affect 
the quality and recovery of the product (Kong et al., 2010).  
 
Filtration experiments of the three feedstreams were performed at room 
temperature using Cuno Zeta Plus 05SP and 30SP membrane filters (Cuno, 
Meriden, USA). 05SP and 30SP filters operate between 1-5 m and 0.5-2 m 
respectively. The filters were cut in-house to enable proper fitting into the custom 
membrane housings. The upper part of the housings was filled with 2 mL of feed 
material and all eight membrane housings were inserted into the custom filter block 
for triplicate runs (figure 5.16). The filtration area was 0.28 cm2 with an operating 
pressure constant at 30 kPa throughout the filtration. A Tecan Freedom 200 EVO 
liquid handling system (Tecan, Reading, UK) was used to automate the filtration 
using a VacS two position vacuum manifold and the liquid handling (LiHa) arm of 
the Tecan (Tecan, Reading, UK). The Freedom EVOware software (Tecan, 
Reading, UK) was used independently to aspirate/dispense the feed material in 
parallel. Beneath each filter were individual tubes for filtrate collection. 
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Figure 5.16: Eight well custom filter block design for parallel microscale filtration. 
(A) cross-section of single filter membrane housing with sample pot on a collection 
plate. (B) top view of the position plate (diagram from Kong et al., 2010) 
 
The liquid handling arm was programmed to detect the retentate level on the top 
side of the membrane at specific time intervals throughout each experiment, which 
was logged for time and retentate volume. The amount of feed material removed 
from the top side of the membrane was assumed equal to the filtrate volume. The 
volumes detected by the LiHa arm and actual volumes (measured manually) had a 
correlation of more than 0.99. The variation for 18 repeated measurements was 
determined to be less than 5%. Data recording was terminated when 100% flux 
reduction rates were achieved.  
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Figure 5.17: Filtration of PEG 12000 15% w/v pH 7.4 (●), PEG 12000 6.25% w/v 
/0.4 M sodium citrate pH 7.4 (○) and clarified homogenate pH 7.4 (▼) through Cuno 
Zeta Plus 05SP (A) and Cuno Zeta Plus 30SP (B) depth filters at 30 kPa pressurey. 
Feed concentrations were 1.3 g L-1, (4.6 g L-1), 1.3 g L-1, (3.7 g L-1), 1.8 g L-1 and 
(3.3 g L-1) of Fab’ and (total protein) for clarified homogenate, PEG 12000 6.25% 
w/v/0.4 M sodium citrate pH 7.4 and PEG 12000 15% w/v pH 7.4 feedstreams 
respectively. Error bars are shown for one standard deviation for triplicate 
experiment repeats 
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Figure 5.17 shows the cumulative filtrate volumes over time for the Cuno Zeta Plus 
05SP and Cuno Zeta Plus 30SP filters respectively (Cuno, Meriden, USA). These 
membranes were selected due to their common availability and low adsorption 
properties. It is apparent from the data collected that the pore size has a significant 
impact on the volumes that can be filtered and on the filtration flux rates. The flow of 
material was quicker using the larger pore 05SP filter. The transmission of the Fab’ 
and total protein was investigated at the end of each run after the filtration process. 
The collected filtrate samples were quantified using Protein G HPLC (GE 
Healthcare, Uppsala, Sweden) and the Pierce BCA assay for total protein (Pierce, 
Rockford, USA) as per sections 2.1 and 2.2 respectively. The experimental data 
shown in table 5.5 showed an increase in clarification when using the 30SP filter. 
The purification factor after filtration with 05SP membranes was 1.3 for the 
homogenate, multimodal and single mode feedstreams respectively. In the case of 
30SP membranes, the purification factor was 1.4, 1.4 and 1.3 after filtration for the 
three feedstreams respectively. In future experiments, the 30SP filter was used as a 
depth filter due to its increase in performance over the 05SP filter.   
 
Filter Feedstreams 
Initial 
Fab’ 
conc 
(g L
-1
) 
Initial total 
protein 
conc  
(g L
-1
) 
Total 
protein 
conc post 
filtration 
(g L
-1
) 
Recovery 
(%) 
Purification 
factor 
05SP 
Homogenate 1.26 4.61 3.69 98 1.30 
Multimodal 1.31 3.68 2.74 97 1.32 
Single mode  1.27 3.31 2.61 99 1.26 
30SP 
Homogenate 1.26 4.61 3.41 100 1.37 
Multimodal 1.31 3.68 2.62 99 1.39 
Single mode  1.27 3.21 2.51 98 1.33 
 
Table 5.5: Purification factor after filtration through Cuno Zeta Plus 05SP and Zeta 
Plus 30SP depth filters (Cuno, Meriden, USA) at microscale 
 
 
The Vmax has been used to successfully describe filtration processes in the 
biopharmaceutical industry (Zydney and Ho 2002). This model describes the 
relationship for filter capacity limitations and flowrate of material through the filter 
(Kong et al., 2010). These parameters can be used to estimate filter sizing (equation 
5.6). 
 
232 
Vmax   
 
        
 
 
Ji =   
 
           
 
 
Area = 
  
  
   (
  
    
  
 
  
) 
 
 
Equation 5.6: Vmax where V is the total filtrate volume collected over time t, Ji is the 
initial volumetric filtrate flow rate (L m-2 h), and Vmax is the maximum fluid volume 
that can be filtered before the membrane is completely fouled (L m-2), Vb is the 
filtration volume (L), tb is the filtration batch time (h) (Zydney and Ho 2002) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
(5.6) 
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Figure 5.18: Vmax for clarified homogenate pH 7.4 (control) (○), PEG 12000 6.25% 
w/v/0.4 M sodium citrate pH 7.4 (multimodal) (▼) and PEG 12000 15% w/v pH 7.4 
(single mode) (●) feedstreams for cumulative filtrate volume using a Cuno Zeta Plus 
05SP filter (A) and Cuno Zeta Plus 30SP filter (B). Vmax for the multimodal 
feedstream was calculated to be 200 and 400 L m-2 for 05SP and 30SP filters 
respectively 
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Vmax for the multimodal feedstream was calculated to be 200 and 400 L m
-2 for 05SP 
and 30SP filters respectively (figure 5.19). A 205 cm2 30SP filter would be sufficient 
to filter 1000 mL of material in 30 minutes.  
 
To complete a process run through, 100 mL of the three feedstreams were prepared 
to generate sufficient material for depth filter clarification and subsequent steps. 
Feedstream 1 was clarified homogenate used as a standard, feedstream 2 was the 
multimodal feedstream where the Fab’ is not precipitated, and feedstream 3 was 
material precipitated by PEG 12000 15% w/v pH 7.4 (single mode). The feed 
material was spun at 6100 rpm for 12 minutes in a Eppendorf 5810R centrifuge 
(Eppendorf UK Ltd., Cambridge, UK), which was equivalent flow rate to settling area 
ratio to the disc stack centrifuge. The spun down material in feedstreams 1 and 3 
were resuspended using 100 mM Tris HCl pH 7.4 to 150 mL. Material was later 
diafiltered using the ÄKTA Crossflow (GE Healthcare, Uppsala, Sweden).  
 
A BioCap 30 Filter (30SP) with 25 cm2 area was used for the purpose of the run 
through. Table 5.6 highlights the clarification of the three feedstreams at 100 mL. 
Purification factor post filtration was 1.2, 1.4 and 1.2 for homogenate, multimodal 
and single mode feedstreams respectively.  
 
Filter Feedstreams 
Initial 
Fab’ 
conc 
(g L
-1
) 
Initial total 
protein 
conc  
(g L
-1
) 
Total 
protein 
conc post 
filtration 
(g L
-1
) 
Recovery 
(%) 
Purificatio
n factor 
30SP 
Homogenate 1.26 4.61 3.66 97 1.21 
Multimodal 1.31 3.39 2.35 98 1.35 
Single mode 1.27 3.22 2.52 96 1.23 
 
Table 5.6: Purification factor after filtration of 100 mL of each feedstream through a 
Cuno BioCap 30 Filter (30SP, 25 cm2 filter area) (Cuno, Meriden, USA) 
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The experimental results showed that the clarification obtained in the multiwell 
filtration design and the conventional unstirred normal flow membrane systems were 
comparable. The microscale method allows for multiple filter and filter types to be 
investigated rapidly using small sample quantities. It was found that membrane pore 
size influence flux and transmission rates. This is in agreement with previous 
findings (Kong et al., 2010). 
 
5.5.3 Tangential Flow Ultrafiltration/Diafiltration Step Prior to Packed 
Bed Studies 
 
It has been reported that monomer could be separated from dimers of the antibody 
Alemtuzumab using ultrafiltration in a stirred cell experiment (Wan et al., 2004). 
Alemtuzumab had a molecular weight of ~155 and pI of 8.5-9.0. The experimental 
set up consisted of a stirred cell ultrafiltration module which had a working volume of 
6.0 mL under constant volume diafiltration. 
 
The aim of this study was to prepare the three feedstreams for packed bed studies 
and to reduce the level of total protein by retaining the Fab’ in the retentate. A 50 
cm2 PES membrane (GE Healthcare, Uppsala, Sweden) was used to buffer 
exchange the feedstreams with 25 mM sodium acetate/25 mM sodium chloride pH 5 
using an ÄKTA Crossflow system (GE Healthcare, Uppsala, Sweden), which had a 
tangential flow mechanism in contrast to the stirred cell apparatus evaluated by 
Wan et al., (2004). The use of ultrafiltration/diafiltration to reduce total protein levels 
has the potential to improve the performance of subsequent packed bed steps. 
 
The three feedstreams were diafiltered using a ÄKTA Crossflow (GE Healthcare, 
Uppsala, Sweden) with a 50 cm2 PES membrane (GE Healthcare, Uppsala, 
Sweden) (table 5.7). Tangential flow was kept constant at 30 mL min-1, with a 
constant TMP of 1 bar. 
 
5.5.3.1 Preproduct Step 
 
An ultrafiltration method was created using the method wizard. The method was 
split into three separate methods, namely preproduct, product and postproduct 
methods, to better control the runs. The method wizard exaggerated the preproduct 
cleaning step, and to reduce the time taken for the ÄKTA Crossflow (GE Healthcare, 
Uppsala, Sweden) to complete the preproduct method, the commands 
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‘Fill_Reservoir_To_Max_Volume’, ‘Stop_Trans_Pump’, and 
‘Empty_Reservoir_Completely’ were deleted from the sub block  
‘Prepare_SystemAndReservoir’ under the main block PREPRODUCT_STEP_CIP. 
The same commands were deleted from the main block 
PREPRODUCT_STEP_WATER_FLUSH.  
 
The preproduct method was used to clean all the inlet and outlet lines of the ÄKTA 
Crossflow (GE Healthcare, Uppsala, Sweden) with 0.1 M sodium hydroxide followed 
by a rinse with the appropriate buffer (table 5.7). The membrane was cleaned and 
conditioned with 2 M sodium chloride, 0.1 M sodium hydroxide followed by 
deionised water prior completing a normalised water permeability (NWP) test. The 
NWP is the rate of clean water flux through the membrane under conditions of 
standard pressure and temperature, and is used for measuring the effect of cleaning 
of membranes. This test was performed in both pre and postproduct steps. 
Following the NWP test, the membrane was conditioned with 25 mM sodium 
acetate/25 mM sodium chloride pH 5 diafiltration buffer. 
 
ÄKTA Crossflow inlet/outlet lines Buffer 
Inlet line 1 100 mL of sample 
Inlet line 2  
25 mM sodium acetate/25 mM sodium 
chloride pH 5 
Inlet line 5 Deionised water 
Inlet line 6 2 M sodium chloride 
Inlet lines 7 0.1 M sodium hydroxide 
Retentate outlet line 1 Flush collected post UF/DF 
Retentate outlet line 2 Waste 
Retentate outlet line 3 Product collected post UF/DF 
Permeate outlet lines 1 to 3 Waste 
 
Table 5.7: ÄTKA Crossflow (GE Healthcare, Uppsala, Sweden) setup. All inlet and 
outlet lines were cleaned with 0.1 M sodium hydroxide followed by a rinse with the 
appropriate buffer. Inlet line 2 was also used for the conditioning of the membrane 
with diafiltration buffer prior to diafiltration. Inlet lines 3, 4 and 8 were not used. The 
permeate was not collected. 
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5.5.3.2 Product Step 
 
The buffer exchange replacing the sample buffer with 25 mM sodium acetate/25 
mM sodium chloride pH 5 was performed over five diavolumes to reduce the 
conductivity of the feedstreams to 4.5 mS cm-1 ± 0.1. The ÄKTA Crossflow (GE 
Healthcare, Uppsala, Sweden) automatically determined when steady state had 
been reached. The diafiltration step was performed prior to the concentration step, 
which was omitted to overcome the precipitation issues occurring at pH 5 when the 
concentration of the feed material increased when using the conventional approach 
of concentration followed by diafiltration. Recovery of the product with a 10 mL flush 
was collected in all experimental runs after the flush had been recirculated for 30 
minutes. 
 
It was observed that the membrane retained significant amount of material (figure 
5.19). The decrease in absorbance levels at the permeate side can be explained by 
rapid fouling of membrane when product was freshly exposed to the membrane. 
The gel layer that was building up across the membrane surface may have affected 
the passage of material through the membrane surface (Wan et al., 2004). 
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Figure 5.19: Typical absorbance (-) and conductivity (-) profiles for the diafiltration 
of the feedstreams collected from the permeate side of the 50 cm2 PES membrane 
(GE Healthcare, Uppsala, Sweden) (clarified homogenate shown in this case). 
Tangential flow was kept constant at 30 mL min-1, with a constant TMP of 1 bar. 
Conductivity of all three feedstreams reached 4.5 mS cm-1 ± 0.1 after 5 diavolumes  
 
5.5.3.3 Postproduct Step 
 
The method was not reduced to avoid comprising the cleaning process of the 
membranes tested. 2 M NaCl and 0.1 M NaOH were used for CIP of the membrane. 
However, the PREPRODUCT_STEP_BUFFER_COND block from the preproduct 
method was inserted at the end of the postproduct method to reduce time taken to 
condition the membrane for subsequent runs. Table 5.8 highlights the Fab’ 
concentration and recovery post UF/DF. The NWP clean postproduct runs for 
homogenate, multimodal and single mode feedstreams were calculated by the 
Unicorn software (GE Healthcare, Uppsala, Sweden) to be 90%, 89% and 87% of 
the original preproduct run value respectively, suggesting some irreversible fouling 
of the membrane. The membrane could have had a better NWP by using a harsher 
cleaning reagent such as 1 M NaOH after 2 M NaCl. 
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Feedstreams 
Initial Fab’ 
concentration 
(g L-1) 
Fab’ 
concentration 
post UF/DF  
(g L-1) 
Recovery (%) NWP (%) 
Homogenate 1.22  1.06  87 90 
Multimodal 1.28  1.24  97 89 
Single mode 1.22  1.13  93 87 
 
Table 5.8: Fab’ concentration and recovery post UF/DF using the ÄKTA Crossflow 
(GE Healthcare, Uppsala, Sweden) at TMP 1 bar, constant retentate flowrate of 30 
mL min-1 
 
5.5.4 Further Purification of Fab’ Using Packed Bed Chromatography 
 
5.5.4.1 Dynamic Binding Capacity, Gradient Elution and Step Elution Studies 
 
The conventional affinity chromatography matrix consists of porous particle beads 
(Brochier et al., 2008). The pores within the particles are blocked, and thus the 
liquid inside them is stagnant (Thömmes and Etzel 2007). Subsequently the 
molecules to be separated are transported between the blocked pores and back to 
the mobile phase via diffusion (Thömmes and Etzel 2007). Diffusion is a slow 
process, and in the case of large molecules with low diffusion coefficients, diffusion 
is the rate determining step of the overall separation time (Brochier et al., 2008). 
Incidentally, separation resolution is dependent on residence time of the sample 
within the stationary phase, and therefore the velocity of mobile phase through the 
column (Brochier et al., 2008).  
 
Proteins have an either net positive or negative charge depending on their 
surrounding environment (i.e. buffer composition), and ion exchange 
chromatography is a key method at separating proteins based on differences in net 
charge. Ion exchange chromatography exploits differences in the net charge of 
proteins. The SP Sepharose (GE Healthcare, Uppsala, Sweden) resin is a strong 
cation exchange resin, which is negatively charged (SO3
-) over a wide range of pH 
values. The buffer conditions used for SP Sepharose (GE Healthcare, Uppsala, 
Sweden) chromatography, results in the proteins having a net positive charge, 
therefore, the protein binds, whilst impurities flow through the column. The bound 
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protein is eluted when buffer conditions are altered with increasing salt 
concentration. 
 
In this section, a 1 mL SP Sepharose Hi Trap pre packed bed column (GE 
Healthcare, Uppsala, Sweden) on a ÄKTA FPLC (GE Healthcare, Uppsala, 
Sweden) was used to capture Fab’ from the three feedstock solutions. The column 
was operated at 1 mL min-1 and washed with ten column volumes of equilibration 
buffer (table 5.9). The feed material was then passed through a 0.22 m filter prior 
to loading. A gradient elution of 25 mM to 200 mM sodium chloride pH 5 over 15 
column volumes (CV) was used to elute bound material from the column. 1 mL (1 
CV) fractions were taken of the load, and elution volume. The strip and post load 
wash (PLW) were collected in separate containers. The column was cleaned with 5 
mL of strip buffer, followed by 2 mL clean with 0.1 M sodium hydroxide. The buffers 
used are listed in table 5.9. A height equivalent of a theoretical plate (HETP) test 
was performed at a flowrate of 1 mL min-1 using 0.02 CV of 0.5 M sodium hydroxide 
injected via a 0.5 mL superloop. The theoretical number of plates were 1849 with an 
asymmetry of 1.01 calculated by the Unicorn software (GE Healthcare, Uppsala, 
Sweden). 
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Step Buffer Volume (CV) 
Equilibration 25 mM sodium acetate/25 
mM sodium chloride pH 5 
10 
Load 1.06 g L-1, 1.24 g L-1 and 
1.13 g L-1 of homogenate, 
multimodal and single mode 
feedstreams respectively 
25 
Post Load Wash 25 mM sodium acetate/25 
mM sodium chloride pH 5 
5 
Elution A: 25 mM sodium 
acetate/25 mM sodium 
chloride pH 5 
B: 25 mM sodium 
acetate/200 mM sodium 
chloride pH 5 
0% B to 100% B over 
15 CV 
Strip 25 mM sodium acetate/2.0 
M sodium chloride pH 5 
5 
Clean 0.1 M sodium hydroxide 2 
Storage  20% ethanol  5 
 
Table 5.9: SP Sepharose (GE Healthcare, Uppsala, Sweden) DBC and gradient 
elution conditions 
 
Dynamic binding capacities (DBC) were estimated by passing the homogenate, 
multimodal and single mode feedstreams at a concentration of 1.1 g L-1, 1.2 g L-1 
and 1.1 g L-1 respectively through the column and measuring the volume at which 
100% breakthrough occurred, using analysis by Protein G HPLC (GE Healthcare, 
Uppsala, Sweden) as described in section 2.1. These data are represented 
diagrammatically in figure 5.20.  
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 V
CP
DBC


            (5.7) 
Equation 5.7: The dynamic binding capacity (DBC) of Fab’ using SP Sepharose 
(GE Healthcare, Uppsala, Sweden) (g L-1) was calculated based on the volume of 
product loaded (P), the product concentration (C) and the column volume (V) 
(Wenger 2010) 
 
 
Figure 5.20: Breakthrough curves of Fab’ in clarified E.coli homogenate (control) 
(●), multimodal (PEG 12000 6.25% w/v/0.4 M sodium citrate) (○) and single mode 
(PEG 12000 15% w/v) (▲) feedstreams using SP Sepharose (GE Healthcare, 
Uppsala, Sweden) at 1 mL min-1. DBC at 100% breakthrough was calculated to be 
8.4 g L-1, 11.1 g L-1 and 9.0 g L-1 respectively for these feedstreams. All runs were 
performed in a column volume of 1 mL and constant feed conductivity of 4.5 mS  
cm-1 ± 0.1 
 
Figure 5.20 presents breakthrough curves obtained at linear velocities of 1 mL min-1 
for the three feedstreams, and table 5.10 compares the dynamic binding capacities 
measured at 5% and 80% of 5% breakthrough for operational purposes. Binding 
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capacity data is used industrially during process development to assess adsorbent 
performance (Staby et al., 2004). The breakthrough curves are very steep for the 
homogenate and multimodal feedstreams, indicating that virtually no Fab’ was being 
adsorbed. In this case, the highest binding capacity observed was for the 
homogenate feedstream at 6.4 g L-1 as it had the sharpest breakthrough curve 
being able to utilise the capacity of the column. There was a minor decrease in the 
binding with the addition of multimodal precipitant of 6.2 g L-1, which was reduced 
further to 5.7 g L-1 for the feed material with single mode precipitant. It is possible 
that in part the concentration of PEG 12000 has an effect on binding capacity 
possibly due to competition between several species for adsorbent binding sites. 
This may be countered by reducing the operating flowrate to increase Fab’ binding 
capacity. In addition, Fab’ is a small protein (~54 kDa) and will have a reduced 
number of binding sites relative to a full IgG protein, which in part explains the low 
binding capacity with this resin. 
 
It was observed that breakthrough curve was shallower for the feedstock with the 
single mode precipitant. This could be explained in part due to the slight 
compression of the bed observed in these experiments. Colby et al., (1996) 
suggested that the compression of the bed has no effect on the performance of the 
system, although it could result in variations in breakthrough curves. The 
compression of the bed reduces void volume resulting in premature breakthrough 
and curve development. 
 
Feedstreams 5% Breakthrough (g L-1) Adjusted 80% of 
5% Breakthrough 
(g L-1) 
Homogenate  6.36 5.09 
Multimodal 6.20 4.96 
Single mode 5.65 4.52 
 
Table 5.10: Binding capacity (g L-1) at various product breakthrough levels for 
clarified feedstock’s at 1 mL min-1 flowrate. All runs were performed with a 1 mL SP 
Sepharose Hi Trap column (GE Healthcare, Uppsala, Sweden) and constant feed 
conductivity of 4.5 mS cm-1 ± 0.1 
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Figure 5.21: Typical gradient elution peak of Fab’ (-) (clarified homogenate shown 
in this case) with SP Sepharose (GE Healthcare, Uppsala, Sweden) at 1 mL min-1. 
All runs were performed in a column volume of 1 mL and constant feed conductivity 
of 4.5 mS cm-1 ± 0.1. Gradient elution conditions were 25 mM sodium acetate/25 
mM sodium chloride pH 5 to 25 mM sodium acetate/200 mM sodium chloride pH 5 
over 15 CV (-) 
 
A gradient elution of 25 mM to 200 mM sodium chloride over 15 CV was used to 
elute bound material from the column. One mL fractions (1 CV) were taken of the 
elution volume programmed to start collecting at 100 mAu OD280 and to stop 
collecting at 100 mAu OD280 from the downslope of the peak. The strip and post 
load wash were collected in separate containers. The gradient elution 
chromatogram (figure 5.21) was typical of the elution profiles observed with all three 
feedstreams. Figure 5.21 shows the elution profile for clarified homogenate. 
 
It was observed that the loading of all three feedstreams at 1 mL min-1 had an effect 
on the pressure drop, causing the system pressure limit of 0.1 MPa to be reached 
after one CV. The system pressure limit was increased to the column pressure limit 
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of 0.3 MPa to overcome the system alarm. It is possible that the increase in the 
pressure drop is related to the accumulation of impurities at the top of the column. 
The conductivity at the midpoint at the downslope occurred in fraction 8, which was 
measured at 11.5 mS cm-1 at 23°C. This was then used to calculate a sodium 
chloride concentration of 99 mM. Subsequently, buffers with the calculated salt 
concentrations were prepared for the step elution runs (table 5.10).  
 
The three feed stocks at a concentration of 1.1 g L-1, 1.2 g L-1 and 1.1 g L-1 for 
homogenate, multimodal and single mode feedstreams were used to run a step 
elution with 25 mM sodium acetate/99 mM sodium chloride pH 5 over 10 CV. 
Therefore, 4.8 mL, 4.0 mL and 4.4 mL of each feedstock was loaded via a 10 mL 
superloop using an ÄKTA FPLC (GE Healthcare, Uppsala, Sweden), which was the 
calculated volume for 80% of 5% breakthrough. This equated to 5.1 mg, 5.0 mg and 
5.0 mg being loaded onto the column per millilitre of matrix respectively for the three 
feedstreams. 
 
Feedstreams Step 
Volume 
collected 
(mL) 
Conc  
(mg mL
-1
) 
Mass 
(mg) 
Total % 
mass  
% 
Recovery  
elution  
Final 
PF 
Homogenate  
Load 4.80 1.06 5.09 
91.4 83.7 2.5 
FT 4.80 0.06 0.24 
Wash  5.00 0.03 0.15 
Elution  10.00 0.43 4.26 
Multimodal 
Load 4.00 1.24 4.96 
90.9 77.8 4.4 
FT 4.00 0.10 0.40 
Wash  5.00 0.05 0.25 
Elution  10.00 0.39 3.86 
Single mode  
Load 4.39 1.13 4.96 
90.7 83.5 3.5 
FT 4.39 0.07 0.31 
Wash  5.00 0.01 0.05 
Elution  10.00 0.41 4.14 
 
Table 5.11: Experimental outputs for Fab’ from the three feed stocks after the step 
elutions using a 1 mL Hi trap SP Sepharose column (GE Healthcare, Uppsala, 
Sweden). Feedstreams were loaded at 80% of 5% breakthrough (table 5.9) and the 
step elution buffer used was 25 mM sodium acetate/99 mM sodium chloride pH 5    
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It was found that the percentage recovery of elution was 84%, 78% and 84% for 
homogenate, multimodal and single mode feedstreams respectively. Total mass 
accounted for was on average 90% for each of the runs. The final process 
purification factor for homogenate, multimodal and single mode feed stocks were 
2.5, 4.4 and 3.5 respectively (table 5.11). The use of multimodal precipitated 
impurities prior to a packed bed step had improved process performance by a PF of 
1.9. Therefore, this investigation of whole process interactions with material 
prepared by precipitation demonstrated the importance of reducing impurities early 
in the process that can negatively interact with subsequent operations. The results 
show how modest purification factor in the initial precipitation steps are amplified by 
interactions with subsequent operations leading to radically differing performance. 
This underlines the importance of whole bioprocess studies and scale down 
methods as a means of achieving this. The impact of which has the further potential 
to improve the longevity of chromatography resins and reducing overall downstream 
purification cost.  
 
5.6 Summary  
 
A high throughput system utilising robotic handling was developed in microwells to 
investigate conditions to increase particle size. It was found that d50 particle size 
was 313 m at low speed mixing conditions (800 rpm) with the addition of 
homogenate to PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 at 900 L s-1 
after 60 minutes of mixing.  
 
A USD system was used to mimic the shear rates found in the feed zone of a disk 
stack centrifuge in the laboratory. Good agreement of clarification was achieved 
between laboratory scale and the pilot centrifuge. Laboratory scale efficiency was 
93%, whereas the pilot scale separation efficiency was 87%.  
 
A process run through was performed with homogenate pH 7.4 (control), multimodal 
(PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4) and single mode (PEG 12000 
15% w/v pH 7.4) feedstreams. The clarification of the precipitated material was 
examined during a membrane filtration operation using an automated multiwell 
filtration technique prior to packed bed studies. Filtration experiments of three 
feedstreams were performed with Cuno Zeta Plus 30SP membrane filters (Cuno, 
Meridan, USA). This was followed by a diafiltration step to prepare material for the 
following cation exchange chromatography step. A 1 mL SP Sepharose Hi Trap pre 
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packed bed column (GE Healthcare, Uppsala, Sweden) was used to capture Fab’ 
from the three feedstock solutions. The final process purification factor for the three 
feedstreams were 2.5, 4.4 and 3.5 respectively. The use of multimodal precipitated 
impurities prior to a packed bed step had improved process performance by PF 1.9.  
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6. CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1 Conclusions 
 
The efficient purification of recombinant proteins for therapeutic applications from 
cell culture fluid has become a major bottleneck for the industry due to the 
increasingly high titers found in upstream feeds (Taipa et al., 2001). These process 
limitations are currently dominated by chromatography, which can account for more 
than 70% of downstream processing costs due to resin expenditure, throughput and 
complexity of scale up (Hahn et al., 2003). Conventional downstream processes 
such as chromatography and filtration will soon reach their limits in terms of 
economics, processing speed and scale, including labour and overhead costs 
(Bensch et al., 2007). Non chromatographic separation techniques such as 
precipitation can be used to remove impurities in cell culture fluid prior to a costly 
chromatography step. The removal of impurities prior to chromatography can be 
cost effective by improving binding capacity, reducing bed volume and buffer 
consumption, and potential for increasing the number of cycles the chromatography 
resin can be efficiently used for.  
 
Conventionally, the study of precipitation conditions will seek to design a step to 
either precipitate the target protein, leaving process related impurities in solution, or 
to precipitate the impurities and leave the target protein in solution. At laboratory 
scale, the screening of a large number of precipitation conditions to find a suitable 
window of operation may not be economically feasible due to the large amount of 
feedstream and resources required for each experiment (10-100 mL). To overcome 
this issue, developing techniques that can generate data with minimal resource 
expenditure by mimicking large scale processes can be invaluable in early 
bioprocess development.  
 
The next generation of bioprocess development will integrate microscale 
bioprocessing techniques into bioprocess development to alleviate the challenges 
facing it. Microscale platforms offer a change in bioprocess development by 
accelerating process development due to the flexibility for parallel experimentation 
and automation while requiring microscale quantities (20-2000 L) of material 
(Galaev 2005, Titchener-Hooker et al., 2008). Critical bioprocess information can be 
obtained earlier in development providing a better opportunity to understand 
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process parameters and for improved understanding of the robustness of each 
processing step. 
 
A key consideration in this approach is the compatibility of microscale platforms with 
laboratory automation, specifically the Tecan robotic platform (Tecan, Reading, UK) 
(figure 4.2) to enable large experimental design spaces to be studied. The key to 
understanding the whole of bioprocess is to enable a fundamental understanding of 
each unit operation, in this case precipitation, and their impact on subsequent unit 
operations. In this thesis, microscale techniques enabled the study of large, 
multiparameter design spaces, specifically facilitated by its high throughput and low 
volume features.  
 
6.1.1 First Major Milestone of Project 
 
1. Development of a high throughput system utilising automated 
robotic handling in 96 microwells at 1 mL scale to enable rapid 
screening of large design spaces in a Quality by Design (QbD) 
approach to integrate microscale bioprocessing techniques into 
conventional bioprocess development.  
In this thesis, the use of a Quality by Design approach outlined in ICH guideline Q8 
(R2) has been utilised. Throughout the thesis this approach was used to select 
process parameters and unit operations that impact critical quality attributes to 
create a robust scalable process. This approach utilised in industry when combined 
with the appropriate control strategy can allow for more flexible regulatory 
applications.     
 
In chapter 2, the release of Fab’ from E.coli cells is described. Cell disruption by 
continuous homogenisation was investigated using an APV Manton-Gaulin Lab40 
(APV International, West Sussex, UK) high pressure homogeniser. An increase in 
micronisation of cell debris occurred with increasing number of homogenisation 
passes, making solid-liquid separation more difficult (figure 2.6). As a result, 
maximal product release while avoiding micronisation was chosen as the criteria to 
determine the number of cycles required for future homogenisation. One pass at 
500 bar was found to be sufficient to release the maximum amount of Fab’ while 
minimising micronisation of cell debris (d50 0.30 m at 500 bar for 1 pass).  
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In chapter 3, a high throughput precipitation process utilising automated robotic 
handling was developed using 1.3 mL 96 deepwell plates (Nunc GmbH & Co., KG, 
Denmark), at 1 mL scale per well, to enable the rapid screening of a large number 
of variables in parallel using a Quality by Design approach based on ICH guidance 
Q8 (R2). 5 mm PTFE magnetic coin stirrers placed at the bottom of the deepwells 
were used for mixing. The strength of the magnets and their interference with each 
other limited throughput to 48 individual experiments on one plate.  
 
The effect of PEG on the precipitation of Fab’ was investigated in a screening study 
to identify key variables and their ranges for further study and scale up. This was 
studied using a full factorial two level Design of Experiments (DoE) approach to 
investigate yield and purification factor of Fab’ by varying PEG molecular weight, 
PEG concentration (% w/v), homogenate concentration and pH. In the range 
investigated, PEG concentration had the most influence on yield and purification 
factor, whilst pH was found to have minimal influence on yield and purification factor 
in the range investigated. A high homogenate dilution factor between 3 and 5 
negatively impacted yield and increased processing volumes whilst increasing the 
purification factor. Therefore, a trade-off between yield and purification factor was 
required, prioritising yield as the precipitation step is proposed as a primary 
purification step. An optimisation study, in the form of a central composite face 
centred (CCF) DoE was then performed. The goal was to adjust the key variables 
so that a favourable response profile with regard to Fab’ yield and purification factor 
was obtained. In this design no further constraints were placed on parameter input 
ranges (pH 5 to 9; dilution factor 1 to 5; PEG molecular weight 4000 to 20000) 
except PEG concentration which was limited to 10% to 20% w/v as it was found that 
less than 10% w/v PEG resulted in unfavourable Fab’ yield ≤ 50%.  
 
Figure 6.1 is a graphical representation of the knowledge space (within the 
unexplored space), which refers to the region of process understanding defined by 
the input boundaries of the CCF DoE. The input boundaries were PEG 4000 to 
20000, PEG concentration 10% to 20% w/v, pH 7.4 and homogenate dilution factor 
of 1. The design space is comprised of the overlap of Fab’ yield (%) and purification 
factor to give a robust region where Fab’ yield was ≥90% with a maximum 
purification factor of 1.7 within the knowledge space. However, the highlighted area 
within the design space is the proposed design space for operational simplicity. This 
is due to the use of PEG as precipitant, since at high molecular weights and 
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concentrations, the high viscosity of PEG could cause difficulties in processing at 
large scale. Therefore the normal operating range (NOR) or control space was 
defined in a way that can be “demonstrated to provide assurance of quality” (ICH 
Q8 (R2) 2009) by having the distance from the edge of the design space at ± PEG 
1000 and ± 1% w/v. This is highlighted by the dashed area in figure 6.1 within the 
highlighted area of the design space; allowing for flexibility and robustness at 
manufacturing scale since “working within the design space is not considered as a 
change” (ICH Q8 (R2) 2009). Movement out of the design space is considered to be 
a change and would normally initiate a regulatory post-approval-change process. In 
essence, the knowledge of the factors affecting Fab’ yield and purity can assist in 
the development of a process manufacturing design space which lies at the heart of 
a practical realisation of Quality by Design.  
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Figure 6.1: Proposed Fab’ precipitation design space comprised of the overlap 
region for yield (%) and purification factor created using MODDE 9.1 (Umetrics, 
Malmö, Sweden). Knowledge space refers to the region of process understanding 
based on the CCF DoE inputs. Inputs were PEG molecular weight, PEG 
concentration, pH 7.4 and undiluted homogenate. The design space is a region 
where the combination of ranges that delivers a Fab’ yield ≥ 90% with a maximum 
purification factor of 1.7. The selected area within the design space was the 
proposed design space for scale up for operational simplicity. Outside of this region, 
viscosity of PEG may become an issue at process scale and therefore the Normal 
Operating Range (NOR) was set to ± PEG 1000 and ± 1% w/v within the dashed 
area of this design space 
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6.1.2 Second Major Milestone of Project 
 
2. Developing a novel multimodal precipitation process combining 
polyethylene glycol (PEG) with ammonium sulphate, sodium citrate 
and sodium chloride for the precipitation of Fab’ and or protein 
impurities from partially clarified homogenised E.coli feedstocks.  
 
In chapter 4, mixing conditions were optimised by use of a microscale mixing 
system incorporating 96 x 5 mm PTFE magnetic coin stirrers (V&P Scientific, San 
Diego, USA). The magnets were mounted onto an acrylic plate, which would sit on 
top of a 1.3 mL 96 deepwell plate (Nunc GmbH & Co., KG, Denmark), suspending 
the coin stirrers approximately 1/6 off the bottom of each well (figure 4.3). This 
allowed use of all 96 wells in the plate increasing productivity by 50% relative to the 
previous mixing method described in chapter 3, and enabled control over the speed 
of the mixing, which enabled Power dissipation per unit volume to be used as a 
scale up parameter. 
 
The system was used to study a novel multimodal precipitation process combining 
PEG with ammonium sulphate, sodium citrate and sodium chloride for the 
precipitation of Fab’ and or protein impurities from partially clarified E.coli 
feedstocks. Each of the salts, members of the Hofmeister series are known to have 
an effect of inducing precipitation when used individually at different levels 
(Balasundaram et al., 2011). A three level full factorial DoE was designed using 
PEG molecular weight, PEG concentration (% w/v), pH, ammonium sulphate 
concentration and sodium citrate concentration. However, with salt concentrations 
greater than 0.8 M combined with PEG concentrations greater than 5% w/v, a two 
phase system was observed. This affected 40% of the design space, which was 
excluded from analysis as a two phase system was beyond the scope of this project 
(this was further discussed in section 4.5.1). 
 
An optimisation DoE (CCF DoE) was then designed to study multimodal 
precipitation of Fab’ and protein impurities, whilst reducing those variables that 
would not have a significant effect on the system based on previous experimental 
data. Input ranges were reduced to using PEG 12000, pH 7.4, and dilution factor of 
feed material of one/undiluted (the dilution of the feed material is undesirable as it 
results in large processing volumes at process scale), with ammonium sulphate, 
sodium citrate and sodium chloride concentrations over a PEG concentration range 
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between 0% to 20% w/v. The maximum total molar salt concentration in the system 
was limited to 0.6 M to prevent aqueous two phase formation between PEG and the 
salts. It was found that PEG concentration (% w/v) was the most important factor for 
Fab’ yield in the range investigated. 90% Fab’ yield with a purification factor of 1.9 
was achievable using 15% w/v PEG 12000/0.30 M sodium citrate/0.15 M 
ammonium sulphate. This was an improvement of 26% relative to the use of 15% 
w/v PEG 12000 pH 7.4 in single mode.  
 
Changes in Fab’ and total protein solubility profiles were observed with varying salt 
concentrations, for example sodium citrate was found to have a Fab’ stabilising 
effect. At ≤ 0.4 M concentrations of sodium citrate Fab’ precipitation was low, < 5% 
at pH 7.4 suggesting that electrostatic interactions dominate at this concentration 
range. The introduction of low concentrations of salt may be thermodynamically 
favourable resulting in an increase in solubility of the protein (Arakawa and 
Timasheff 1982). It is thought that this in part due to the positive interaction between 
Fab’, salt and PEG attributed in part to the binding of positively charged Fab’ via 
electrostatic interactions with negatively charged species such as micronised cell 
debris and chromosomal DNA in the homogenate which disassociates in the 
presence of salt (Balasundaram et al., (2011). It was observed that at low 
concentrations of PEG and sodium citrate, ~20% protein impurities were 
precipitated in preference to Fab’, which presented an opportunity for removal of 
protein impurities via a precipitation step (figure 6.2).  
 
Figure 6.2 is a graphical representation of the knowledge space, which refers to the 
region of process understanding defined by the input boundaries of the combination 
of the full factorial and CCF DoE with sodium citrate and PEG 12000. The input 
boundaries were 0 to 1 M sodium citrate, PEG 12000, PEG concentration 0% to 
20% w/v, pH 7.4 and homogenate dilution factor of 1. The design space, within the 
knowledge space, is comprised of the overlap of Fab’ yield (%) and purification 
factor to give a robust region where purification factor was ˃ 0.8 and Fab’ loss was ≤ 
10%. The normal operating range (NOR) or control space was defined by a 
combination of PEG and sodium citrate concentration ranges as ± 0.5% w/v and ± 
0.05 M respectively. This is highlighted by the dashed area in figure 6.2 within the 
design space to give a region of assurance of quality, flexibility and robustness at 
manufacturing scale.  
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Working within the NOR, a flow through precipitation strategy with PEG 12000 
6.25% w/v/0.4 M sodium citrate pH 7.4 (homogenate dilution factor of one) was 
used to precipitate protein impurities early in the downstream process. The 
advantage at process scale is the potential ease of processing due to removal of a 
solubilisation step and the significantly reduced viscosity of the precipitating agent 
relative to that of PEG in the NOR shown in figure 6.1. 
 
Figure 6.2: Proposed protein impurity precipitation design space comprised of the 
overlap region for yield (%) and purification factor created using MODDE 9.1 
(Umetrics, Malmö, Sweden). Knowledge space refers to the region of process 
understanding based on the full factorial and CCF DoE inputs. Inputs were PEG 
12000, PEG concentration, sodium citrate concentration, pH 7.4 and homogenate 
dilution factor of 1. The design space is a region where the combination of ranges 
that delivers purification factor ≥ 0.8 and Fab’ loss ≤ 10%. The Normal Operating 
Range (NOR) was set to as a minimum of ± PEG 0.5% w/v and ± 0.05 M sodium 
citrate concentration within the dashed area of the design space 
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6.1.3 Third Major Milestone of Project 
 
3. Scale up validation of the microscale approach to 50 mL laboratory 
scale and 5 L pilot scale for process interaction studies 
   
6.1.3.1 Particle Size Characterisation 
 
In chapter 5, the size and strength of the precipitates was evaluated by microscale 
mimics. For example, the amount of shear caused by mixing speed and the rate of 
addition of the precipitating agents are important variables affecting particle 
formation. These factors were investigated at microscale on a robotic platform and 
verified at pilot scale. This was followed by a process run through ending with a 
cation exchange chromatography step at laboratory scale. 
 
The rate of addition of precipitant, speed of mixing and mixing time were 
investigated by using a full factorial DoE with an automated robotic platform with d50 
particle size as the model output. At low mixing speed (800 rpm) and high rate of 
addition of precipitant (900 L s-1) after 60 minutes of mixing, a reduction in the 
number of small particles was observed. The d50 particle size at this condition was 
313 m for PEG 12000 6.25% w/v/0.4 M sodium citrate pH 7.4 relative to 0.30 m 
for Fab’ homogenates. Good agreement of d50 particle size was observed between 
laboratory and pilot scale.   
 
6.1.3.2 Centrifugation  
 
It was possible to incorporate a ultrascale down (USD) shear device in microscale 
studies with the aim of mimicking the impact of the high shear regions in the inlet of 
a CSA-1 disk stack centrifuge (Westfalia Separator, AG, Germany). To best mimic 
the pilot scale centrifuge, feed materials were exposed to shear rates similar to 
those found in the feed zone of the CSA-1 disk stack centrifuge prior to laboratory 
centrifugation. Good agreement of clarification was achieved between laboratory 
scale and the pilot centrifuge. The pilot scale separation efficiency was 87%. The 
same conditions at laboratory scale with material exposed to high shear, 93% 
separation efficiency was achieved.  
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6.1.3.3 Filtration 
 
The clarification of the precipitated material was investigated during a membrane 
filtration operation using an automated multiwell filtration technique prior to packed 
bed studies. The normal flow filtration method used was established by Kong et al., 
(2010). Filtration experiments of three feedstreams, namely Fab’ homogenate, 
multimodal precipitated material (PEG 12000 6.25% w/v/0.4 M sodium citrate pH 
7.4) and single mode precipitated material (PEG 12000 15% w/v pH 7.4) were 
performed with Cuno Zeta Plus 30SP membrane filters (Cuno, Meridan, USA). This 
was followed by a diafiltration step to prepare material for the cation exchange 
chromatography step.  
 
6.1.3.4 Chromatography 
 
1 mL SP Sepharose Hi Trap pre packed bed columns (GE Healthcare, Uppsala, 
Sweden) was used to capture Fab’ from the three feedstock solutions. Final 
purification factor (PF) for control (homogenate), multimodal (PEG 12000 6.25% 
w/v/0.4 M sodium citrate) and single mode precipitated (PEG 12000 15% w/v) feed 
stocks were 2.5, 4.4 and 3.5 respectively. The use of multimodal precipitated 
impurities prior to a packed bed step had improved process performance by PF 1.9. 
Therefore, this investigation of whole process interactions with material prepared by 
precipitation demonstrated the importance of reducing impurities early in the 
process that can negatively interact with subsequent operations. The results show 
how modest purification factor in the initial precipitation steps are amplified by 
interactions with subsequent operations leading to radically differing performance. 
This underlines the importance of assessing the interaction of individual processing 
steps, and the implementation of appropriate scale down models as a means of 
achieving process parameter ranging understanding. The impact of which has the 
further potential to improve the longevity of chromatography resins and reducing 
overall downstream purification cost. 
 
6.1.3.5 Final Remarks 
 
In this thesis, techniques have been demonstrated for the precipitation of Fab’ and 
protein impurities using microscale processing as an integral part of a high 
throughput and small scale mimic of large purification processes. This approach can 
be invaluable at the process definition stage of drug development when pilot scale 
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trials are unfeasible or material is scarce i.e. for high value products and limited 
feedstream availability.  
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6.2 Future Directions 
 
Future challenges to the current purification of antibody based therapeutics will be 
provided by the scale of production for these types of products (Shukla et al., 2007). 
One result of this is that in recent years, the successful increase in upstream titer, 
and challenging target molecules have resulted in the downstream process to 
become the limiting factor in the bioprocess industry (Farid 2006). After highlighting 
the outcome of the work performed in this thesis (Section 6.1) this section will 
present the necessary work in the short term and longer term in order to obtain a 
better understanding of the microscale precipitation systems developed in this work. 
 
6.2.1 Future Short Term Directions in Homogenisation 
 
Viscosity is an important property of the process stream and a significant factor in 
the optimisation of downstream processing unit operations such as homogenisation 
and centrifugation. The traditional mechanical method for cell disruption described 
in this thesis is very intense, resulting in the complete disruption of the cell. The 
subsequent release of chromosomal DNA increases the viscosity of the process 
stream significantly which will affect the efficiency of the subsequent solid-liquid 
separation step (indicated by Stoke’s Law, equation 1.5). By reducing viscosity this 
can result in significant gains in the efficiency of downstream processing unit 
operations such as centrifugation and precipitation. This presents a greater 
challenge for the selective release of product from the periplasm (Balasundaram et 
al., 2010). As a short term project for 6 to 9 months with one FTE, experiments can 
be conducted in relation to the above to reduce the viscosity of the process stream 
to improve subsequent processing steps. This has in part been investigated by 
Balasundaram et al., (2009) who reported a reduction in the viscosity of 
homogenised material by reducing chromosomal DNA with nuclease to help 
improve further downstream processing. Furthermore, lipid removal can be 
investigated to further improve the feedstream.  
 
An alternative 6 to 9 month project for the assessment of product release with one 
FTE could be the investigation of a combination of heat extraction and 
homogenisation, and by combining unit operations product release and purity can 
achieved in the same step (Balasundaram et al., 2010). For example, prior to 
homogenisation, heat could be used to weaken cell walls, which could potentially 
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reduce the homogenisation discharge pressures required for product release. A 
broad range of temperatures can be studied so that a better understanding of the 
impact of cell disruption methods can be achieved. This is to enable the analysis of 
the different process trade-offs which may emerge. However, to investigate 
alternative process strategies, a large number of variables must be evaluated, which 
can involve large amounts of material. Therefore, employing microscale techniques 
that are representative of large scale processes may be more suitable for these 
studies. 
 
6.2.2 Future Medium Term Directions in Precipitation 
 
Further limitations stem from limited tankage for buffers and the inability to increase 
large scale chromatography column diameters to beyond 2 m without encountering 
significant issues with flow distribution and packing (Low et al., 2007). It is possible 
that non chromatographic purification techniques such as precipitation will be further 
developed and improved over time resulting in a gradual evolution of the 
downstream purification platform over the next decade (Low et al., 2007). 
Precipitation has been used in the plasma protein industry to purify proteins at large 
scale. The ability to reduce the impurity burden upstream of the purification process 
is the key in reducing the complexity of downstream processing steps. Lowering the 
levels of impurities can improve loading capacity and performance of costly 
chromatography columns. To achieve this, the development, validation and 
automation of high throughput microtiter scale platforms are important for enabling 
the investigation of the large operating experimental space for precipitation based 
processes. The development of a scale down automated precipitation process 
described in this thesis has allowed the use conventional DoE, such as factorial and 
central composite designs, for the investigation of a large range of operating 
parameters to support the definition of robust operating spaces for scale up 
manufacture.  
 
As a medium term project for 2 to 4 years with one FTE, experiments are proposed 
to combine alternative polymers such as dextran with salts such as acetate and 
nitrate with zeta potential measurements to better understand precipitant 
interactions. Zeta potential describes the charge characteristics of particle surfaces, 
which can be used to determine the stability of proteins in solution, which will 
change with pH and salt content.  
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This microscale platform can be used to investigate alternative precipitation 
reagents such as acids and polyelectrolytes. A full factorial DoE to investigate these 
factors and interactions can produce over 1000 experiments. The use of sequential 
DoE can be employed to reduce experimental load, in which experiments are 
performed in a direction of improvement until the optimum is encircled. For example 
the simplex DoE method can accommodate a large number of variables with limited 
experimental runs, and does not require any assumptions with regards to the 
underlying model. Subsequent experiments are calculated by reflection towards 
improved conditions, for example to improve yield and purification factor. A simplex 
algorithm for the identification of Fab’ precipitation operating conditions was partially 
investigated by Chhatre et al., (2011) who reported 50% to 70% fewer points to the 
optimum compared to a conventional DoE approach. In essence, a simplex method 
can adjust the size of the design to further increase the rate of improvement (Box et 
al., 1978).  
 
Furthermore, the microscale platform which was developed and evaluated in 
Chapters 3 and 4 can be further assessed by applying it in the study of other 
industrially relevant feeds, such as mammalian cells and Pichia pastoris, which 
would cover a broad range of precipitation characteristics. The microscale mixing 
system described in chapter 4 for mixing in microwell plates could be used for 
mapping of these different feedstreams to mimic mixing at larger scale systems. 
Further development work for this application is needed, for example in this thesis 
the rate of addition of feed to the precipitant was kept constant throughout micro, 
laboratory and pilot scale, which resulted in increasing time of feed addition 
throughout these scales. This may have affected resultant particle size and 
strength, which will need to be further investigated. Experiments are proposed 
where the rate of precipitant addition at different scales is scaled up accordingly to 
maintain time of addition. However, achieving the full potential of microtiter 
bioprocessing techniques relies on validation methods, which can predict pilot and 
manufacturing scale performance without laboratory scale verification. The 
incorporation of a scale down shear device and laboratory centrifuge for the 
prediction of pilot scale performance in this thesis is an example of such a 
possibility.  
 
There are challenges for the implementation of analytical techniques into high 
throughput process development (HTPD). A number of assays such as BCA total 
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protein assay and host cell protein ELISA can be automated on a robotic platform 
improving throughput and reducing labour. The time scale to carry out analytical 
techniques varies considerably with assays ranging from minutes, hours to days for 
incubation and conditioning of the samples prior to read out of the assay results. 
Assays require comparative measurements for quality control at defined time points 
involving blank, standard, and control samples for calibration (Fattinger 2010). 
Some of these issues can be reduced by improving the throughput of analytical 
methods. The arrangement of the samples in a linear array facilitates “parallel 
processing and conditioning” of the samples prior to readout of the assay results. 
The integration of the samples to be analysed in this way allows for integration of 
many process steps in the assay, such as allocation of the samples, sample 
preparation, incubation and conditioning and parallel readout of the analytical 
results (Fattinger 2010). It is important to the analytical strategy that well planned 
experiments with good experimental designs are performed to avoid overwhelming 
analytical groups.  
 
In this thesis, microtiter experiments were performed with either four or eight 
channel arms dependant on the robotic platform. Tecan (Tecan, Reading, UK) have 
introduced 96 channel arms, which will be capable of utilising all 96 wells for parallel 
experiments in a single run. This is an increase in throughput by a factor of 12, 
reducing pipette delay times and will enable the implementation of high throughput 
assays such as the BCA total protein assay simultaneously with precipitation 
experiments for example. Incorporating these technologies with automated 
techniques can potentially reduce the bottleneck of high throughput development 
processes. 
 
6.2.3 Future Medium Term Directions in Chromatography 
 
Cation exchange chromatography at 1 mL laboratory scale was used post 
precipitation detailed in chapter 5. However, in terms of bioprocess development 
and the seamless integration of microscale bioprocessing techniques, the use of 
micro tip chromatography to investigate chromatography conditions is proposed as 
a medium term project for 2 to 4 years with one FTE. Chromatography is an integral 
part of the protein purification process and the capacity to use microscale 
chromatography can make an important contribution towards the development of 
robust and well characterised processes. Chromatography resins packed in micro 
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tips allows for robotic automation to mimic larger scale chromatography (Wenger 
2010). Therefore using this approach multiple types of resins such as multimodal 
resins can be scouted for favourable binding conditions successfully. For example a 
multimodal resin such as Capto MMC (GE Healthcare, Uppsala, Sweden) can have 
a high salt tolerance and its elution conditions can be varied to remove product 
variants and aggregates, which may improve performance over traditional ion 
exchange resins such as SP Sepharose (GE Healthcare, Uppsala, Sweden) used in 
this thesis.        
 
6.2.4 Future Long Term Directions in Bioprocess Development 
 
Microscale techniques can shorten bioprocess development timelines by the early 
integration of these methods. These methods are used to acquire information to 
understand how best to implement control strategies that enable regulation of 
manufacturing operations, thus supporting validation package submissions when 
registering a process. The ability to understand how design parameters affect 
processes can provide information in how to operate at full scale. This capability is 
the practical basis on which Quality by Design is realised. In the long term 
microscale based research that seeks to mimic larger scale processes will be 
implemented throughout the whole of bioprocess development. For example, 
microscale data for fermentation process in terms of cell growth, product titer, and 
metabolite profiles have shown to be comparable to those obtained at pilot scale 
(Zhang et al., 2007). The integration of microwell fermentation and cell culture 
operations will provide a resource for accelerated selection of cell hosts, expression 
systems, and conditions for growth with an additional consideration of processing 
implications. Adopting such an integrated approach to the whole of process 
development is becoming of greater importance as the recovery capacity of 
downstream processes are struggling to keep up with the rapid improvements in 
yield being achieved upstream (Tait et al., 2009). Additionally, the same engineering 
principles have been shown previously for downstream processes such as 
centrifugation by Hutchinson et al., (2006) and have been applied to 
chromatography (Wenger 2010). 
 
A proposed integration of microtiter techniques based on a Quality by Design 
approach is shown in figure 6.3 using precipitation as an example. The results of 
microscale experiments are verified at laboratory scale with appropriate risk 
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management taken throughout the process stages (ICH guidelines Q8 (R2) and 
Q9). This is followed by scale up to pilot and manufacturing scales by providing a 
model for quality that can be implemented throughout product life cycle (ICH 
guideline Q10).        
 
 
 
Figure 6.3: Proposal for the integration and validation of microscale techniques into 
process development to facilitate QbD process development. Precipitation 
methodology as described in this thesis was used an example 
   
However, there are limitations to high throughput process development (HTPD) and 
some applications are difficult to scale. For example, HTPD systems as a scale 
down model for a chromatography step further downstream presents significant 
challenges, as there are many dynamic phenomena active in process columns that 
do not scale well from batch binding and single stage HTPD systems (Fattinger 
2010). It has been suggested that by the next decade purification development 
HTPD will connect with multiple platform processing, such as multimodal protein 
conjugation (to toxins, or PEG) and chromatographic modelling, to accelerate 
process development.  
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A key focus of continued technology development efforts is to template as many 
parameters as possible for each unit operation. Improved understanding and 
refinement of the fundamentals microscale process development is an important 
area of future work (Shukla et al., 2007). HTPD can be useful for emphasising 
concepts central to precipitation, chromatographic separations, experimental design 
and scale up (Kelly and Lester 2010). However, the complexity of biotech products 
and processes makes complete characterisation a challenge.  
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